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Summary
There have been phenomenal advances in the field of reproductive medicine and success
rates following in vitro fertilisation have improved dramatically in recent years.
The aim of this project was to improve our understanding of human preimplantation embryo
development by identifying potential markers of viability that may aid us in selecting the best
embryo for uterine transfer in the clinical embryology laboratory.
Investigations into the distribution of cytoskeletal F-actin in human embryos demonstrated
that a highly organised actin cortex is important for embryo cleavage and continued
development to the blastocyst stage. Whilst they are polarised in the mouse from the oocyte
to the blastocyst, the regulatory proteins leptin and STAT3 are co-localised only at the oocyte
stage in humans, and are distributed within different cytoplasmic domains in human cleavage
stage embryos and blastocysts. Whether polarity in humans is predetermined in the oocyte
remains elusive, but none of the evidence generated in this thesis supports this idea.
Leptin transiently activates STAT3 via the long form of the leptin receptor, and most
significantly in the ICM of human day 6 blastocysts. Morphological features of blastocysts
that can be visualised microscopically, such as a double ICM and cytoplasmic projections
connecting the ICM to the TE, provide clues to their viability and may help us to choose the
most suitable embryo from a cohort when deciding which to transfer. Nuclear volumes may
in future contribute to this selection.
Using time lapse technology to study cleavage patterns is now a routine occurrence in the
clinical embryology laboratory. The results in this thesis show that distinctive patterns of
divisions and the site at which blastocysts hatch can provide us with more information than a
snap-shot morphological evaluation.
Finally, contributing to the development of modelling software and predictive algorithms for
the study of human embryos, particularly in time lapse imaging, means that our
understanding of this fascinating area of medicine will continue to progress.
[33]
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Chapter One
General Introduction
1.1 Infertility
Infertility, defined as the inability to conceive after regular unprotected intercourse
for a period of twelve months or more (De Melo-Martin 2002; WHO), affects around
one in seven UK couples, a situation that has remained largely unchanged since the
first investigations began during the 19th century (Evers 2002). While the prevalence
of the condition has not significantly altered since statistics were first published
around 30 years ago (Hull et al 1985), the number of people seeking help for fertility
problems has increased (NICE 2013). Primary infertility describes a delay in
conception with no previous pregnancies, whilst secondary infertility means
successful conception has previously occurred, regardless of whether the pregnancy
resulted in a live birth (Taylor 2003). Primary and secondary infertility may relate to
individuals or to a couple. The aetiology of infertility varies greatly, with the
National Institute for Health and Care Excellence (NICE) estimating male factors at
30% combined female factors at 45%, and unexplained factors at 25% (NICE, 2014).
However, published research data estimates male factor infertility at 17%, female
factors at 49-72%, and unexplained infertility at 12-32% (Haxton and Black 1987;
Kuivasaari-Pirinen et al 2012). These discrepancies are likely to be due to the
specific patient populations included in clinical research, which are frequently
conducted at fertility centres and therefore may show population bias. The
underlying cause of infertility reportedly has no influence on first trimester
[35]
pregnancy loss after intracytoplasmic sperm injection (ICSI) (Bahceci and Ulug
2005), although female factors specifically contribute to a higher risk of preterm
birth, and male factors to an increased chance of neonatal intensive care admission
(Kuivasaari-Pirinen et al 2012).
1.2 Assisted reproductive treatment
There have been marked improvements in success rates during recent years.
Reasons for this may include the introduction of ICSI into routine clinical practice
(Palermo et al 1992), and the current trend towards extended culture of embryos to
the blastocyst stage of development (5-6 days after fertilisation) in specially
formulated sequential media (Gardner and Lane 1998). In vitro fertilisation (IVF)
treatment has expanded at a phenomenal rate since the birth of Louise Brown in
1978 (Steptoe and Edwards 1978; Wang and Sauer 2006). However, human assisted
reproductive treatment (ART) is still relatively inefficient; with live birth rates
approximating 32% in women <35 years to 2% in women aged ≥45 years, according 
to the most recently published data from the HFEA. The ultimate aim for clinical
embryologists is to identify the single most viable embryo from an available cohort,
with a view to achieving a healthy singleton pregnancy and live birth for every
patient (Montag et al 2013).
There are two predominant modalities of ART utilised in clinical embryology
laboratories, namely standard IVF and ICSI. IVF has been successfully used in
humans since the 1970s (De Kretzer et al 1973; Steptoe and Edwards 1976; Steptoe
and Edwards 1978), whilst ICSI, a treatment specifically aimed at treating male
infertility due to low sperm numbers or quality, was introduced into clinical practice
[36]
in the early 1990s (Palermo et al 1992). In the UK, 224,196 babies were born as a
result of ART between 1991 and 2012, and in 2011 2.2% of all UK newborns were
conceived following ART (HFEA 2012). It is estimated that at least 5 million babies
have been born worldwide as a result of ART to date (Kamel 2013).
1.3 Oocyte maturity
In order for an oocyte to achieve the ability to become fertilised, it must first reach
maturity. The dormant oocyte, suspended at prophase of the first meiotic division
during foetal life, proceeds to metaphase I and completes anaphase and telophase,
entering metaphase II just prior to ovulation (Cha and Chian 1998). The prophase I
oocyte is characterised by the presence of a large nucleus, the germinal vesicle
(GV), located eccentrically in the ooplasm, whilst the metaphase I stage oocyte is
identifiable by the lack of both a visible GV and a visible polar body (PB). Metaphase
II oocytes have a visible PB in the perivitelline space (PVS), a result of extrusion of
half of the maternal genetic material at the first meiotic division. At this stage,
homologous chromosomes are paired (Mandelbaum 2000). This entire process is
initiated and controlled during clinical ART procedures by manipulating the
menstrual cycle and inducing oocyte maturation using hormonal medication, as
detailed in section 2.3 of this thesis. Oocyte maturity is normally assessed using light
microscopy following the removal of the surrounding cumulus cell complexes using
digestive enzymes prior to ICSI, as described in section 2.3, or after co-incubation
with spermatozoa, as described in section 2.4.
Whilst the aim of a controlled ovarian stimulation regime is to induce oocyte
maturation prior to follicular aspiration, in vitro oocyte maturation (IVM) is an
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alternative method, most commonly employed when a minimal stimulation ART
protocol is favoured, such as for oncology patients or women with pre-diagnosed
polycystic ovaries who are at increased risk of ovarian hyperstimulation syndrome
(OHSS) (Chang et al 2014). Since the first report of a live birth following IVM (Cha et
al 1991) there has been variable success with in vitro matured human oocytes
(Roesner et al 2012).
Previously published data identified a link between exposure of mouse oocytes to
high concentrations of Follicle-Stimulating Hormone (FSH) during IVM, and an
increase in chromosomal abnormalities (Roberts et al 2005). A comparison of the
developmental potential of in vitro versus in vivo matured mouse oocytes
determined that fertilisation rate, synchronous cleavage, and blastocyst
development were adversely affected by in vitro oocyte maturation, and that
abnormalities in cellular symmetry and nuclear morphology were also apparent
(Sanfins et al 2015). Furthermore, the developmental incompetence of human
oocytes matured in vitro is thought to relate to dysfunctional gene transcription or
modification of genes post-transcription, which may disrupt normal gene utilisation,
thus affecting the development of embryos derived from these oocytes (Jones et al
2008). This may also contribute to the low efficacy of human in vitro fertilisation,
since some oocytes aspirated from the ovary during clinical IVF cycles will undergo
final maturation spontaneously in vitro from MI to MII, in the time period between
collection and insemination.
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1.4 Human fertilisation and preimplantation embryo development
Standard IVF usually involves the co-incubation of oocytes and spermatozoa for a
period of 16-18 hours, although reduced gamete incubation times of ~2 hours may
improve the number of top quality embryos available, the clinical pregnancy rate,
and the implantation rate in women ≤30 years (Li et al 2016). Prior to ICSI, cumulus
cells surrounding the oocyte are enzymatically digested and mechanically removed
in order to ascertain the maturity of the oocyte. A single spermatozoon is
immobilised and injected into the ooplasm of mature oocytes in an area away from
the first extruded PB, to minimise the chance of damaging the meiotic spindle,
which is purported to reside in the same hemisphere as the first PB (Hardarson et al
2000; Woodward et al 2008). Interestingly, despite injecting oocytes with the PB at
the 12 o’clock position, approximately 10% of metaphase spindles may contain
decondensed sperm heads (Flaherty et al 1998), suggesting that the position of the
spindle does not always correspond with the location of the first PB. Visualising the
meiotic spindle in oocytes using polarised light microscopy prior to injection
resulted in significantly higher normal fertilisation rates, percentage of early
cleaving embryos, and implantation rates when compared to oocytes that were
injected without prior spindle visualisation (Madaschi et al 2008).
Fertilisation is defined as the combining of male and female chromosomes following
penetration of the oocyte by the spermatozoa, resulting in the formation of a
zygote (Plachot 2000). Normal fertilisation is evidenced by the appearance of two
extruded PB in the PVS, and two centrally located abutting pronuclei (PN) in the
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ooplasm 16-18 hours post-insemination (Nagy et al 1994). Abnormal
multipronucleate (MPN) fertilisation occurs in approximately 7% of zygotes derived
from standard IVF (Englert et al 1986) and approximately 4% of zygotes resulting
from ICSI (Grossman et al 1998), and is characterised by the presence of three or
more PNs in the ooplasm of oocytes 16-18 hours post-insemination. MPN formation
following IVF is thought to occur most commonly due to polyspermy (diandric)
(Englert et al 1986) and following ICSI due to retention of the second PB (digynic)
(Grossman et al 1998). Stimulation regimes <10 days have been found to increase
the incidence of tripronucleate fertilisation after ICSI, and a higher rate of MPN
formation within a cohort of zygotes is a significant predictor of reduced
implantation following transfer of an embryo originating from a normally fertilised
zygote (Rosen et al 2006). The majority of triploid conceptuses spontaneously abort
early in pregnancy, and account for ~10% of all miscarriages (Hassold et al 1980),
however it is possible for triploid embryos to develop to term, giving rise to babies
with severe disabilities which are incompatible with life (Sherard et al 1986).
Examples of normally and abnormally fertilised zygotes are shown in figure 1.1.
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(a)
(b)
Figure 1.1: (a) normally fertilised oocytes with two pronuclei and two
extruded polar bodies (b) abnormally fertilised oocyte with three
pronuclei and one extruded polar body.
The extrusion of the second polar body is thought to occur by 8 hours post-
insemination for IVF oocytes and by 4 hours post-injection for ICSI oocytes (Nagy et
al 1998). The apposition of the male and female PNs in the centre of the ooplasm
precedes the assembly of the parent chromosomes on the mitotic spindle of the
zygote prior to the first cleavage division (Plachot 2000).
The morphology of the PN has been suggested as a predictor of embryo quality, and
successful pregnancies have been achieved following the transfer of day 1 zygotes
(Scott and Smith 1998). Likewise, superior morphology PN are reportedly
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significantly more likely to develop into good quality blastocysts (Scott et al 2000).
The fusion and disappearance of the pronuclei following breakdown of the nuclear
membranes approximately 6 hours after they first appear in the ooplasm is termed
syngamy (Papale et al 2012).
Cleavage of the zygote into two distinct blastomeres 25-27 hours post insemination
or injection is associated with a significantly higher proportion of good quality
embryos, significantly higher blastocyst development rate, and increased
pregnancy, implantation and live birth rates (Lundin et al 2001; Van Montfoort et al
2004). Indeed, this method of predicting which embryo has the highest
implantation potential is hailed as superior to pronuclear scoring (Brezinova et al
2009). Several studies have confirmed early cleavage as a predictor of embryo
viability leading to an improvement in pregnancy rates (Shoukir et al 1997; Sakkas
et al 1998; Sakkas et al 2001; Lundin et al 2001; Lee et al 2012), and early cleavage
assessments can be performed in the laboratory rapidly with a simple microscopic
evaluation causing minimal disruption to the embryo culture system. Therefore,
early cleavage checks are considered a highly valuable inclusion into routine embryo
morphology scoring procedures.
The expected timeline of human preimplantation embryo development following
fertilisation has been established over many years via observations in research and
clinical laboratories (Niakan et al 2012). Embryos may begin to divide into two cells
as early as 24 hours post-insemination (Van Montfoort et al 2004), with normally
developing embryos cleaving to four cells by the morning of day 2, and eight cells by
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the morning of day 3 (Alpha Scientists in Reproductive Medicine and ASHRE Special
Interest Group in Embryology 2011), as shown in figure 1.2.
(a)
(b)
(c)
Figure 1.2: Cleavage stage embryos (a) 2-cells (b) 4-cells (c) 8-cells
Evaluation of cleavage stage embryo quality takes into consideration the symmetry
of each blastomere and the degree of fragmentation within the confines of the zona
pellucida (ZP) (Hardarson et al 2001), as described in section 2.7. Poorer quality
cleavage stage embryos are associated with the subsequent development of a
significantly higher percentage of poor quality and chromosomally abnormal
blastocysts (Hardarson et al 2003). Compaction of distinct blastomeres into a
cohesive mass of cells, the so-called morula, is expected to begin on day 4 post-
insemination (Prados et al 2012), as shown in figure 1.3.
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Figure 1.3: Compacting embryo (morula)
The next phase of preimplantation embryo development, namely cavitation and
expansion of the blastocoel, should occur by day 5 post-insemination, as described
in section 2.7. The formation of a blastocyst, the final stage of preimplantation
embryo development and differentiation, will only occur following the activation of
the embryonic genome, itself a pre-requisite for implantation (Dey et al 2004).
Figure 1.4 shows examples of a cavitating embryo, an early blastocyst, and a fully
expanded hatching blastocyst.
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(a) (b)
(c)
Figure 1.4: (a) cavitating embryo (b) early blastocyst (c) fully expanded
hatching blastocyst
Blastocyst culture is used as an additional selection tool at a time when the uterus is
at its most receptive to implantation. The blastocyst stage is considered to be the
time at which the embryo and the endometrium are most physiologically
synchronised (Maheshwari et al 2016). Extended culture to the blastocyst stage
(day 5-6 post insemination) is becoming more commonplace clinically, and is
associated with an increase in pregnancy and implantation rates (Gardner et al
1998), but only when laboratory culture conditions are optimised. It is thought that
the prolonged culture period allows the selection of the most developmentally
competent embryos for transfer (Schwarzler et al 2004) since many embryos will
not survive the transition to a blastocyst, and will therefore be removed from the
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pool available for transfer. Additionally, there is a window of implantation in
humans that opens six days after ovulation, and remains open for a maximum of
four days (Wilcox et al 1999).
Current blastocyst grading systems examine the morphological appearance of the
cells of the trophectoderm (TE) and inner cell mass (ICM), along with the extent of
expansion of the fluid-filled cavity known as a blastocoel (Gardner et al 2000).
Desirable features include a TE made up of many tightly-packed cells, a distinct
peripherally located ICM, and a fully expanded blastocoelic cavity (Van den Abbeel
et al 2013). There are many studies of blastocyst culture, with diverse outcomes;
however, meta-analysis of clinical trials indicates an advantage of blastocyst culture
in terms of pregnancy rate. For example, a study by Kalu et al observed that transfer
of a single day 5 blastocyst yielded pregnancy rates of 59.0% in women aged ≤37 
years, whilst transfer of two blastocysts in the same group resulted in pregnancy
rates of 60.7%. The multiple birth rates in each group were 2.3% and 47.6%
respectively (Kalu et al 2008). In the same study, women between the ages of 38-43
years having a single blastocyst transferred achieved a live birth rate of 29.4%,
whilst those who had two blastocysts transferred had an overall live birth rate of
44.3% (Kalu et al 2008), indicating that while present selection methods are
certainly a valuable tool in identifying the most viable embryo for transfer, there is a
definite need for improvement if we are to reduce the incidence of multiple
pregnancies by moving towards single embryo transfer, without affecting the
success rates of IVF. This ideal may be realised with more informed morphological
evaluation of blastocysts with regard to ICM and TE appearance. The shape and size
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of the ICM in expanded day 5 blastocysts has been positively correlated with
implantation rates, with slightly oval larger ICMs being more likely to implant than
rounder and elongated smaller ICMs. Interestingly, blastocysts that fully expanded
on day 6 post-insemination generally had smaller, more elongated ICMs (Richter et
al 2001). Similarly, a blastocyst diameter of >190µm on day 5 was associated with
an increase in clinical pregnancy rates, whilst smaller blastocysts and those
expanding on day 6 were predictors of reduced clinical pregnancy (Shapiro et al
2008). Additionally, higher cell numbers in the ICM and TE of frozen-thawed
blastocysts have been related to superior morphological quality (Matsuura et al
2010). In contrast to the findings of Richter et al (2001), the cell number of the TE
combined with the quality of the cells has been recently shown to be a significant
predictor of pregnancies that progress to live birth, however the shape and size of
the ICM was not found to be related to pregnancy and implantation rates (Ebner et
al 2016). Interestingly, whilst superior ICM and TE morphology have been confirmed
to be strongly indicative of viability, the expansion and hatching stage of blastocysts
has been previously identified as the most significant predictor of live birth (Van
den Abbeel et al 2013).
Complete hatching of the blastocyst from the ZP is a prerequisite for implantation
(Ren et al 2013). Since it is not feasible, from either a practical or ethical point of
view, to study the process of human preimplantation embryo hatching in vivo,
research is restricted to animal models and in vitro studies. In humans, progressive
expansion and an accumulation of fluid in the blastocoelic cavity leads to a 2- to 3-
fold increase in volume, an increase in internal hydrostatic pressure, and thinning of
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the ZP (Sathananthan et al 2003), following which the blastocyst herniates through
one or more breaks in the ZP. It is hypothesised that “zona breaker” cells, distinct
plump TE cells with secretory vesicles and micronuclei that gather around the
hatching site, may aid in this process by interacting with the ZP, suggesting that a
chemical element exists in the process of hatching in vitro (Sathananthan et al
2003). Failure of the blastocyst to hatch may be due to hardening of the ZP or to
suboptimal culture conditions (Sathananthan et al 2003). Hardening of the ZP in
fertilised bovine oocytes in vitro is characterised by an increase in the stiffness of
the ZP, with a concomitant increase in resistance to digestion by proteolytic
enzymes (Papi et al 2010). Transfer of spontaneously hatched human blastocysts
resulted in significantly higher live birth rates when compared to non-hatched
blastocysts, with no increase in multiple gestation rates (Chimote et al 2013).
Assisted hatching (AH) involves artificially creating breaks in the ZP using
mechanical or chemical processes, to aid the escape of the blastocyst in preparation
for implantation, prior to uterine transfer (Sallam et al 2003). Laser-assisted
hatching of frozen-thawed human embryos resulted in significantly higher
implantation and clinical pregnancy rates when compared to non-hatched embryos;
however there was a simultaneous significant increase in multiple gestations
(Balaban et al 2006). This concurs with an earlier study, in which one of the risk
factors for a monozygotic pregnancy was AH (Abusheika et al 2000). The site at
which the artificial opening is made in relation to the position of the ICM reportedly
has no significant influence on clinical pregnancy, implantation, or live birth rate
(Ren et al 2013), although complete hatching of the blastocyst may be significantly
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more likely to occur when the ZP breach is nearer to the ICM (Miyata et al 2010).
Murine blastocysts are thought to initiate hatching in vitro at the mural TE under
the influence of proteolytic enzymes (Perona and Wassarman 1986). Studies of
hamster blastocysts have shown that blastocyst hatching in vivo involves the
uniform thinning and disappearance of the ZP, in contrast to those hatching in vitro,
where focal lysis of the ZP occurred, followed by escape of the blastocyst, with a
comparative time delay of ≥29 hours. The authors concluded that uterine 
contributions are likely to be a factor in hamster blastocyst hatching in vivo, and
that the behaviour of in vitro cultured blastocysts was markedly different (Gonzales
and Bavister 1995), a finding similar to that in early bovine studies, which seemed to
suggest that factors controlling the digestion of the ZP in vivo differed from those in
vitro (Wright et al 1976).
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1.5 Implantation
The ultimate evidence of embryo competence is implantation and development. In
humans, implantation begins when the blastocyst assumes a fixed position, with the
inner cell mass orientated towards the uterine epithelium (Bischof and Campana
1996). Hatched human blastocysts attach to and invade human endometrial stromal
fibroblasts with the ICM apposed to the cell layer, indicating that attachment is
mediated via the polar trophectoderm (Carver et al 2003). For successful
implantation to occur, the endometrial lumen epithelium must acquire the
transient receptivity required to accept a hatching blastocyst (Dey et al 2004), with
the trophoblast invasion eliciting a decidual response. Implantation is initiated
when the trophoblast cells of the hatched blastocyst attach to the luminal
epithelium of the receptive endometrium, and stromal cells at the site of
attachment proliferate and differentiate. This process is known as decidualisation,
and is essential to promote development of the placenta and foetus (Abrahamsohn
and Zorn 1993). Implantation is a fundamental event in the establishment of
pregnancy, and would be impossible without the differentiation of the
endometrium via oestrogen and progesterone into a receptive state. This is
hypothesised to represent a natural selection process whereby the endometrium
acts as a biosensor for developmentally incompetent embryos, rejecting those that
have arrested and are therefore incapable of implanting (Teklenburg et al 2010).
This idea appears to be supported by the findings that decreased levels of the
decidual marker prolactin, in association with increased levels of implantation
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promoter prokineticin-1, were observed in endometrial biopsies of women suffering
from recurrent pregnancy loss. It seems that defective maternal-embryonic
communication due to impaired decidualisation results in a disruption of the natural
selection capacity of the endometrium, which may facilitate implantation of non-
viable embryos, yet culminate in spontaneous abortion (Salker et al 2010). Embryos
entering the undifferentiated uterus will not implant (Catalano et al 2005). In
humans, this response is under cyclic maternal control and occurs spontaneously,
thus if no embryo is available to implant, menstrual shedding results.
Whilst assisted reproductive technologies have vastly increased our understanding
of human preimplantation embryo development, implantation remains the limiting
factor in the achievement of a successful pregnancy in many cases (Fatemi and
Popovic-Todorovic 2013). The failure to achieve a pregnancy following three cycles
of IVF with embryos transferred may be considered a case of recurrent implantation
failure (Margalioth et al 2006). The process of blastocyst attachment to the
receptive endometrium is summarised in figure 1.5.
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Figure 1.5: Human embryo implantation in utero (A) Endometrium
proliferates under estrogen enhancement. (B) Progesterone from
luteinized follicles leads to endometrial differentiation. (C) The blastocyst
enters the uterus through the ostia and rolls freely over the endometrium
under signals by L-selectin. (D) Mucin-1(MUC-1) repels the blastocyst and
prevents its adhesion to endometrial areas with poor chances of
implantation. (E) Chemokines and cytokines attract the blastocyst to the
optimal implantation spot. (F) Adhesion molecules (e.g. integrins and
cadherins) firmly attach the blastocyst to the endometrial pinopods to
ensure further successful implantation (Achache and Revel 2006)
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1.6 Implantation models
In vitro, the initial stages of in vivo implantation can be modelled to assess
interaction between the blastocyst and the uterus, which may involve culturing
human blastocysts with substrate containing endometrial stromal cells, or on an
extracellular matrix such as Matrigel, a commercially available gel containing similar
structural proteins and growth factors to the endometrial matrix (Ghaffari Novin et
al 2007). Early studies involving the co-culture of mouse embryos with Matrigel
found that significantly higher numbers of blastocysts reached the hatching stage
when cultured with Matrigel, as compared to culture with medium alone (Carnegie
et al 1995). Similarly, in human studies, a significantly higher percentage of embryos
developed into blastocysts and proceeded to hatch when cultured with Matrigel-
supplemented medium, in comparison with those cultured in medium alone
(Ghaffari Novin et al 2007).
1.7 Optimisation of the culture system
Optimisation of the embryo culture system is crucial if human preimplantation
embryo development is to be supported and maintained to the hatching blastocyst
stage, in order to achieve the best possible clinical outcomes. Early culture media
were based upon simple balanced salt solutions, supplemented with glucose and
phosphate. However, with increasing understanding of human embryo nutritional
and energy requirements, more complex media containing amino acids, EDTA,
vitamins and antibiotics were developed (Mantikou et al 2013). The varying
metabolic requirements of embryos at different developmental stages, namely
pyruvate at the cleavage stage and glucose at the blastocyst stage, caused difficulty
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with finding single media to support the development of competent blastocysts
(Hardy et al 1989; Gardner 1998). Sequential media systems, which provided the
developing embryo with tailored substrates according to the metabolic needs at a
particular stage of development, were subsequently produced and introduced into
clinical practice (Gardner and Lane 1998). The rationale behind the development of
sequential media was the fact that, in vivo, the developing human preimplantation
embryo experiences exposure to vastly differing secretory regions in the female
reproductive tract (Schultz and Heyner 1993; Bavister 1995). Supplementation of
culture medium with granulocyte-macrophage colony-stimulating factor (GM-CSF)
resulted in a significant increase in the clinical pregnancy rate in women >35 years
(Zhou et al 2016).
A systematic review of commercially available culture media discovered that very
little high quality research has been conducted into the selection of media to use in
the clinical embryology laboratory (Mantikou et al 2013), and the brand of media
used is widely empirical, perhaps a historical decision, or based upon value for
money (Bavister 1995). Additionally, despite fears regarding the health of children
born following ART, neither the brand of culture medium used nor the duration of
culture (3 versus 5 day post-insemination) has been shown to influence the
birthweight of live born singletons (De Vos et al 2015).
Recently, single-step culture media systems, which support development from the
zygote to the blastocyst, have emerged as an alternative for use in the clinical IVF
laboratory. Benefits of using a single-step media system, particularly when the
medium is used as intended without refreshing for the entire incubation time,
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include minimal disruption of the embryos during the culture period, along with
cost-saving and a decrease in the laboratory workload due to lower usage of
consumables and eliminating the need to transfer embryos from one medium to
another during the culture period. The blastulation rates using single-step media
are comparable to those achieved using sequential media systems (Machtinger and
Racowsky 2012). The principle behind single step medium is to “let the embryo
choose”, that is to provide all nutrients and energy substrates in one medium, and
allow the embryo to utilise as necessary, according to the requirements at each
developmental stage (Biggers 2001). Studies have shown an increase in blastocyst
development during single-step uninterrupted culture, and comparable
implantation and pregnancy rates to embryos cultured in sequential media systems
(Stout et al 2013). The use of single-step media as an adjunct to uninterrupted time
lapse monitoring in the clinical embryology laboratory may aid in the reduction of
stress experienced by the developing embryo.
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1.8 Multiple pregnancy
The inefficiency of IVF treatments in the early days prompted many clinics to adopt
a multiple embryo transfer strategy (Martikainen et al 2001), resulting in a
concomitant increase in multiple pregnancies. Initially, this was viewed by clinicians
as necessary and by patients as an added bonus (Child et al 2004); however
tolerance of the consequent high rate of multiple pregnancies has now waned due
to increasing evidence about the adverse consequences associated with twin and
higher order gestations (Gerris et al 1999). Multiple gestations remain the single
most problematic outcome of in vitro fertilisation treatments, with associated
medical, social, and financial consequences to consider (Templeton and Morris
1998; Chambers et al 2007). Twins are associated with a neonatal mortality rate
seven-fold higher than singletons, along with a six-fold increase in the incidence of
cerebral palsy (El-Toukhy et al 2006) whilst higher rates of miscarriage, pregnancy-
induced hypertension and pre-eclampsia, ante-partum haemorrhage, gestational
diabetes, operative delivery, maternal morbidity and prematurity, are additional
maternal and perinatal complications commonly reported in multiple pregnancy
(Kalu et al 2008). Furthermore, these problems are exacerbated with each
additional foetus in utero (Min et al 2010). The increased financial burden and social
consequences of multiple births on the healthcare system, the parents and existing
children in the family must also be taken into consideration (Shenfield et al 2003).
Interestingly, the risk of pre-term birth in women ≥35 years decreases in 
comparison with younger women following IVF treatment, in both singleton and
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twin pregnancies (Xiong et al 2014). However, risk factors for monozygotic twin
pregnancies following ART include female age at treatment ≥35 years (Abusheika et
al 2000) and prolonged in vitro culture of embryos (Vaughan et al 2016).
The incidence of monozygotic twin pregnancies following IVF treatment is
significantly higher than that reported in natural conceptions, the incidence being
around 0.4% in natural conception (Abusheika et al 2000; Saito et al 2000). Whilst
the underlying mechanism for monozygotic multiple gestations is clear, the splitting
of a single preimplantation embryo, the speculative causes of this are varied. The
incidence of monozygotic multiple gestations in ART has been previously reported
at up to 8.9% (Abusheika et al 2000). One theory suggests that artificially breaching
the ZP via chemical or mechanical means may impair the ability of the blastocyst to
hatch normally, causing division of the ICM into two (Cohen et al 1990). Indeed,
those patients requiring preimplantation genetic diagnosis (PGD) were deemed at
higher risk of monozygotic twinning, even higher than those specifically opting for
AH (Vaughan et al 2016). The occurrence of monozygotic multiple pregnancy after
ICSI is increased substantially in comparison to IVF (7.2%-8.9% versus 0.9%-1.5%
respectively), which may be related to the breach of the ZP at the time of
microinjection (Abusheika et al 2000; Saito et al 2000). A quadruplet pregnancy
after transfer of a single day 4 embryo which had been biopsied on day 3, and a
triplet pregnancy following transfer of a single day 5 blastocyst have been reported
(Saravelos et al 2016), providing further evidence of an association between
monozygotic higher order pregnancies, ZP manipulation and prolonged in vitro
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culture. Both of the pregnancies reported were selectively reduced, providing yet
another reason to avoid multiple gestations wherever possible.
Studies in the mouse have demonstrated that double ICMs may form after IVF,
which are capable of continuing to develop and form trophoblastic outgrowths. The
incidence of double ICMs in the in vitro cultured blastocysts was greatly increased in
comparison with the in vivo derived blastocysts (3.1% and 0.6% respectively),
indicating that in vitro culture may predispose to monozygotic twinning via this
mechanism (Chida 1990). A human monozygotic triplet pregnancy has been
reported after transfer of a blastocyst with two inner cell masses (Meintjes et al
2001), suggesting that such blastocysts should be avoided if possible when selecting
prior to uterine transfer. Perhaps the most curious finding in the investigation of
monozygotic twin pregnancies has been the discovery of a clustering pattern, with
an increase in such pregnancies during the last six months of the calendar year
(Vaughan et al 2016). This is a remarkably under-researched area, and further
studies into the potential causes of increased incidence of monozygotic twinning
after ART are necessary, particularly if morphological clues exist that can be
microscopically identified in the clinical IVF laboratory, thus aiding us in the
selection of embryos prior to uterine transfer.
1.9 Single embryo transfer
The introduction of the HFEA Multiple Births Minimisation Strategy in 2009 meant
that clinics were required to find ways in which to reduce the incidence of multiple
gestations whilst maintaining acceptable pregnancy rates. There has been a major
shift towards single embryo transfer (sET) in the last 15 years or so, with a view to
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reducing the incidence of multiple gestations (Gerris et al 1999; Gerris and Van
Royen 2000; De Neubourg et al 2002; Hamberger and Hardarson 2003; Pandian et
al 2005). In our clinic, sET is currently performed in ~80% of fresh treatment cycles,
with a multiple pregnancy rate of ~4%, a figure comparable with previously
published data (Martikainen et al 2001). Success rates have steadily increased, and
it is now recommended that sET should always be the preferential option for
women with a good prognosis for pregnancy, having two or more good quality
embryos, aged 37 years or younger in the initial fresh cycle, and any subsequent
frozen cycles (Min et al 2010). A significant increase in the clinical pregnancy rate
and a significant decrease in the multiple pregnancy rate after day 5 blastocyst sET
in good prognosis patients (four top quality embryos on day 3) has been previously
reported (Khalaf et al 2008). Furthermore, the live birth rate after sET has recently
been reported as 52%, with a multiple birth rate of 6% in women aged between 18-
38 years (Bensdorp et al 2015)
1.10 Embryo cryopreservation
The increase in elective sET has led to a simultaneous increase in the number of
good quality supernumerary preimplantation embryos being cryopreserved for use
in future treatment cycles (Stokes et al 2007), with pregnancy results comparable to
those attained after fresh embryo transfer. Certainly, cumulative pregnancy rates in
women aged 25-37 years who had a frozen blastocyst replaced if the corresponding
fresh cycle was unsuccessful were higher than those achieved after transfer of two
fresh blastocysts (Kalu et al 2008). Indeed, a significantly higher implantation and
clinical pregnancy rate may be achieved after the transfer of good quality
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blastocysts in frozen embryo transfer cycles in comparison to fresh cycles (Ozgur et
al 2015), thought to be due to the physiologically more natural state of the uterus.
Zygotes, embryos and blastocysts may be cryopreserved using controlled rate
freezing or vitrification (Stokes et al 2007; Balaban et al 2008), which are discussed
in more detail in the methods section of this thesis.
1.11 Improving human embryo selection
Any method routinely applied in the clinical situation has to be non-detrimental to
embryo development, and ideally non-invasive. However, such methods do not
have high predictive value, ie, implantation of poor morphology embryos regularly
occurs, while good morphology embryos frequently fail to implant. Whilst the
aforementioned zygote, embryo and blastocyst morphology scoring are useful
minimally-invasive selection tools, human embryo selection is inefficient and
flawed. The continual need to improve the efficacy of human embryo selection
means that advancements in methods used to identify viable embryos are
necessary if the desired high pregnancy rates from single embryo transfers are to be
achieved (Montag et al 2013). Many techniques have been proposed as tools to
determine human embryo viability; however some of these are highly invasive, and
others may require expensive specialised equipment.
Extended culture of embryos to the blastocyst stage is hypothesised to improve
pregnancy rates partly due to a mechanism of natural selection whereby those
embryos with abnormal constitution, such as aberrant chromosome complement or
delayed cleavage, arrest in their development and are not transferred (Magli et al
1998; Rubio et al 2007). However, some studies have suggested that singletons
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born after blastocyst transfer on day 5 post-insemination have significantly higher
birthweights than those born following embryo transfer on day 2 post-insemination
(Makinen et al 2012), and on day 3 post-insemination (Zhu et al 2014).
There was early speculation that euploid cells were preferentially allocated to the
ICM, which will become the embryo proper, and aneuploid cells were allocated to
the TE, which gives rise to the placenta and extraembryonic membranes (Hardy et
al 1989). However, several researchers have since found that the proportion of
aneuploid cells in the ICM was similar to the proportion in the blastocyst as a whole
(Evsikov and Verlinsky 1998; Liu et al 2012; Capalbo et al 2013) so the mechanism of
cellular control, selection and allocation within the blastocyst remains uncertain. In
particular, embryos can have a range of different chromosomal abnormalities,
including consistent aneuploidy in every cell, or partial aneuploidy where only
certain cell lines are affected (Rubio et al 2007). It has been shown that aneuploid
embryos are around 25% more likely to arrest between day 3 and days 5-6 (59%)
than euploid embryos (34%), and although chromosomally abnormal embryos are
capable of developing to the blastocyst stage, the likelihood of implantation failure
thereafter is increased (Magli et al 2000). Certain classifications of chromosome
abnormalities are not conducive to the continuing development of pre-implantation
embryos, such as autosomal monosomies, haploidy and polyploidy (Munne et al
2003). Conversely, some abnormal embryos can progress to blastocyst and implant,
although analysis of embryos undergoing biopsy and preimplantation genetic
diagnosis (PGD), demonstrates that those embryos exhibiting two chromosomally
abnormal cells are more likely to arrest prior to blastocyst formation than those
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with one aneuploid and one euploid cell (Rubio et al 2007). Bearing in mind that
implantation of chromosomally compromised embryos can result in either
spontaneous abortion or the birth of genetically abnormal babies, it is imperative
that developmentally competent, chromosomally normal embryos are selected
prior to uterine transfer (Campbell et al 2013). However, a further unusual property
of embryos is the ability to ‘self-correct’ by jettisoning abnormally developing cells
(Bazrgar et al 2013), which may be via apoptosis in cells destined to the foetal
lineage, and proliferative defects in those destined for the placental lineage, thus
progressively eliminating aneuploid cells in the blastocyst (Bolton et al 2016). This
phenomenon is not well understood but may result in rescue of otherwise
abnormal embryos resulting in birth of normal offspring.
Preimplantation genetic diagnosis (PGD) and screening (PGS) are routinely used in
clinical embryology in order to identify chromosomal and genetic disorders which
may result in implantation failure and foetal loss (Sermon et al 2004). Aneuploidy is
the most commonly occurring chromosomal anomaly in human embryos,
accounting for the majority of spontaneous abortions and congenital birth defects
(Hassold et al 2007). The incidence of aneuploidy in meiotically mature human
oocytes following controlled ovarian stimulation has been estimated at between
~8% and ~49% (Van Blerkom and Henry 1988; Gianaroli et al 2010) rising to
between ~52% and ~57% (Kuliev et al 2003; Gianaroli et al 2010) in women of
advanced maternal age.
Several techniques are available in order to the obtain material necessary for
genetic testing of human oocytes and preimplantation embryos (Sermon et al 2004).
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PB biopsy may be performed in order to ascertain the maternal genotype of the
oocyte (Verlinsky et al 1992; Strom et al 1998), whilst biopsy of one or more
blastomeres from the cleavage stage embryo is a widely utilised technique (Sermon
et al 2004). Recent advances in successful culture of embryos to the blastocyst stage
have led to the implementation of TE biopsy as an alternative to cleavage stage
biopsy (Mir et al 2016). Both cleavage stage and TE biopsy generate results
representative of the genetic complement of the whole embryo, the main
difference being that biopsied blastocysts must be cryopreserved and transferred in
a later cycle in order to wait for the results of the analysis (Mir et al 2016), which
may have an impact on the clinical outcome.
It has been previously reported that removal of one or two blastomeres from
human embryos at day 3 post-fertilisation has no significant adverse effects on
viability, metabolism, or blastocyst development (Hardy et al 1990). Likewise,
removal of two cells from a day 3 embryo containing ≥7 cells does not reduce the 
pregnancy or implantation rate following day 3 or day 4 embryo transfer (Van de
Velde et al 2000). However, a different study has shown a significant influence on
blastocyst formation rate and quality when comparing the removal of one versus
two blastomeres from day 3 embryos (Goossens et al 2008), and blastocyst
formation and live birth rates after 1-cell biopsy were significantly better in
comparison to those after 2-cell biopsy (De Vos et al 2009). Additionally, mouse
blastocyst inner cell mass formation arising from biopsied 2-cell embryos was
significantly impaired in comparison with non-biopsied controls (Nijs and Van
Steirteghem 1987), suggesting that removal of blastomeres at early developmental
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stages substantially reduces cellular mass, and may disrupt polarised allocation of
cells in the blastocyst. Moreover, mice derived from embryos that had been
biopsied were of a lower birthweight than those from non-biopsied embryos,
possibly as a result of steroid metabolism dysfunction during pregnancy (Sugawara
et al 2012).
Other advanced methods of predicting human embryo viability are non-invasive,
and include time-lapse imaging, which is discussed in greater detail later in this
chapter. Whilst time lapse imaging has become routinely utilised in some clinical
embryology laboratories in recent years, other techniques were initially employed
when searching for suitably accurate methods with minimal manipulation and
disruption to the developing embryo. One such method is the measurement of
pyruvate and glucose in the culture medium surrounding developing human
preimplantation embryos as a predictor of viability, since a higher utilisation of
these energy substrates from fertilisation to blastocyst may indicate optimal
development in vitro (Hardy et al 1989). Other non-invasive techniques to predict
human embryo viability include analysis of the follicular fluid, cumulus cells, and
spent culture media (Montag et al 2013), although these methods are not easily
implemented in a clinical setting, and require time and expertise for execution.
1.12 Time lapse imaging
Time lapse cinematography has been used to investigate the dynamics of embryo
development for more than five decades (Bavister 1995). For many years, visual
markers of embryo growth and morphology were assessed at 24-hourly intervals
including embryo cleavage rate, cell number, cell shape, cell surface contact, degree
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of fragmentation (Prados et al 2012), and blastocyst expansion status, ICM location
and appearance, and TE morphology (Hardarson et al 2012). These were the
predominant methods of identifying potentially viable embryos in the clinical
embryology laboratory. The introduction of live cell imaging to improve selection
criteria, using techniques based upon precise timings of more complex markers such
as the appearance and disappearance of pronuclei, and early cell division, have
provided a much more comprehensive view of embryo development, and offered
further insight into the prediction of preimplantation embryo viability (Lemmen et al
2008; Azarello et al 2012; Montag et al 2013), without compromising the
developmental capability of the embryos being monitored (Lemmen et al 2008;
Nakahara et al 2010). An assessment of 102 zygotes using a novel time lapse
imaging system, determined that there was no detrimental effect of imaging
embryos every five minutes from day one (zygote) until day two (cleavage stage)
with regard to early cleavage and embryo quality (Lemmen et al 2008). Similarly, no
significant differences in fertilisation rate or percentage of top quality embryos was
observed after culture in a time lapse incubator capturing images at 15 minute
intervals, in comparison with a conventional incubator without regular image
capture (Nakahara et al 2010).
With the widespread introduction of advanced time lapse technology into routine
clinical practice during the past five years or so (Armstrong et al 2014), previously
unreported phenomena surrounding the development of human preimplantation
embryos are emerging. Atypical embryo behaviour, which would ordinarily be
missed using traditional “snap-shot” morphological assessment, has increased our
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understanding of aberrant developmental events and their relationship to embryo
viability, allowing de-selection of such embryos for uterine transfer. Additionally,
the embryos may remain undisturbed for the entire culture period, thus minimising
embryo stress (Meseguer et al 2012; Montag et al 2013).
The seminal paper on advanced time lapse imaging evidence correlated live cell
time lapse images with molecular profiles of human embryos, indicating that
development of embryos to the blastocyst stage in vitro can be predicted two days
post-insemination using information on cell division patterns (Wong et al 2010).
Additionally, analysis of the gene expression profiles of cultured embryos at various
stages points to evidence of maternally-derived transcripts that determine
developmental success or failure prior to embryonic gene activation, suggesting that
some aspects of human embryo fate are established early in development as a
result of determinants inherited from the oocyte (Wong et al 2010).
Since the publication of the Wong et al study, several groups have described using a
plethora of spatio-temporal features of human preimplantation embryo
development to identify which embryos are likely to result in a pregnancy, and
which embryos are not (Chen et al 2013). One study reported that live birth rates
were significantly associated with pronuclear breakdown later than 20h45min post-
injection (Azarello et al 2012). Euploid embryos reportedly display a unique division
pattern until the 4-cell stage, and analysis of fragmentation in conjunction with
these parameters may indicate chromosomally normal embryos, to aid in selection
and potentially avoid miscarriage (Chavez et al 2012). Atypical embryo phenotypes
have been identified as prevalent in human preimplantation embryos, and which
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relate to significantly reduced development potential (Athayde Wirka et al 2012).
Abnormal syngamy, whereby pronuclei movement within the cytoplasm of the
fertilised oocyte is disordered prior to disappearance, has been observed in 25.1%
of zygotes, whilst oolemma ruffling and the appearance of pseudo furrows, as well
as the timing of the first complete cell division were noted in 31% of zygotes. Direct
cleavage of the zygote or one of the daughter cell into more than two cells has been
observed in 17%-18%, and disordered cleavage behaviours in 15% of embryos
assessed (Athayde Wirka et al 2012; Hlinka et al 2012). Elsewhere, directly cleaving
embryos have been reported as having a significantly reduced chance of implanting
(Rubio et al 2012), however, such cleavage anomalies do not necessarily preclude
successful outcomes (Stecher et al 2014), and so caution is advised when deciding
whether to discard or transfer embryo based upon these observations. Early
cleavage timings appear to be predictive of blastocyst formation (Milewski et al
2015) and implantation potential (Dal Canto et al 2012; Chamayou et al 2013). A
rather interesting finding was that embryos that had one blastomere removed for
PGD began compaction, cavitation and blastocoelic expansion significantly later
than their non-biopsied counterparts (Kirekegaard et al 2012).
The use of time lapse in the clinical embryology laboratory is a useful tool for
selecting (or de-selecting) embryos prior to transfer, however the technology is still
relatively new and further studies into the usefulness of time lapse monitoring for
the selection of embryos are needed (Kirkegaard et al 2015). Additionally, the
equipment is expensive, and non-automated systems require a great deal of time
dedicated to annotating the images. Semi-automated systems using darkfield
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microscopy may make on-screen morphology scoring difficult, and lead to
disturbance of the embryos if their quality is to be assessed using a standard
brightfield microscope, thus causing a reduction in the benefits of uninterrupted
embryo culture.
1.13 Embryo polarity
In animal species such as insects, fish, reptiles and birds, the spatial arrangement of
the oocyte and the preimplantation embryo is known to be important for its
developmental potential (Ajduk and Zernicka-Goetz 2015). Polarised development
from the fertilised egg to the implanting embryo gives rise to the eventual axes of
the organism, a fundamental requirement for normal function. However, the
mechanisms involved in the establishment and maintenance of polarity before and
at implantation are the subject of continuing debate and are known to vary among
species (Edwards and Beard 1997). In most species the polarity of the whole
organism can be traced back to the polarity of the egg; however mammals were
thought to be the exception to this rule, with the axes of the embryo developing
only post-implantation (Weber et al 1999). Conversely, some evidence suggests that
establishment of axes during normal murine development can indeed be traced
back to the preimplantation embryo (Weber et al 1999). However, in contrast to
model mammalian species, human embryos do not necessarily follow this pattern
and are more variable in appearance, which requires examination in terms of axis
development. Whether the body plan of the human adult relates to the polarity of
the early preimplantation embryo is yet to be determined.
The polar axes in the human are shown diagrammatically in figure 1.6.
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Figure 1.6: The polar axes in the human (Hill 2016)
Oocyte polarity in non-mammalian species is well-documented, as demonstrated by
pigment distribution in Xenopus laevis and by shape in Drosophila and C. elegans.
(Ajduk and Zernicka-Goetz 2015).
In mammals, oocyte polarity is less obvious, but may be implied by the location of
the first polar body marking the animal pole and the non-random site of the second
polar body, extruded after fertilisation, indicating the position of the embryonic
pole (Gardner 1997). Embryonic differentiation and the formation of AV, dorso-
ventral (DV) and left-right (LR) embryonic axes are fundamental to life, and are
regulated by polarised ooplasmic determinants giving rise to an animal pole and a
vegetal pole. The position of the animal pole, containing nuclear material and
indicated by the first polar body, is positioned diametrically opposite the yolk-
containing vegetal pole in the oocyte, establishing the first embryonic axis (Edwards
and Beard 1997). It is hypothesised that rotation of pronuclei within the cytoplasm
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of fertilised oocytes in order to direct their axis towards the second polar body in a
standardised orientation may prepare the zygote for normal development (Edwards
and Beard 1997). Indeed, the orientation of the pronuclear axis relative to the first
polar body is significantly correlated with embryo morphology, where a greater
deviation is related to decreasing embryo quality, possibly due to a higher degree of
cytoplasmic turbulence and subsequent disturbance in the achievement of axes
polarity and consequent disruption of normal division (Garello et al 1999),
suggesting that oocyte polarity influences embryonic developmental competence.
Zygotes with eccentric pronuclei have a significantly increased chance of developing
irregularly shaped blastomeres than those with centrally placed pronuclei (Garello
et al 1999).
Following the first cleavage division along the meridian of the pronuclear axis, the
first dividing blastomere of the newly formed 2-cell will form a cleavage furrow
along the meridian axis prior to division into daughter cells which pass through the
embryonic and vegetal poles. The second-cleaving blastomere then rotates and
divides transversely, resulting in the classical “crosswise” 4-cell arrangement
observed in normally cleaving embryos (Edwards and Beard 1997), thus providing
evidence that cleavage planes are regulated rather than random, and reiterating the
concept of oocyte polarity.
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Examples of tetrahedral and non-tetrahedral cleavage patterns are shown in figure
1.7.
Figure 1.7: Tetrahedral and non-tetrahedral cleavage patterns (Cauffman
et al 2014)
Disruption of normal cleavage may lead to interruption of formation of axes, and
thus embryonic developmental delay or lethality. During cleavage, cell division may
be symmetrical or asymmetrical, giving rise to inside and outside cell populations
that differentiate into the inner cell mass and the trophectoderm in the blastocyst
(Bischoff et al 2008), although it is hypothesised that cells of the ICM can
differentiate into TE cells (Pierce et al 1988). Evidence of polarity in mammalian
species becomes obvious at the light microscopy level only at the blastocyst stage
(day 5/6 post-insemination), with the development of the peripherally placed ICM
within the blastocoelic cavity (Edwards and Beard 1997), although polarity is evident
using scanning electron microscopy at the compaction stage (day 4 post-
insemination) (Nikas et al 1996).
Tracking individual blastomeres throughout cleavage and development to the
blastocyst stage provides a direct method of detecting developmental regulation
within the embryo, and previous studies have indicated that cellular allocation is a
non-random event, and that the frequency of symmetric/asymmetric divisions of a
[71]
blastomere correlates with its origin in relation to the AV axis of the zygote (Bischoff
et al 2008). Furthermore, symmetrically dividing cells contribute more frequently to
the cells of the trophectoderm (outside cells), whilst asymmetrically dividing cells
are more likely to contribute to the cells of the inner cell mass (inside cells), and
that the positioning of the cavity, and thus the orientation of the embryonic-
abembryonic axis, is influenced by the pattern of earlier cell divisions (Bischoff et al
2008). The transcription factor Oct-4, a product of the OTF3 gene, is expressed at a
level 31-times higher in the ICM in comparison to the TE cells of human blastocysts,
suggesting that Oct-4 may play a role in maintenance of cellular totipotency (Hansis
et al 2000), and the expression of Oct-4 by blastomeres of the cleavage stage
human embryo may predict whether they will develop into ICM or TE cells at the
blastocyst stage (Hansis et al 2001). These findings confirm those previously
reported in murine studies (Palmieri et al 1994). Also In the mouse, heterogeneous
expression of Oct-4 transcription targets in the 4-cell embryo creates bias towards
cell fate into ICM or TE cells (Goolam et al 2016), which is in agreement with
previously published data showing that slower rates of nuclear export and import
kinetics of Oct-4 in individual blastomeres of the cleavage stage mouse embryo
predict preferential differentiation into cells of the ICM (Plachta et al 2011).
Certain polarised molecular markers have been identified in mice and other species,
but very little research has studied polarity in human embryos. Moreover, human
embryos are more variable morphologically than those of other animals, on average
having lower implantation potential, and there are no reliable routine markers of
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quality to select the best embryos during clinical infertility treatments. Disorganised
development of polarity may at least partially explain delayed embryo growth, poor
embryo morphology and low fertility in women.
It is thought that chromatin becomes polarised in newly fertilised oocytes, with that
in both the paternal and maternal pronuclei rotating to face each other internally
within the ooplasm, becoming highly condensed during pronuclear apposition, with
the male pronucleus seemingly influencing the formation of the polar axes (Van
Blerkom et al 1995). Ooplasmic rotation, as observed following intracytoplasmic
sperm injection, and prior to second polar body extrusion (Payne et al 1997), may
account for the polarisation of the apposed pronuclei in line with the second polar
body, with the axis orientated through the centre of the pronuclei in preparation for
the first cleavage division. Some pronuclei, however, appear to become arranged at
right angles to the second polar body (Edwards and Beard 1997).
With the evidence of polarity in oocytes and embryos, and the potential effects of
this on subsequent development, it follows that assessment of polarised
characteristics and markers may provide an additional measure of embryonic
developmental viability and enable the selection of the embryo most likely to result
in pregnancy and live birth. The identification of suitable markers to delineate
polarised regions in oocytes and embryos will aid in the process of determining
which molecules are restricted to the embryonic and vegetal hemispheres (Fulka Jr
et al 1998), which in turn will increase the understanding of the influence of polarity
on future development and enable clinically relevant tools to be developed for use
in laboratory procedures.
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Evidence of embryo polarity is suggested by the spatial arrangements of organelles
such as mitochondria (Van Blerkom et al 2000), the regulatory proteins leptin and
STAT3 (Antczak and Van Blerkom 1997), cell surface structures such as microvilli
(Nikas et al 1996), and the cytoskeletal protein actin (Wedlich-Soldner and Li 2004)
in developing embryos. For example, the cytoskeletal protein actin undergoes
rearrangements during embryonic development, resulting in polarised
morphogenesis (Hall and Nobes 2000), and the putative animal pole is characterised
by increased concentrations of cytoplasmic organelles such as mitochondria
(Calarco 1995). Mitochondria are essential for embryonic development, and may
be disproportionately inherited by blastomeres during development as a result of
asymmetrical cleavage (Van Blerkom et al 2000). Those blastomeres with
mitochondrial deficiencies as a result of unequal inheritance subsequently arrest
and lyse, and are shown to have a reduced ATP content, suggesting that diminished
ATP generation can adversely affect developmental competence. Indeed, it is
suggested that the number of blastomeres affected by disproportionate
mitochondrial inheritance may be an indicator of developmental potential (Van
Blerkom et al 2000), and may also be important in mtDNA inheritance.
Mitochondria-related activity, such as ATP production, may be influenced by the
magnitude of the inner mitochondrial membrane potential, which has a
heterogeneous distribution within cells of the preimplantation embryo (Van
Blerkom et al 2002). Mitochondrial membrane potential may be quantified in cells
using the cationic lipophilic carbocyanine-based dye JC-1, which accumulates within
the mitochondrial matrix and emits a green (low-polarised) or red (high-polarised)
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fluorescence reflecting the formation of J-aggregates, resulting from a unique
chemical reaction (Van Blerkom et al 2002). It is hypothesised that the shift from
uniform distribution of J-aggregate fluorescence throughout the cytoplasm of the
germinal vesicle stage oocyte, to an accumulation of J-aggregate fluorescence
specifically in the animal hemisphere of the MII stage oocyte, may signal an early
regulatory event in the activation of the embryonic genome. Furthermore, a role for
domains of high-polarised mitochondria in the Ca2+dependant activation of oocytes
may have downstream effects on developmental competence in morphologically
normal preimplantation embryos that arrest prior to blastocyst formation or fail to
implant after uterine transfer. It is possible that there is a link between the
distribution of high-polarised mitochondria within the blastocyst and the generation
of polar and apolar cells which form the diverse cell populations of the
trophectoderm and the ICM respectively (Van Blerkom et al 2002). The distribution
of mitochondria is associated with cytoplasmic microtubular organisation, which in
turn is associated with cell function, ie blastomeres deficient in mitochondria are
also deficient in microtubules (Van Blerkom et al 2000). In cases where indicators of
competence are apparent at the pronuclear stage, such as pronuclear alignment
and the presence of a cytoplasmic halo, unequal distribution of mitochondria may
still occur between blastomeres, thus these authors considered that the degree of
disproportionate mitochondrial distribution, rather than its presence, was most
relevant to developmental potential (Van Blerkom et al 2000). Assessments of
mitochondrial organisation may perhaps be useful for predicting which embryos are
most likely to arrest. Analysis of spent culture medium for the detection of mtDNA,
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implied that a high mtDNA to genomic DNA (gDNA) ratio was positively correlated
with improved blastocyst formation and implantation potential (Stigliani et al 2014),
which may provide a non-invasive method of predicting embryo viability in the
clinical embryology laboratory.
1.14 Molecular markers associated with preimplantation embryo development
1.14.1 Actin
Actin is an omnipresent structural protein with particular roles in the control of
embryo cleavage and compaction (Danilchik and Brown 2008), and has a key
function in maintenance of cell shape and structure, cytokenesis, cell motility, and
in the establishment of cell-cell interactions (Small et al 1999). The human
preimplantation embryo comprises large cells, which approximately halve in volume
with each normal cell division at least until the 8-cell stage. The actin cytoskeleton
undergoes dynamic rearrangements during embryonic development, resulting in
polarised morphogenesis as a response to early signalling events in the
establishment of cell polarity (Hall and Nobes 2000). Fragments present in poor
quality embryos are also reportedly surrounded by a regular intact actin cortex.
Furthermore, the actin cytoskeleton is of uniform distribution and thickness in all
blastomeres of an embryo apart from those which have begun to degenerate, when
a total disorganisation of the protein framework is noted. This is also observed in
embryos that have failed to survive thawing after cryopreservation, ie those
exhibiting no intact blastomeres upon thawing (Levy et al 1998). During the
blastocyst hatching process immediately preceding implantation, trophectoderm
cells protrude through a hole in the ZP. In some species such as mouse, hatching
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requires contraction and expansion of the embryo (Perona and Wassarman 1986).
Similar expansion and collapse has been observed in human embryos, but does not
appear to be mandatory for hatching (Ebner et al 2007). Molecular induction of cell
motility involves components of the actin cytoskeleton, and actin filaments play a
part in mammalian cell movement (Mitchison and Cramer 1996), with
trophectoderm motility during blastocyst hatching thought to be promoted by the
action of actin filaments (Niimura and Wakasa 2001). This appears to be confirmed
by the findings that the hatching rate of mouse blastocysts was significantly
reduced in those incubated with the actin polymerisation inhibitor H-89 (Suzuki and
Niimura 2010). This research suggests that actin is involved in both maintenance of
cell structure and in physiological dynamic processes. Thus by investigating the
distribution of this cytoskeletal protein in human embryos, not only are we able to
study the spatial distribution of protein within the embryo, but we may also gain
insight into aspects of developmental capacity and implantation potential.
1.14.2 STAT3, pSTAT3 and leptin
Signal transducers and activators of transcription (STATs) are a family of cytoplasmic
proteins which remain latent until activated by specific binding of polypeptides to
receptors on the cell surface (Duncan et al 1997). Six STAT proteins (STAT1 –STAT6)
have thus far been identified (Takeda et al 1997). The structure of STAT3 is similar to
other STAT proteins, having a conserved amino-terminus, a DNA-binding domain, an
SH2 domain, and a carboxy-terminal transactivation domain (Levy and Lee 2002).
The structure of STAT3 is shown in figure 1.8.
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Figure 1.8: Structure of STAT3β protein (Becker et al 1998)
STAT3 is expressed by developing human and mouse embryos (Antczak and Van
Blerkom 1997), and is thought to be localised exclusively to the region of the oocyte
at which the first polar body is extruded, the presumed animal pole (Antczak and
Van Blerkom 1997). The distribution of STAT3 may remain polarised throughout
embryo cleavage, where it is differentially distributed between the daughter cells of
early embryos and the ICM and TE of the blastocyst (Antczak and Van Blerkom
1997). STAT3 is implicated in the process of successful apposition, adhesion and
penetration of the luminal epithelium by the trophoblast of the hatched mouse
blastocyst (Nakamura et al 1997), in agreement with findings which have implicated
STAT3 in embryo attachment, invasion and decidualisation via interaction with the
progesterone receptor in mice (Lee et al 2013). It has also been suggested that
STAT3 is critical for implantation since decidualisation of the luminal epithelium,
essential for attachment of the blastocyst, does not occur in STAT3-deleted mice
(Sun et al 2013). Furthermore, dysregulation of the LIF-STAT3 pathway due to high
levels of circulating oestrogen in diabetic mice leads to impairment of implantation
(Wang et al 2015), and STAT3, in association with myeloid cell leukaemia 1 (MCL-1),
is regulated by oestrogen and progesterone during the implantation window in mice
(Renjini et al 2014). Additionally, STAT3 regulates the OCT4-NANOG circuit in the
maintenance of ICM cell pluripotency (Do et al 2013).
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Cytoplasmic STAT molecules remain in a dormant state until they are activated via
the Jak-STAT pathway, when a single tyrosine residue is phosphorylated, forming
dimers, and results in translocation of STAT3 to the nucleus from the cytoplasm
(Teng et al 2004). Here, they have the ability to transcribe target genes (Duncan et
al 1997).
The Jak-STAT signalling pathway is summarised in figure 1.9.
Figure 1.9: The Jak-STAT signalling pathway (Jatiani et al 2010)
Activation of STAT3 (pSTAT3) in mouse endometrium occurs only during the
implantation window, four days post-fertilisation, which suggests that pSTAT3 has a
role in the preparation of uterine receptivity in readiness for implantation (Cheng et
al 2001). Furthermore, inhibition of STAT3 activation in murine endometrium has
been found to reduce implantation significantly (Catalano et al 2005). Analysis of
endometrial biopsies collected 6-10 days after the luteinising hormone (LH) surge
from women presenting with unexplained infertility, found a significant reduction in
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pSTAT3 staining in the uterine glandular epithelium, compared to fertile age-
matched controls (Dimitriadis et al 2007). Detection of pSTAT3 during
decidualisation in mice also suggests that it is involved in the establishment and
maintenance of early pregnancy (Teng et al 2004). STAT3, in both latent and active
forms, has been investigated extensively in humans in the pathology of cancers,
particularly breast (Banerjee and Resat 2016), but it has not been investigated in
human embryonic implantation in any great detail.
The putative role of leptin in reproductive processes is controversial and the
published data are contradictory (Herrid et al 2014). Leptin, the protein product of
the obese gene, is a 16kDa non-glycosylated regulatory peptide hormone
synthesised by several cell types, including adipose tissue (Zhang et al 1994) and
human placenta (Senaris et al 1997), is expressed by human follicular granulosa and
cumulus oophorus cells (Cioffi et al 1997), and is present in the human
endometrium and the blastocyst (Cervero et al 2005). The structure of leptin is
shown in figure 1.10.
Figure 1.10: Structure of a leptin molecule (Farooqi and O’Rahilly 2005)
Leptin is associated with the activation of STAT3 (Takeda et al 1997), via the long
form of the leptin receptor, OB-RL, belonging to the class I cytokine receptor
superfamily (Tartaglia et al 1995). Leptin receptor is found in the human pre-
[80]
implantation embryo and in the endometrium (Cervero et al 2005). The detection of
leptin receptor in mature murine oocytes and the ability of exogenous recombinant
leptin protein to phosphorylate STAT3 in these oocytes suggest that STAT3 has a
pivotal role in preimplantation mouse embryo development (Matsuoka et al 1999).
Whilst both the long and truncated forms of leptin receptor mRNA and protein are
highly expressed in human endometrium, leptin mRNA and protein are not
(Kitawaki et al 2000). It is hypothesised that leptin may play a specific role in
acceptance of the blastocyst and support of early pregnancy (Kitawaki et al 2000).
Like STAT3, the distribution of leptin may remain polarised throughout embryo
cleavage, where it is differentially distributed between daughter cells of early
embryos and the ICM and TE of the blastocyst (Antczak and Van Blerkom 1997). This
differential distribution apparently originates with the specific planes of cell division
through the polarised leptin/STAT3 domains during each cleavage round, and since
the relative localisation of regulatory molecules within the oocyte may influence
subsequent embryo development, this could represent a significant molecular
process in the generation of specialised cells with diverse developmental potential
within the preimplantation embryo (Antzcak and Van Blerkom 1997). Significantly
higher numbers of mouse two-cell embryos developed into expanded and hatching
blastocysts with the addition of 10ng/ml human recombinant leptin into the culture
system, whilst the addition of 100ng/ml appeared to have an inhibitory effect on
embryo development (Herrid et al 2006), and whilst leptin mRNA was absent in
mouse cleavage stage embryos, long and short leptin receptors were present,
[81]
suggesting that leptin influences preimplantation embryo development via a
paracrine signalling system (Herrid et al 2006).
1.15 Image acquisition using fluorescence microscopy
High-resolution confocal imaging of fluorescently-labelled internal cell structures
enables the acquisition of high quality, 3-dimensional images of high volume
specimens (Liu and Chiang 2002). A confocal microscope samples diffraction-limited
regions of fluorescently labelled specimens in a point-by-point fashion to build a
stacked image, without the degradation of the image by the fluorescence of out-of-
focus structures. This offers an advantage over conventional epifluorescent
microscopy when studying an increasing number of closely packed cells in a
constant overall embryonic volume (Levy et al 1998). The result is an image of
considerably greater resolution, particularly with regard to the spatial distribution
of specific macromolecules within multi-cellular structures such as embryos
(Paddock 1994). However, photobleaching of illuminated, fluorescently labelled
molecules may occur during image collection, particularly if repeated scanning is
required over time, such as during optical slicing in confocal microscopy, resulting in
decreased image quality, and impaired resolution of spatially orientated molecules.
This usually occurs in excited molecules that undergo permanent structural changes
following reaction with another species such as oxygen or dye molecules (Bernas et
al 2004).
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1.16 Medical imaging and visualisation
The assessment of embryo morphology may be more accurately achieved using
medical imaging techniques such as segmentation alongside conventional grading
systems. Segmentation is a method utilised for the visualisation of 3-dimensional
images of various tissues including brain, cardiac and tumour tissues as well as
embryos, and allows images to be partitioned into regions to enable the extraction
of specific features and obtain informative measurements (Rogowska 2000). One
such application of medical imaging assessed the thickness of the ZP of human
embryos, and involved edge mapping of the externa and interna membranes with
an automated active contour model (snake segmentation) to distinguish the
boundaries, and allow the exact measurements to be obtained. The ZP thickness
variation was then retrospectively compared with pregnancy results in order to
identify a correlation, and provides evidence for utilising this technique to provide
additional selection criteria for embryos prior to uterine transfer (Morales et al
2008).
There are several different classifications of segmentation techniques depending
upon their intended application including but not limited to, manual, automatic and
semi-automatic, pixel-based and region-based, manual delineation, and classical
(Rogowska 2000). Edge-based segmentation identifies distinct boundaries between
regions with different characteristics, and this technique is suitable for imaging
embryos since they contain several membranes enclosing various cell structures ,
for example the ZP surrounding the cytoplasm of zygotes, individual blastomere
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membranes in cleavage stage embryos, and the cells of the inner cell mass and
trophectoderm of blastocysts. Definition of boundaries depends upon the local pixel
intensity gradient, with images created according to both the magnitude and
direction of the gradient, and by calculation of the summation of localised pixel
intensities (Rogowska 2000). Semiautomatic edge linking, where the operator
manually draws the edge when the automatic tracing becomes ambiguous,
circumvents the problem of incomplete enclosure of the cell often seen with
segmentation. Multimodal or multispectral techniques incorporate data from a
series of images during which the intensity gradients alter but the anatomical
structure remains constant, such as those acquired in embryo time-lapse
recordings. These allow the incorporation of data from a spectrum of features,
providing an array of information for use in segmentation and imaging. The
parametric analysis technique, where the pixel intensity for each region of interest
is plotted against time, is commonly employed when analysing serial images
procured over extended time periods. Parameters are selected according to the
functional characteristics of the object in question (eg an individual blastomere),
such as time of occurrence of minimum and maximum intensities, and an image
calculated for each of the parameters, hence the term parametric imaging. Edge
detection segmentation can be used to create 3-dimensional images, and combined
with 3-dimensional rendering, allows for detailed analysis of image structures
(Rogowska 2000).
Visualisation aims to develop tools that allow the “inside” of complex living systems
to be observed and explored, and involves the use of computing environments,
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graphics hardware and software that facilitate the interaction between humans,
machines and data. Visualisation techniques enable the generation of realistic 3-
dimensional images, development of automated methods for manipulation of
multidimensional images and their associated parametric data, advancement of
measurement tools for analysis of images, and the design and validation of models
that improve the interpretation of diagnostic and clinical applications (Robb 2000).
Virtual reality facilitates interactive visualisation, allowing the operator to control
detailed computer-generated 3-dimensional images that mimic real-life situations,
enabling manipulation of images in such a way that the operator may “enter” the
visualisation and change their viewpoint as if the image were a real object (Robb
2000). This has huge implications in the development of tools for the purposes of
teaching and demonstrating, as well as for diagnostic applications, and virtual
procedures have been found to provide accurate, reproducible visualisations that
are clinically useful and minimally invasive (Robb 2000). This suggests that the
inclusion of virtual models in the routine clinical environment is a very real
possibility, and may prove invaluable in the future of medical advancement.
Visualisation in medicine may be characterised, according to the complexity of the
resulting user interaction, as illustrative, investigative or imitative. Illustrative
visualisation presents extracted data in the form of three-dimensional displays,
whilst investigative visualisation is more focussed on explorative techniques such as
multidimensional interpretations useful for clinical tools. Imitative visualisation
refers to virtual reality systems, simulators and modelling (Solaiyappan 2000).
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The use of computer software for the development of advanced image processing
systems has led to an increase in the application of digital imaging to human
medicine. Medical visualisation describes the generation of three-dimensional (3D)
models using digital algorithms, based upon living specimens, to increase the
understanding of biological structures and their functions (Klauschen et al 2009),
and is a useful tool when attempting to understand the mechanisms of
development and/or abberant behaviours. Therefore, development of semi-
automated human embryo analysis tools may assist in generating high volumes of
data to increase understanding of cell division patterns in relation to clinical
outcomes, and may improve our ability to select the most viable embryos from a
cohort from an early stage of development.
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Aims
The overall aim of this project was to investigate possible molecular, morphological
and kinetic markers of preimplantation human embryo viability, with a view to
increasing our understanding of human embryo development and improving
embryo selection methods in the clinical embryology laboratory.
Briefly, the main aims of this project were:
• To detect and confirm the distribution of the actin cytoskeleton in cleavage
stage, compacting, and arrested human preimplantation embryos and blastocysts.
• To establish whether the regulatory proteins STAT3 and leptin are polarised
within human oocytes and preimplantation embryos
• To determine the number of cells in the inner cell mass and the
trophectoderm in human blastocysts during in vitro development, and to consider
morphological characteristics of blastocysts and their relationship with quality and
possible clinical outcomes.
• To investigate the occurrence of chromatin-containing fragments and
micronuclei in human preimplantation embryos of all developmental stages
• To establish whether STAT3 activation may represent a mechanism by which
the embryo and endometrium communicate at implantation in humans.
• To detect the presence of leptin receptor mRNA on human blastocysts in
order to determine whether the leptin system plays a role in the activation of STAT3
in human pre-implantation embryos.
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• To investigate the interaction between embryos and Ishikawa cells, as a
model of the endometrial epithelium.
• To identify potential markers of embryo viability and predictors of embryo
development by assessment of human preimplantation embryos using time lapse
monitoring.
• To assess the potential effect of deliberately damaging the daughters of the
first dividing cell at the third cleavage division (4-8 cells) with respect to ensuing
cleavage patterns and blastocyst formation, to determine whether damage of
specific blastomeres may impact on axis establishment and subsequent embryo
development.
• To identify the initial site of blastocyst hatching from the ZP with respect to
the position of the inner call mass, to establish whether there is any association
between the site of hatching and pregnancy potential.
• To explore different options for computer-assisted image analysis of human
embryos at different stages of development and using different image types.
• To apply the most effective semi automated computer-assisted options to
investigate the nuclear to cell ratio in cleavage stage human preimplantation
embryos, and the nuclear volumes of different cell lineages in blastocysts, using
data derived from a semi-automated computer programme developed in
collaboration with colleagues at the Warwick Digital Laboratory, and Manchester
University School of Computing.
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Chapter Two
Methods
2.1 Introduction
This chapter describes in detail all the methodologies employed during the
preparation and execution of experiments carried out during the course of this
project.
2.1.1 Governance
This project received ethics approval (Coventry Research Ethics Committee, LREC
04/Q2802/26) and was licensed by the HFEA, project number R0155, for conduct at
the University of Warwick Clinical Sciences Research Laboratories (CSRL), and the
Centre for Reproductive Medicine (CRM), UHCW NHS Trust. Approval from the
Research and Development Department at the Trust was also granted (R&D
GH04/0504).
The project title is ‘Indicators of oocyte and embryo development’ and the Person
Responsible to the HFEA is Professor Geraldine Hartshorne, who was my supervisor
on this project. The work was conducted according to standard operating
procedures for the standardised processes involved. Where appropriate,
documents were controlled under ISO 9001 at CRM.
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2.2 Embryos
Embryos were donated by patients undergoing in vitro fertilisation (IVF) treatment
at the CRM, University Hospitals Coventry and Warwickshire NHS Trust, Bath
Fertility Centre (BFC), Royal United Hospitals NHS Trust, and Leicester Fertility
Centre (LFC), University Hospitals of Leicester NHS Trust. During this project,
oocytes and embryos that were collected or created during the current treatment
cycle but deemed unsuitable for uterine transfer or cryopreservation due to failed
or abnormal fertilisation, retarded development, or poor morphological quality
were used. Additionally, good quality embryos that were cryopreserved during
previous IVF treatment cycles but were no longer required by the patients were also
used. No patient was disadvantaged as a result of this research project.
2.3 Acquisition of fresh oocytes and embryos for research
During the pre-treatment information session, patients were provided with a
research pack including information about the project and a consent form, for them
to consider. If the patients indicated a willingness to be approached about research
projects in section 5.1 and 5.2 of the HFEA consent to treatment (MT and WT)
forms, a discussion regarding specific project consent took place shortly before
oocyte retrieval. This involved a short verbal explanation of the project and the type
of material required, and an opportunity for the patients to ask questions prior to
making a decision regarding consenting. Patients could consent to oocytes, fresh
embryos and/or frozen embryos being included. Both male and female members of
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the couple (or the gamete donor if appropriate) must have consented if embryos
were to be used for research.
Patients were prepared for oocyte collection according to a standard protocol with
clinical decisions regarding the appropriate ovarian stimulation regimen depending
upon patient-specific factors. Usually, the pituitary GnRH agonist Buserelin (Sanofi,
Paris, France) was administered until down-regulation of pituitary hormones was
confirmed by a scan of the ovaries showing quiescence and an absence of follicles
≥10mm. This was followed by ovarian stimulation with gonadotrophin injections 
daily for up to two weeks. The most commonly used gonadotrophin preparation
was Menopur (Ferring, Middlesex, UK). Growing follicles in the ovaries were tracked
via ultrasound scanning until the leading follicle reached 14mm diameter. Oocyte
collection was then scheduled with instructions given to self-administer 10,000 iu of
human chorionic gonadotrophin (hCG) by subcutaneous injection (MerckSerono,
Middlesex, UK) 36 hours prior to the planned oocyte collection time, to cause
oocyte maturation in vivo.
For the oocyte collection procedure, patients received sedation with or without
anaesthetic. Follicle contents were aspirated under ultrasound guidance using a 17
gauge x 31cm needle with 60cm fluorinated ethylene propylene tubing attached
(Casmed, Epsom, Surrey). Oocytes, in their cumulus cell clusters, were identified in
the aspirated fluid using light microscopy, and were collected into 250µl drops of
pre-equilibrated HEPES-buffered sperm preparation medium (Origio) under sterile
light paraffin oil (Origio). Oocytes were transferred into 100µl drops of pre-
equilibrated IVF medium (Origio) under sterile paraffin oil upon completion of the
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oocyte collection and incubated in an incubator at 5% CO2 and 37°C. For standard
IVF treatment, oocytes were inseminated approximately 4 hours after collection,
with the addition of approximately 150,000 prepared sperm per ml to a maximum
of two oocytes in 100µl drops of IVF medium (Origio) under oil. For intracytoplasmic
sperm injection (ICSI) treatment, cumulus cells were removed from oocytes
approximately 4 hours after collection using 100µl 80 U/ml Cumulase (Origio)
enzymatic digestion and a 135µm denuding pipette (Hunter Scientific, Essex, UK).
Approximately 2 µl of prepared sperm was added to a 5µl drop of
polyvinylpyrrolidone (PVP) (Origio) to decrease the velocity of the sperm prior to
immobilising. Oocytes were transferred to 5µl drops of sperm preparation medium
(Origio) in a pre-prepared 50x9mm petri dish (Falcon, BD Biosciences) and each
injected individually with one immobilised spermatozoa using a micromanipulator
(Research Instruments, Cornwall, UK) with an IX51 inverted microscope (Olympus).
After insemination or injection, oocytes were transferred to pre-equilibrated IVF
medium (Origio) under oil, and incubated at 37°C in an atmosphere of 5% CO2in air
overnight.
2.4 Embryo culture
Embryo culture dishes were prepared 24 hours prior to requirement to allow
equilibration of the media in a 5% CO2environment. The protocol used was the
Origio sequential media culture system, capable of supporting embryo development
from fertilisation on day 1 to the blastocyst stage on day 5 or 6.
Pronuclear formation was assessed 16-18 hours after insemination or injection (day
1), and normally fertilised embryos, identified by the presence of two pronuclei and
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two polar bodies, were transferred to pre-equilibrated ISM1 medium (Origio) under
oil at 37°C in 5% CO2. Embryos were assessed the following day (day 2) to assess
cleavage and morphology. Those embryos deemed suitable for extended culture to
the blastocyst stage were transferred to BlastAssist medium (Origio) at
approximately 4pm on day 2, whilst those of poorer quality or with a retarded
developmental rate were either transferred to BlastAssist medium (Origio) at the
same time, or remained in ISM1 medium (Origio) for one more day before transfer
into BlastAssist medium (Origio), depending on the decisions made regarding the
other embryos.
Fresh oocytes and embryos donated for research were collected from the
embryology laboratory at any time from day one after oocyte collection (immature
oocytes, unfertilised and multi-pronucleate) until day seven (arrested cleavage
stage and poor quality blastocyst stage embryos), dependent upon the time at
which they became no longer needed by the patient and therefore available for
research. Oocytes and embryos donated to research were then transferred to a
separate research incubator in the presence of a clinical embryologist who acted as
a witness. A checklist for collecting fresh embryos for research was completed to
ensure that all necessary procedures were followed.
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2.5 Acquisition of frozen embryos for research
Patients with cryopreserved embryos in storage were contacted approximately
annually with a regular mailing to confirm their wishes with regard to the embryos.
If they wished to donate them to research, they were provided with written
information by letter regarding the project and were asked to complete the
appropriate consent forms. If the patients (both partners of the couple) requested
that they be donated for research, the frozen embryos were then transferred to the
dedicated research embryo storage tank in the presence of a witness, and could be
used at any time within the HFEA-authorised storage period. Availability of donated
embryos was documented in an index card file. Patient consents were filed in the
notes and cross-checked for expiry date and signatures. Identity was verified with at
least three identifiers (e.g. name/date of birth/hospital number).
In all cases, to ensure auditable records of traceability complying with HFEA
legislation, details of each embryo used for research purposes were recorded.
Reversible anonymisation was performed by allocating each patient a unique code
for research use. The completed anonymisation forms were filed together with
copies of patient consent forms, whilst non-identifying relevant clinical and
laboratory information was recorded on data sheets. Completion of detailed
laboratory logbooks and index cards summarising the fate of each anonymised
embryo ensured that a robust two-way audit trail was maintained.
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2.6 Thawing embryos
When required, research embryos were thawed according to CRM protocol
depending upon the mode of cryopreservation. For embryos that were frozen using
controlled rate freezing, which was the preferred method at the CRM until 2009 and
also the method used by LFC, embryos were thawed using an adapted version of
the Origio standard clinical protocol.
Two hours prior to thawing, embryo thawing media solutions 1-4 (Origio, Reigate,
UK) were dispensed into non-toxic 5-well plates (Nunc, Thermo Scientific, Roskilde,
Denmark) in 0.5ml aliquots, and equilibrated at room temperature. Embryos were
removed from liquid nitrogen (LN2) and the straw warmed for approximately 1
minute until the contents had liquefied. Embryos were removed from the straw into
the centre of the 5-well plate. The 5-well plate was then placed on a heated stage at
room temperature, and the stage turned on with a set temperature of 37°C, to
gradually warm the embryos as they thawed. Embryos were placed in each of the
four sequential thawing solutions for 5 minutes each. Following thawing, the
embryos were transferred to 25µl drops of pre-equilibrated ISM1 or BlastAssist
(Origio) culture media under paraffin oil and incubated at 37°C/5% CO2until ready
to use.
Some embryos had been originally cryopreserved using a vitrification technique.
Vitrification was routinely used at the CRM from 2009. Vitrified embryos from CRM
were warmed as follows, using the Origio standard protocol.
Thirty minutes prior to use, the vitrifcation warming medium was warmed to 37°C,
whilst the dilution media and washing media were warmed to room temperature.
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Embryos were removed from liquid nitrogen and the support immersed in the
warming medium to allow the embryo to float off the tip. After exactly three
minutes, embryos were transferred through two dilution media and two washing
media steps, each for three minutes, before transfer to pre-equilibrated ISM1 or
BlastAssist (Origio) media for a minimum of two hours prior to quality assessment.
For those embryos originating from BFC, vitrified embryos were warmed according
to the Irvine Scientific Vit Kit® (Irvine Scientific, Santa Ana, Ca) protocol.Heat-sealed
straws containing embryos were removed from liquid nitrogen and swirled in a 37°C
water bath for approximately 3 seconds, then wiped dry using a sterile tissue.
Sharp sterile scissors were used to cut the straw just below the seal at the thicker
end, and the metal jacket moved up the shaft to reveal the thinner end of the
straw. A syringe with plunger withdrawn to the halfway position was attached to
the cut end of the straw with a connector ensuring a secure seal, before the fine
end was snipped just below the seal. The embryos were expelled as a small drop
directly into a pre-dispensed 50µl drop of thawing solution by depressing the
syringe and touching the tip of the straw on the media. After exactly one minute,
the embryos were transferred to a 25µl drop of dilution solution, pipetted to rinse,
and then left undisturbed for four minutes. During this time, two 25µl drops of
washing solution were dispensed into the same dish. The embryos were transferred
to the bottom of the first drop for four minutes, and then to the top of the final
wash drop for four minutes undisturbed. Finally, the embryos were transferred to
pre-equilibrated ISM1 or BlastAssist media (Origio) under oil for further culture.
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2.7 Embryo grading
All research embryos were assessed for quality based upon their cell number and
appearance by light microscopy both at the time of collection or thawing and at the
time of subsequent imaging, to detect changes in cell number or quality between
collection or thawing and processing of the embryo. Each cleavage stage embryo
was allocated a grade from 1 to 4 based upon the shape of the cells, symmetry of
division, cell orientation, degree of fragmentation, appearance of membranes and
ZP shape.
The criteria for the grading of cleavage stage embryos are summarised in table 2.1
(Balaban et al 2001).
Grade Blastomeres Fragmentation
1 Equal size
Homogenous
<10%
2 Equal size
Homogenous
10-20%
3 Equal/unequal size
Homogenous/non
homogenous
20-50%
4 Equal/unequal size
Homogenous/non
homogenous
>50%
Table 2.1: Cleavage stage grading criteria
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Compacted/morula stage embryos were graded according to the criteria
summarised in table 2.2 (Tao et al 2002).
Score Compacting cells Morphology Fragmentation
1 100% Full size, close to
sphere with
smooth profile
<5%
2 >75%
65-75%
Close to sphere
with shallow
indent
Close to sphere
with smooth
profile
<25%
3 50-65% Irregular with deep
indentation
>50%
4 <50% Irregular with
small compact
mass
>50%
Table 2.2: Compacted/morula stage grading criteria
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Blastocysts were graded using the criteria described by Gardner et al (1999),
according to the extent of expansion of the blastocoel, and the quality and
appearance of the inner cell mass and trophectoderm cells (Teranishi et al 2009).
Blastocyst grading criteria are summarised in table 2.3 and table 2.4.
Size Degree of expansion
1 An early blastocyst with a blastocoel ≤ half the volume of the 
embryo
2 A blastocyst with a blastocoel ≥ half the volume of the embryo 
3 A full blastocyst with a blastocoel completely filling the embryo
4 A fully expanded blastocyst with large blastocoel and thinning
zona
5 A hatching blastocyst with the trophectoderm starting to
herniate through the zona
6 A fully hatched blastocyst, in which the blastocyst has completely
escaped through the zona
Table 2.3: Grading criteria for the degree of expansion and hatching status of the
blastocyst
Grade Inner cell mass
A Tightly packed, many cells
B Loosely grouped, several cells
C Very few cells
Grade Trophectoderm
A Many cells forming a cohesive epithelium
B Few cells forming a loose epithelium
C Very few large cells
Table 2.4: Grading criteria for the inner cell mass and trophectoderm of the
blastocyst
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The expected development rate during culture was also taken into account, as
detailed in table 2.5.
Day of culture Stage of development
2 4 cells
3 8 cells
4 Compacting or cavitating
5 Early blastocyst to expanded blastocyst
6 Expanded blastocyst to hatching blastocyst
Table 2.5: Expected development rate of embryos at all stages from day 2 to day 6
post-insemination
2.8 Sperm preparation for creation of research embryos
For some experiments embryos were created in vitro for research by using
intracytoplasmic sperm injection to attempt to fertilise oocytes available due to
failed fertilisation or in vitro maturation. The women whose oocytes were used for
this gave informed consent, while the sperm was from a donor who approved
research use in this project.
Approximately 10-15% of oocytes display no evidence of fertilisation 16-18 hours
following insemination (Kalantar et al 2007). In addition, 15-20% of oocytes
(Reichman et al 2010) may be immature at collection at either prophase I (germinal
vesicle) or metaphase I (no germinal vesicle and no polar body) but exhibit polar
body extrusion (assessed to indicate metaphase II stage) after one day in culture.
Such oocytes are considered to have matured in vitro. ICSI using previously frozen
sperm from a consenting donor was used to create embryos from such oocytes for
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use in experimental procedures. Prior to performing ICSI, sperm were prepared in
order to isolate a population of viable spermatozoa free from debris and seminal
plasma.
A heat-sealed straw containing semen in a 50:50 mixture with glycerol-based Sperm
Freezing Medium (Origio) was removed from liquid nitrogen, and the sample date
and number recorded. Following thawing at 37°C for approximately 10 minutes,
sperm concentration was estimated by assessing a 10µl drop on a Makler counting
chamber (Irvine Scientific, London, UK) to ensure sufficient motile sperm were
available. A sample of sperm suitable for injection was prepared as follows:
A two layer density gradient was constructed by layering 1ml 55% SupraSperm®
medium upon 1ml 80% SupraSperm® medium (Origio) in a non-toxic sterile conical
tube (BD Biosciences, Oxford, UK). Immediately, 2ml of cryopreserved semen was
added to the top of the column, and centrifuged at 1600rpm for 10 minutes. The
seminal plasma and gradient media were removed using a glass pipette, and the
pellet was re-suspended in 1ml sperm preparation medium (Origio) and centrifuged
at 3000g for 5 minutes to wash.
If the concentration of motile sperm was insufficient for preparation using a
discontinuous density gradient, the sample was prepared by centrifugation at 3000g
for 5 minutes, plus washing the pellet twice in 1ml sperm preparation medium
(Origio). For both preparation methods, the uppermost 0.5ml of media was
removed after the second centrifugation step, and the preparation incubated at
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37°C for approximately 30 minutes to allow motile spermatozoa to swim out of the
pellet.
2.9 Intracytoplasmic sperm injection for creation of research embryos
ICSI was performed as for clinical insemination, using an Olympus IX51 inverted
microscope (Olympus) with integrated micromanipulator (Research Instruments) as
described in section 2.3.
Individual sperm were selected for injection using high power magnification based
upon their morphology and motility. Oocytes were held with the polar body at the
12 or 6 o’clock position to avoid injection at the purported spindle location. An
immobilised sperm was positioned head first at the tip of the injection pipette prior
to insertion of the pipette through the zona of the oocyte and into the ooplasm.
Suction was applied until the oolemma was ruptured and cytoplasm was sucked
into the pipette. The sperm was then deposited in the centre of the cytoplasm,
taking care to avoid introducing excess medium into the oocyte, and the injection
needle slowly removed to avoid damaging the oocyte or causing the sperm to exit,
as shown in figure 2.1.
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Sperm Oocyte Polar body Injection needle
Figure 2.1: Intracytoplasmic Sperm Injection (ICSI) technique (Merchant et al 2011)
2.10 Microscopy
Assessment of oocyte and embryo morphology and development during routine
clinical IVF treatment employs the use of brightfield, phase contrast and Hoffmann
optical microscopes, with UV exposure avoided by inclusion of neutral density
filters.
2.10.1 Research microscopy
Brightfield and fluorescence live cell time lapse images and fixed cell images were
acquired using an Olympus IX81 microscope with integrated Solent Scientific
environmental chamber(Solent Scientific, Portsmouth, UK), high resolution digital
CCD camera (Hamamatsu, Hertfordshire, UK), and CellM imaging system software
(Olympus, Middlesex, UK).
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Some live embryos were imaged using a Cryo Innovation PRIMO Vision compact
continuous monitoring system (Parallabs, St Albans, UK), placed inside an Heraeus
BB6220 incubator set to 37°C and 5% CO2.
Additionally, live embryos were imaged using the Unisense FertiliTech
Embryoscope™ time-lapse system, a fully integrated 5% C02/37°C incubator with
Leica Hoffman modulation contrast optics and camera. Images were analysed using
EmbryoViewer software (Unisense FertiliTech A/S, Denmark).
Fixed cell fluorescent images were captured using a Zeiss LSM 510 laser scanning
confocal microscope and LSM5 software package version 4.0 (Zeiss, Hertfordshire,
UK). In order to excite the AlexaFluor488, FITC and DAPI fluorophores, the
microscope was configured prior to imaging by selecting the Enterprise and Argon
lasers and the CY2 (488) and DAPI (364) filters.
2.11 Fluorescent labelling of embryos
Labelling fixed human preimplantation embryos with fluorophores enables the
visualisation and imaging of cellular, sub-cellular and microscopic structures in a
three-dimensional arrangement. Specifically targeted fluorescent probes may be
used to highlight proteins of interest in order to study the spatial organisation of
cellular components, such as the cytoskeleton, and temporally expressed regulatory
proteins, which may be polarised to specific regions of cells.
2.11.1 Actin labelling
50 embryos were labelled for the cytoskeletal protein F-actin using the fluorescent
probe AlexaFluor® 488 phalloidin (Invitrogen, Paisley, UK). Embryo fixation in 1ml
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3.7% formaldehyde/PBS for ≥1 hour at room temperature was followed by washing 
in PBS for 5 minutes at room temperature, permeabilisation in 0.1% Triton X-
100/PBS (Sigma-Aldrich, St Louis, MO) for 5 minutes at room temperature, and a
second PBS wash. Embryos were then incubated in 100µl IVF media (Origio)
containing 5µl (1 unit) AlexaFluor® 488 for 20 minutes at room temperature
protected from light, followed by a final wash in PBS for 5 minutes at room
temperature. All washing steps and AlexaFluor® 488 incubations were performed in
Nunc 5-well plates (Thermo Scientific). Following staining, the embryos were
transferred to 10µl drops of IVF/ISM1 media (Origio) overlaid with mineral oil
(Origio) and stored at 4°C wrapped in foil until imaged. Embryos were either imaged
immediately or the next day.
2.11.2 STAT3, pSTAT3 and leptin labelling
33 embryos were labelled for STAT3 using an affinity purified rabbit polyclonal
antibody raised against mouse (C-20-R) as the primary antibody (Santa Cruz
Biotechnology, Santa Cruz, Ca) and either anti-rabbit IgG FITC conjugate developed
in goat (Sigma-Aldrich) or anti-mouse IgG Texas Red™ Sulfonyl Chloride conjugate
developed in rabbit (Abcam, Cambridge, UK) as the secondary antibody.
47 Embryos were labelled for pSTAT3 using an affinity purified goat polyclonal
antibody raised against human as the primary antibody (Santa Cruz Biotechnology)
and anti-rabbit IgG FITC conjugate developed in goat (Sigma-Aldrich) as the
secondary antibody.
41 embryos were labelled for leptin using an affinity purified rabbit polyclonal
antibody raised against human (Ob Y-20) as the primary antibody (Santa Cruz
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Biotechnology) and anti-rabbit IgG FITC conjugate developed in goat (Sigma-Aldrich)
as the secondary antibody.
All embryos were fixed in 1ml 3.7% formaldehyde for ≥ 1 hour at room 
temperature, and either stored in Falcon 5ml round bottom tubes (BD Biosciences)
in the fixative at 4°C until ready to label, or immediately removed from the fixative
and transferred to PBS wash for 5 minutes at room temperature. Permeabilisation
with 0.1% Triton X-100/PBS (Sigma-Aldrich) for 1 hour at room temperature, was
followed by a second PBS wash (5 minutes, room temperature). Embryos were
transferred to 1% BSA/PBS (Sigma-Aldrich) and incubated for 1 hour at 4°C, then
transferred to fresh 1% BSA/PBS (Sigma-Aldrich) for a further incubation (≥1 hour, 
4°C). Embryos were kept in this solution until ready for staining, or washed in PBS (5
minutes, room temperature) and stained immediately. For incubation with primary
antibody, embryos were transferred to 4µg/ml anti-STAT3, anti-pSTAT3 or anti-
leptin antibody in 100µl IVF medium under oil, and left overnight (≥ 8 hours) at 4°C 
wrapped in foil.
Following primary antibody incubation, embryos were washed in 1% BSA/PBS for 30
minutes at 4°C to prevent non-specific binding of the primary antibody with any
remaining free protein, before incubation with FITC (Sigma-Aldrich) or Texas Red
(Abcam) secondary antibody solution (both 1:100 dilution) for 2 hours at 4°C in foil
wrap. A final wash in 1% BSA/PBS (Sigma-Aldrich) for 30 minutes at 4°C completed
the staining procedure. Embryos were either imaged immediately or stored at 4°C
in 1% BSA/PBS protected from light, until imaged. All washing steps, antibody
incubations and storage were carried out in Nunc 5-well plates (Thermo Scientific).
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Negative controls were performed by culturing the embryos overnight in 100µl IVF
media under oil, omitting the primary antibody. All other conditions and
subsequent steps were retained.
2.12 Confocal Imaging
Prior to imaging, up to three embryos were transferred to 5µl Vectashield media
containing 4',6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Burlingame,
CA), diluted in a 1:4 ratio with PBS. DAPI mounting medium serves the dual purpose
of preserving the fluorescence signal during imaging and labelling chromatin in the
cell nuclei. Embryos were mounted in a 35mm gamma-irradiated collagen-coated
plastic petri dish with a 14mm x 1.5mm glass well insert designed especially for high
resolution microscopy (MatTek, Ashland, MA), as shown in figure 2.2.
Plastic petri dish Glass insert
Figure 2.2: Petri dish with glass well insert (MatTek)
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Embryos were covered with a round 13mm diameter, 1.5mm thickness coverslip
(Scientific Laboratory Supplies) mounted on petroleum jelly columns to prevent the
coverslip from squashing the embryo, and to enable the entire vertical axis (z-axis)
of the embryo to be successfully imaged.
Images were obtained as both single plane and z-stack series with CY2/DAPI filters
and Argon/Enterprise lasers (see figure 2.3), at a magnification x400 under oil
immersion. Optical slices were taken at 1μm intervals through the z-axis and saved 
in Tagged Image File Format (TIFF) using the Zeiss LSM5 image browser software.
Single track beam path and laser configuration produced images more rapidly as
both tracks were simultaneously scanned, but since more than one fluorophore was
present in each embryo, this resulted in bleed-through of target colours. Therefore,
multiple track configurations were enabled to allow sequential scanning of
channels, thus minimising cross-talk of fluorescence emissions and optimising image
resolution. Images were analysed using LSM5 software and Image J.
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Argon laser module Enterprise laser module
Microscope
Figure 2.3: Zeiss LSM510 confocal microscope and laser modules
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2.13 Image analysis
The distribution of STAT3 and leptin in the embryos was determined by measuring
the relative intensity of the fluorescent signal in the reconstructed confocal z-stacks
using Image J.
Figure 2.4: A single plane confocal image of a blastocyst imported into Image J
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The Z-stacks could then be transformed into 3-dimensional GIF files, as shown in the
static image in figure 2.5.
Figure 2.5: 3D reconstruction of the entire confocal z-stack of the blastocyst seen
in figure 2.4, imported into Image J
A sampling technique was employed when comparing the fluorescence intensities
at different areas within blastomeres, to investigate whether the target proteins
were polarised intercellularly. Small areas around the cell periphery and centre
were selected using the oval or elliptical selection tool as shown in figure 2.6, and
the RGB pixel values of each selected area measured using the “Analyze” plugin.
The average of each sampled area from around the periphery and the centre of
each cell were calculated, and the values compared to determine whether
differences in relative fluorescence intensity existed between different areas of the
cells.
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Figure 2.6: Example of sampling technique used to measure relative fluorescence
intensity in a 2-cell embryo
When the average fluorescence intensity of the cell as a whole was required, to
determine whether the target proteins were differentially distributed between the
blastomeres of the embryo, RGB values of the whole cell were measured by
selecting the entire cell area using the oval or elliptical selection tool, as shown in
figure 2.7.
Figure 2.7: Example of whole-cell selection technique used to measure relative
fluorescence intensity in a 3-cell embryo
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High volumes of data were generated using the sampling technique (~150
measurements for a 0PN up to ~700 measurements for a 6-cell embryo), and
although a much smaller data set was generated using the whole-cell method, the
pixel values were comparable using either technique, as shown in figure 2.8.
Figure 2.8: Comparison of sampling technique and whole-cell technique used to
measure relative fluorescence intensity in a 2-cell embryo
In order to validate the relative fluorescence intensity measurement methods, the
same technique was used to measure fluorescence intensity in embryos which had
no primary antibody exposure, as described in section 2.11.2. Additionally,
fluorescence intensity was measured in pre-labelled beads on three different
occasions using the same confocal microscope settings, to demonstrate that there
was minimal variation in the levels of fluorescence detected. These results are
summarised graphically in figure 2.9 and 2.10.
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Figure 2.9: Measurment of relative fluorescence intensity using Image J on three
separate days, using pre-labelled beads and the same confocal settings as those
used for all embryo analysis.
Figure 2.10: Measurement of relative fluorescent intensity in a blastocyst and a
cleavage stage embryo that had not been exposed to primary antibody during
labelling, in order to demonstrate the specificity of the analysis tool used.
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In order to measure fluorescence intensity gradients across a single cell or ICM, the
line selection tool was used, as detailed in figure 2.11.
Figure 2.11: Example of line technique to measure relative fluorescence intensity
in a blastocyst ICM
The numerical values generated in Image J were exported to Microsoft Excel
databases for analysis, and graphical representations produced for ease of
interpretation.
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2.14 Time lapse monitoring
Time lapse monitoring was undertaken to identify visual markers of embryo growth
and morphology at key developmental stages, to improve our understanding of the
temporal events involved in human pre-implantation embryo development.
During time lapse monitoring using the Cryo Innovation PRIMO Vision system
(Parallabs), a major problem initially encountered was the movement of embryos
out of the field of view. To overcome this, embryos were secured to the culture dish
using Cell-Tak™ (BD Biosciences). Immediately prior to use, a stock solution
containing 5µl Cell-Tak in 10µl 0.1M sodium bicarbonate (NaHCO3) was prepared,
and 5µl added to a Falcon 35mm culture dish (BD Biosciences). The Cell-Tak was
allowed to air dry for a minimum of 20 minutes in the laminar flow hood, and the
residue washed off with sterile water. The remaining footprint determined the
position of the culture media drop, which was initially made with sperm preparation
media (Origio) because its low protein constitution increased the adhesive qualities
of the Cell-Tak. The drop was covered with sterile oil (Origio). The sperm
preparation medium was then substituted with ~25µl ISM1 or BlastAssist, which
was equilibrated in a 37°C/5% CO2 incubator (Heraeus) for a minimum of two hours.
Once equilibrated, the embryo was placed in the media drop, where the zona
pellucida adhered to the Cell-Tak and remained secured in place. Embryos could be
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easily removed from the Cell-Tak by applying gentle pressure with a denuding
pipette.
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61 zygotes and embryos were monitored using the PRIMO Vision (Parallabs) system
placed inside a Heraeus 5% CO2 incubator set to 37°C, see figure 2.12.
PRIMO Vision intra-incubator system
Camera one Camera two
Microscope stage Fine focus
Figure 2.12: PRIMO Vision intra-incubator continuous monitoring system
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The dish containing the embryo was placed on the microscope stage, and the
integrated fine focus used to locate the embryo whilst viewing on the CryoEmbryo
Capture software (Parallabs) installed on the attached laptop monitor. The interval
time (minimum 10 minutes) and length of capture duration were specified, and a
unique project code assigned to each time lapse sequence, followed by initiation of
the programme. Embryos were assessed on-screen each day, and transferred to
dishes containing fresh medium and Cell-Tak every two days, followed by fixation in
3.7% formaldehyde. Time lapse sequences were saved to the hard drive and
analysed using CryoEmbryo Analysis software (Parallabs) and Image J. The data
generated was exported to Microsoft Excel files.
Due to the poor quality of acquired images and data, this work was subsequently
excluded from the final version of this thesis.
33 embryos were imaged using the Olympus IX81 (Olympus) inverted microscope
with Solent Scientific integrated environment-controlled chamber, as shown in
figure 2.13.
The chamber was pre-calibrated and set to 37°C/5% CO2, and constantly monitored
using an EasyLog USB data logger (Lascar Electronics, Salisbury, UK). Embryos were
transferred into 10 µl drops of pre-equilibrated stage-appropriate media under oil
in a Falcon 35mm culture dish (BD Biosciences). The dish was placed on the
microscope stage inside the chamber and the embryos located at 100x
magnification using the microscope eyepieces and fine focus. Once located, the
magnification was increased to 200x and the camera switched on to enable viewing
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of the microscopic field on the computer monitor. The focus was adjusted to
optimise the on-screen image, and the CellM Experiment Manager used to specify
the interval time (usually 5 minutes) and duration of capture required. Once the
monitoring period was complete, the time lapse sequences were converted to
Audio Video Interleave (AVI) files for analysis.
Laser module
Environmental chamber Camera control unit
Microscope
Figure 2.13: Olympus IX81 microscope with Solent Scientific environmental
chamber
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39 frozen-thawed research embryos and 403 freshclinical embryos were imaged
using the Embryoscope (Unisense Fertilitech) self-contained embryo monitoring
system, as shown in figure 2.14.
Embryoscope EmbryoViewer
Figure 2.14: Unisense Fertilitech EmbryoScope™ self-contained embryo monitoring
system
Sterile EmbryoSlides®, as shown in figure 2.15, were prepared by filling each
microwell with ~1µl ISM1 or BlastAssist (Origio) culture medium using a plastic
135µm EZ-Squeeze™ denuding pipette (Research Instruments) to avoid scratching
the bottom of the well, and topping up the medium in the well to 25µl using a
Gilson pipette, to minimise the formation of bubbles. All 12 wells were covered with
a 1.2ml layer of sterile light paraffin oil (Origio), and the EmbryoSlide equilibrated in
a 37°C 5% CO2 atmosphere for a minimum of 2 hours prior to use, according to the
media manufacturer’s protocol.
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EmbryoSlide Well Oil reservoir
Figure 2.15: Unisense Fertilitech EmbryoSlide®
Embryos were loaded into the EmbryoSlide (Unisense Fertilitech) using a sterile
plastic EZ-Squeeze denuding pipette (Research Instruments). The “add slide”
function was selected on the EmbryoScope menu to prompt the next available slide
holder to appear at the loading door, and the EmbryoSlide (Unisense Fertilitech)
placed inside the chamber. The EmbryoScope software auto-focus function located
each embryo within the individual well, before image acquisition commenced. Each
embryo was imaged on seven focal planes every 20 minutes, and captured images
were automatically saved using the EmbryoScope software, and converted to Audio
Video Interleave (AVI) files to enable the development of each embryo to be
visualised in a continuous time lapse video. Once the imaging period was complete,
each embryo was manually annotated using the EmbryoScope (Fertilitech) software
package. Using the EmbryoViewer, each cleavage division was inputted, along with
the number of visible nuclei and degree of fragmentation, to allow temporal-
dynamic changes in the developing embryo at specific time points to be identified.
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The data generated was exported as a comma separated value (csv) file, and
converted to a Microsoft Excel file for analysis.
2.15 Data analysis
Microsoft Excel was used to analyse cleavage times, time spent at each
developmental stage, compaction rate, cavitation rate, and blastocyst formation
rate of all embryos. Dynamic properties of some embryos, such as fluctuations in
the cytoplasm or membranes, and the rearrangement of blastomeres within the
confines of the ZP were also observed.
The results were used to compare fresh and frozen embryos of varying quality and
developmental stage, as well as the time lapse system used to acquire the data.
The two-tailed student’s T test, independent group’s T test, ANOVA, and Chi-square
tests were used to determine significance depending upon the data sets being
analysed.
2.16 Alteration of blastomere fate
To investigate whether removal or damage of specific identifiable blastomeres from
cleavage stage embryos had any effect on consequent development, time lapse
monitoring of preimplantation embryos from day 1 to day 3 post- insemination was
undertaken in the EmbryoScope (Fertilitech) to identify and track the first dividing
cell. The daughters of the desired cell were then deliberately damaged using a
micromanipulation technique similar to the ICSI procedure described in section 2.3,
and further development of the embryo monitored by EmbryoScope (Fertilitech)
time lapse imaging until day 5, 6 or 7. Assessment of themorphological
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characteristics and developmental progress of the embryo were noted, before
fixation in 3.7% formaldehyde.
Each embryo AVI file was annotated as described in section 2.13, and the data
exported as a csv file before conversion to a Microsoft Excel file for analysis.
2.17 Culture of embryos with leptin protein
To assess whether leptin affects human embryo development in vitro, day 4, 5 and
6 frozen-thawed embryos (n=14) were cultured with human leptin recombinant full
length protein (ab13987) (Abcam) at a concentration of 1µg/ml or 20ng/ml in pre-
equilibrated BlastAssist media (Origio) under sterile paraffin oil in a K-Systems G185
desktop incubator (Hunter Scientific) at 37°C/5% CO2 for a period of 10 minutes, 20
minutes, 30 minutes, or 24 hours. Embryos were assessed for blastocyst
development and quality, and then fixed in 1ml 3.7% formaldehyde.
To determine whether the expression of pSTAT3 was influenced by the presence of
leptin, blastocysts that had been cultured with 20ng/ml human recombinant leptin
were fixed in 3.7% formaldehyde and fluorescently labelled for pSTAT3 using a
polyclonal antibody (TYR-705) as the primary antibody (Cell Signalling), and FITC
conjugate (Sigma-Aldrich) as the secondary antibody, according to the method
described in section 2.1.11.2. Embryos were imaged using the Zeiss LSM 510
confocal microscope (Zeiss).
Image stacks were imported into Image J, and analysed as described in section 2.13
using the elliptical selection tool and the RGB measurement plugin, in order to
determine the relative fluorescence intensity. Measurements were taken in the
cytoplasm and nuclei of the inner cell mass and trophectoderm cells, as shown in
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figures 2.14 and 2.15. Each 1µm optical slice was analysed in turn from the top to
the bottom of the z-stack.
Figure 2.16: Selection technique used to measure the relative fluorescence
intensity in each nuclei of the trophectoderm in a blastocyst (selection tool shown
in yellow)
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Figure 2.17: Selection technique used to measure the relative fluorescence
intensity in the cytoplasm and nuclei of the trophectoderm and inner cell mass of a
blastocyst
The pixel data generated was exported to Microsoft Excel files for analysis. The
relative fluorescence intensity of FITC was measured separately in the inner cell
mass and trophectoderm cytoplasm, and the inner cell mass and trophectoderm
nuclei for comparison. Those embryos previously labelled for pSTAT3 without
exposure to leptin protein were used as a control. Two-tailed student’s t test was
used to determine statistical significance.
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2.18 Polymerase Chain Reaction
In order to determine whether leptin receptor and SUMO-1 ribonucleic acid (RNA)
was present on human oocytes and pre-implantation embryos, quantitative Real-
Time Polymerase Chain Reaction (qRT-PCR) was performed on frozen-thawed
oocytes (SUMO-1), zygotes and embryos (SUMO-1 and leptin receptor) at varying
developmental stage and quality, obtained 1-7 days post-insemination.
2.18.1 Cell Lysis
The Ambion Single Cell-to-CT™ Kit (Life Technologies Ltd, Paisley, UK) Single Cell
Lysis Solution, Single Cell DNase 1, and Single Cell Stop Solution were removed from
the -20° freezer and thawed for approximately 5 minutes. For each oocyte/embryo,
9µl Single Cell Lysis Solution was mixed with 1µl DNase 1 (Life Technologies) in a
sterile 0.5ml flat cap PCR tube (Starlab Group, Milton Keynes, UK). The zona
pellucida of each oocyte/embryo was removed by rinsing through Acid Tyrodes
Solution (Origio) and ISM1 medium (Origio) with a 135µm denuding pipette (Origio).
The zona-free oocytes/embryos were added to the PCR tubes containing
lysis/DNase solution and incubated for 5 minutes at room temperature. The cell
lysis reaction was halted by adding 1µl Single Cell Stop Solution (Life Technologies)
to each tube and incubated for a further 2 minutes at room temperature. The tubes
were stored at -20°C until ready for processing.
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2.18.2 RNA Reverse Transcription
The Ambion Single Cell-to-CT™ Kit (Life Technologies) Single Cell VILO™RT Mix and
the Single Cell SuperScript® RT were removed from the -20°C freezer and kept on
ice.
When thawed, 3µl Single Cell VILO™ RT Mix (Life Technologies) was added to 1.5µl
Single Cell SuperScript® (Life Technologies) per reaction in a sterile 0.5ml flat cap
PCR tube (Life Technologies), and centrifuged to ensure all solution was mixed in
the bottom of the tube. Each pre-prepared lysed cell sample tube was centrifuged
prior to addition of 4.5µl RT reaction mix.
The sample tubes were centrifuged once more before transferring to a pre-heated
Hybaid PCR Sprint Thermal Cycler (Thermo Scientific, Ma, USA). Reverse
transcription of RNA to complementary deoxyribonucleic acid (cDNA) was achieved
by running a three-step programme. Copying the RNA to produce a strand of cDNA
was accomplished by holding the PCR tubes at 25°C for 10 minutes. Extending the
copies of the resulting cDNA strand occurred at 42°C for 60 minutes, and the
reverse transcriptase was stopped by holding at 85°C for 5minutes. Samples tubes
were removed from the thermal cycler, allowed to cool, and kept at -20°C until
ready to perform cDNA preamplification.
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2.18.3 cDNA Preamplification
In order to preamplify the cDNA prior to performing RT-PCR, lypholised primers for
the detection of leptin receptor (Sigma) or SUMO-1 (Sigma) were resuspended in
RNase/DNase free sterile water according to the required nanomolar concentration.
Thesense primers, sequence 5’CTATGAGGACGAAAGCCAGAG3’ (leptin receptor) and
5’TTTGTAAACCCCGGAGCGA3’ (SUMO-1) were resuspended in 394µl, and the anti-
sense primers, sequence5’GACTGAACTATTTATAAGCCCTTGT3’ (leptin receptor) and
5’TTCAACTGAGGACTTGGGGG3’ were resuspended in 404µl. The tubes were
centrifuged to ensure complete mixing, and 2µl of each primer mix per reaction was
added to 68µl of pH 8.0 Tris/EDTA buffer (TE buffer) (Applied Biosystems), to
produce a final concentration of 20nmol.
2.18.4 Real-Time PCR
For each reaction, 5µl of Ambion Single Cell PreAmp Mix (Applied Biosystems) was
added to 6µl of the prepared primer mix in a sterile 0.5ml flat cap PCR tube (Life
Technologies) and centrifuged. Finally, 11µl of the preamplification mixture was
added to each cDNA sample. The sample tubes were centrifuged once more before
transferring to a pre-heated Hybaid PCR Sprint Thermal Cycler (Thermo Scientific).
Preamplification of cDNA was achieved by holding the temperature at 95°C for 10
minutes, then denaturing and extending the cDNA copies at 95°C for 15 seconds
and 60°C for 4 minutes respectively. This cycle was repeated 14 times, followed by
enzyme deactivation at 99°C for 10 minutes. The preamplified cDNA samples were
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diluted 1:2 with RNase/DNase free water in sterile 0.5ml flat cap PCR tubes,
centrifuged and stored on ice until ready to proceed with the RT-PCR step.
Lypholised primer and double-dye Taqman probe mixture for detection of leptin
receptor or SUMO-1 (PrimerDesign Ltd, Southampton, UK) were resuspended in
330µl sterile RNase/DNase free water, then vortexed and centrifuged briefly to
ensure complete resuspension. In a sterile 1.5ml flat cap PCR tube, 1µl of the
primer/probe mixture was added to 10µl Precision-LR MasterMix and 4µl
RNAse/DNAse free water per reaction. A Micro Amp Fast Optical 96-well Reaction
Plate (Applied Biosystems) was prepared by reverse-pipetting 15µl
primer/Mastermix into each well, and adding 5µl 1:10 diluted specific cDNA
solution. Each reaction was performed in triplicate, and negative control wells were
included containing only RNase/DNase free water to ensure cross contamination of
the wells or sample had not occurred. The plate layout is shown in figure 2.18. For
the SUMO-1 run, the plate layout was similar, although wells A1 and B1 contained
oocyte cDNA solution, and subsequent wells in column 1 contained zygote stage,
cleavage stage and blastocyst stage cDNA solutions.
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RNase/DNase-free water only
Figure 2.18: Layout of 96-well PCR plate for detection of leptin receptor RNA.
Once prepared, Thermal Seal RT2 optically transparent film (Sigma) was sealed
around the top of the plate to cover all wells, and the plate centrifuged at 3000rpm
for 7 minutes.
Amplification was achieved using an Applied Biosystems 7500 Fast Real Time PCR
system (Life Technologies) at standard speed. Enzmye activation was attained by
heating the plates at 95°C for 10 minutes, followed by denaturation at 95°C for 15
seconds and fluorogenic data collection at 60°C for 60 seconds. The cycle was
repeated 50 times.
Data was collected and visualised using the integrated 7500 StepOne Software.
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2.19 Extracellular Matrix Protein 3D implantation model
Matrigel™ Basement Membrane Matrix (BD Biosciences) is a solubilised basement
membrane preparation extracted from the Engelbreth-Holm-Swarm (EHS) mouse
sarcoma, containing similar structural proteins and growth factors to the
endometrial matrix (Ghaffari Novin et al 2007). In order to study cell adhesion and
invasion, mimicking the implantation process in vivo, 19 embryos at days 4-7 post-
insemination were cultured on Millicell (Millipore, Watford, UK) inserts containing a
mixture of Matrigel (BD Biosciences) and BlastAssist (Origio) culture media in
Corning Costar 24 well culture plates (Sigma-Aldrich).
Prior to commencing the implantation model experiments, the Matrigel was
thawed overnight at 4°C. To ensure homogeneity in the reconstituted solution, the
vial was swirled prior to dispensing into 250µl aliquots using pre-cooled pipettes,
tips (Gilson Scientific, Luton, UK), and 0.5 ml micro tubes (Sarstedt, Leicester, UK) to
minimise repeated freezing and thawing. The aliquots were then refrozen and
stored at -20°C until required, when one aliquot of the solution was thawed at 4°C
overnight.
Liquefied Matrigel (BD Biosciences) and pre-equilibrated BlastAssist (Origio) culture
medium were mixed in a 1:1 ratio (100µl each) and layered onto the bottom of the
Millicell insert. The insert was placed into a 24 well culture plate (Sigma-Aldrich)
containing 500 µl BlastAssist (Origio) medium to ensure that the insert membrane
was immersed, and equilibrated at 37°C/5% CO2 for at least two hours, in
accordance with the media manufacturer’s instructions. Fresh and frozen-thawed
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embryos at day 4-7 post-insemination were placed inside the Matrigel/culture
medium and incubated at 37°C/5% CO2. Embryos were visualised by light
microscopy at 24-hour intervals to assess the adhesion and outgrowth during
attachment and hatching of the blastocysts. Once the culture period was complete
the permeable membrane on the bottom of the Millicell insert was detached using
a fine gauge needle to cut around the edge, and the membrane and gel disc placed
into a Falcon 50x9mm petri dish with snap-shut lid (BD Biosciences) and flooded
with 3.7% formaldehyde in order to fix the whole mount.
2.20 Culture of embryos in conditioned medium
In order to determine the effect of adhesion- and invasion- stage endometrium
secretions on human preimplantation embryo marker profiles, day 5 and day 6
blastocysts were incubated with supernatant media from decidualised and non-
decidualised human stromal cell cultures, or supernatant media from Ishikawa cell
cultures, for varying time periods.
2.20.1 Endometrial biopsy preparation and media collection
Endometrial biopsies were collected from patients attending the recurrent
miscarriage clinic at the CRM. The biopsies were prepared by transferring the tissue
into 100mm Corning plastic culture dishes (Sigma-Alridch) and drawing off any
excess fluid and mucus with a 1000µl Gilson pipette tip. Digestion of the tissue was
achieved by mashing for 5 minutes using scalpel blades, adding 10mls filtered
Dulbecco’s Modified Eagle Medium (DMEM) F12 serum-free medium supplemented
with 100µl collagenase and 100µl DNAse (Invitrogen), and incubating at 37°C/5%
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CO2 in Corning 25cm
2 flasks (Sigma-Aldrich) for one hour, shaking every 20 minutes
to mix.
The enzymes were deactivated after one hour by adding DMEM F12 serum-
supplemented media, and the cells spun down, resuspended and transferred to
Corning 25cm2 flasks (Sigma-Aldrich) for incubation at 37°C/5% CO2 in air.
Cell cultures were checked every day, and media changed every two days until a
convergent layer had grown on the bottom of the flask. The supernatant media
removed from the cell cultures was collected in 5ml round-bottom tubes, aliquoted
into 0.5ml eppendorf tubes, and stored at -80°C.
2.20.2 Blastocyst culture
Frozen blastocysts at day 5 or 6 post-insemination were thawed as described in
section 2.6, and incubated in pre-equilibrated BlastAssist media (Origio) under oil at
37°C/5% CO2 for two hours.
Blastocysts (n=3) were exposed to stromal cell or Ishikawa cell- conditioned media
for 10 minutes or 20 minutes, and immediately fixed in 3.7% formaldehyde. The
embryos were labelled for pSTAT3 as described in section 2.11.2, imaged using
confocal microscopy, and the z-stacks imported into Image J for analysis as
described in section 2.13.
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2.21 Image processing for creation of computer-generated models
The confocal and time-lapse images acquired were exported in TIFF or AVI file
format to the International Digital Laboratory, WMG, University of Warwick, and
the School of Computing, Mathematics and Digital Technology, Manchester
Metropolitan University.
Here, the images were pre-processed for 3-dimensional computer modelling and
development of semi-automatic software tools using algorithms scripted in Matlab
(MathWorks, Cambridge, UK). All image analysis and programme development was
performed by colleagues at the University of Warwick, and Manchester
Metropolitan University, using embryological datasets obtained as described in
sections 2.12 and 2.14.
[137]
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in advance of the point at which it was known whether or not they had any surplus
material available that could potentially be used for research, often patients were
consented who subsequently had no material that was suitable for use in the
research. The process of consenting was therefore time consuming and inefficient,
but complied with all regulatory expectations.
A total of 445 embryos were donated for use in research procedures, such as fixing
and fluorescent staining, and cell damage experiments (the experimental group).
However, ~30% of these were not usable due to the embryos being degenerate, not
recovered from the freezing straw, or not found in the transportation tube. Fresh
oocytes and embryos accounted for 60% of the total, whilst 40% were frozen
embryos. The details of the patient population providing this research material are
the focus of this chapter.
Data from 924 embryos that were monitored using time lapse technology as part of
routine clinical treatment were used for time lapse studies (the clinical group). Due
to the relatively recent implementation of the Embryoscope™ as a clinical tool, only
limited data about the couples donating these embryos was available at the time of
writing this thesis, and therefore the only the details regarding patient age,
aetiology, treatment type, number of oocytes retrieved, and urinary hCG pregnancy
test in this group are included.
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3.2 Patients
In total, 165 couples were involved in donating the experimental material to the
project, and 76 patients had their clinical embryo data analysed. The age of the
female patients in the experimental arm ranged from 23-44 years, with a mean age
of 34.6 (±4.05) years. BMI ranged from 17-42 kg/m2, with an average 25.3 (±4.60)
kg/m2.
In the clinical group, the female age ranged from 25-41 years, with a mean age of
34.5 (±3.91) years.
Male factor infertility was the most prevalent specific aetiology in the experimental
cohort of patients, with 50% of couples affected. This is a relatively high proportion
in comparison to published data, although since 40% of the embryos used in this
study were frozen surplus embryos, this is not entirely unexpected. Embryos derived
from couples where male factor infertility predominates are more likely to be of
superior quality, since there is no known female factor influencing the subfertility.
Tubal disease accounted for 19% of infertility problems, and 11% of cases involved
unexplained infertility. In 8% of cases, the aetiology of infertility was attributed to
ovulatory dysfunction, and 5% to age-related decreased ovarian reserve. 2% of all
female patients recruited for this study had been diagnosed with endometriosis,
and 4% had been diagnosed with polycystic ovaries (PCO) as the major factor of
infertility. This is considerably lower than that reported in the general population,
which is estimated at up to 20% (Sirmans and Pate 2014), although similar
occurrence of PCO has been reported in previous studies (Bahceci and Ulug 2004).
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The variation in the occurrence of PCO as a cause of infertility suggests that there
are several factors influencing the infertility status of these patients. Pre-
chemotherapy fertility preservation accounted for 1% of the patients involved in
this study.
In the clinical group, 62% of patients had a female factor as the predominant
underlying cause of infertility, 36% male factor, and 2% unexplained. This high
incidence of female factor may be due to the nature of the patients opting for time
lapse imaging, for instance those who have previously had an unsuccessful cycle and
who would benefit from the additional information about their embryo
development provided by the generated images. Poor embryo development may be
related to reduced oocyte quality, and thus would be indicative of female-related
factors.
65% of couples in the research cohort presented with primary infertility, compared
to 35% of couples with secondary infertility.
3.3 Treatments
The majority of couples (52%) who donated research embryos for this project were
attempting their first fresh cycle of IVF or ICSI treatment. Other couples were
embarking on a second (32%), third (14%), fourth (5%) or fifth (6%) fresh attempt.
One couple had previously had five fresh attempts, and the embryos donated to this
project were created during their sixth fresh cycle. The chance of a live birth
reportedly increases with cumulative cycles of ART, using fresh and frozen embryos
(McLernon et al 2016).
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Most of the couples undergoing treatment were having ICSI (60%), which is
consistent with the high incidence of male infertility in the recruited cohort.
Standard IVF accounted for 38% of treatments, whilst 2% of couples opted for an
IVF/ICSI split.
In the clinical group, the treatment type was virtually identical to the research
group, with 60% of the couples having ICSI. This does not correlate with the lower
percentage of male factor patients, but may be explained by a higher number of
couples with a previously failed cycle electing for ICSI as a precaution against poor
fertilisation rates, for those with low oocyte numbers, or for patients with several
factors contributing to their infertility, but for whom female factors predominate.
3.4 Lifestyle
Female patients who admitted to smoking comprised 6% of the total for whom this
information was available, whilst 2% claimed to be former smokers. More than
twice as many male patients (15%) admitted to smoking. However, this may not be
reliable, because NHS funding criteria often specify that those funded must be non-
smokers. No tests or further investigations are routinely carried out to verify non-
smoking status. The number of smokers in this study is too small to study any
potential link between smoking and treatment outcome, however female smoking
has been linked to reduced ovarian response and lower clinical pregnancy rates in
ART cycles (Freour et al 2008).
Alcohol use was commonplace in this patient group, with 87% of females and 83%
of males consuming alcohol. Females drinking more than the government
recommended limit of 14 units per week comprised 11% of alcohol consumers,
[143]
whilst 17% of males were drinking more than 21 units of alcohol per week. A
pregnancy rate of only 11% was observed when the female partner consumed more
than 14 units of alcohol per week, although the number of subjects in this category
was small (n=9).
3.5 Number of oocytes collected
The number of oocytes collected from each patient in the research group varied
from 3-68, with a median of 11, and in the clinical group from 2-26, with a median
of 9. The numbers of oocytes at the top end of the range are extremely large;
however the number of patients with high oocyte numbers was minimal. Clearly,
the patients studied had surplus material so low responders who had low numbers
of oocytes collected were under-represented in this group. The optimal number of
oocytes required from a fresh ART cycle to maximise cumulative live birth rate has
previously been reported as 10 or more (Drakopoulos et al 2016). I found no
significant correlations between the numbers of oocytes collected and the female
patient age, female BMI, primary versus secondary infertility, attempt number, or
treatment type. Neither was the number of oocytes collected linked to pregnancy
result. These findings are in contrast to published data, where the number of
oocytes retrieved decreases with patient age (Tan et al 2014; Drakopoulos et al
2016), and is reportedly strongly correlated with live birth rate (Sunkara et al 2011).
There was a trend towards an increased number of oocytes collected for those
couples where male factor infertility was the predominant aetiology, although the
difference was not significant.
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These unexpected results may reflect the cohort of patients included in the research
group, who generally had a better prognosis by default due to them having surplus
material available, and/or frozen embryos. This group of patients is therefore not
representative of the general IVF population.
3.6 Embryo development and utilisation
The number of zygotes formed following insemination in the research group ranged
from 0-42, with an average of 6.7 (±4.45), and the overall fertilisation rate was 55%.
The majority of patients had 2 embryos transferred (76%), whilst 28% of patients
had a single embryo transfer. One patient aged 44 years had 3 embryos transferred
on day 5 (1x early blastocyst; 2x morula), resulting in a biochemical pregnancy.
Transfer of 3 embryos is discouraged by the HFEA, although is permitted in
exceptional circumstances for women aged 40 years or over. No suitable embryos
were available to transfer in 4% of couples who took part in this study.
The first priority for all patients is to have any surplus good quality embryos
cryopreserved. It is only after cryopreservation of any suitable embryos has taken
place that other embryos can be considered for research use. The number of
embryos frozen in each cycle varied from 0-12, not including those cycles requiring
all zygotes or embryos to be frozen electively (n=3) in order to avoid a transfer at
that time, for example due to cancer therapy or adverse endometrial environment.
The total embryo utilisation rate, which takes into account the percentage of
embryos transferred or cryopreserved in each cycle, ranged from 0-100% (average =
52%).
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3.7 Outcomes
In total, 47% of patients involved in the research arm of this study had a positive
urinary hCG test in the fresh cycle in which the donated embryos were created 12-
14 days post-transfer, depending upon the developmental stage of the embryo
transferred. Seven weeks post-transfer, 75% of those patients had a foetal heart
beat detected by ultrasound scan. Biochemical pregnancy was diagnosed in 16% of
cases at this time, whilst 9% of patients suffered a miscarriage after the seven week
scan. The multiple pregnancy rate for this group of patients was 33%.
Increasing patient age was correlated with a decline in pregnancy rate in this group
of patients, as shown in figure 3.1.
Figure 3.1: Bar chart to show patient age versus urinary hCG result. Increasing
patient age is correlated with decreasing positive pregnancy result
[146]
The percentage of embryos utilised in each cycle was positively correlated with
pregnancy, as shown in figure 3.2.
Figure 3.2: Scatter plot showing the embryo utilisation rate (%) versus the urinary
hCG result. A higher utilisation rate correlates with positive pregnancy result
[147]
Additionally, the higher percentage of embryos utilised in each cycle was associated
with ongoing pregnancy. Those patients who had a lower embryo utilisation rate
were significantly more likely to suffer a biochemical pregnancy or a miscarriage
than those with a higher embryo utilisation rate (*p=0.004; two-tailed t test).
Figure 3.3: Bar chart showing the mean embryo utilisation rate (%) versus th
pregnancy outcome. A higher rate of embryo utilisation is correlated with
successful pregnancy outcome
For the clinical group of patients, whose embryos were monitored in the
Embryoscope (Unisense Fertilitech) and whose outcomes were reported, the ov
pregnancy rate was 49%.e
erall
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Analysis of the number of embryos frozen in each cycle shows that positive
pregnancy is associated with embryo cryopreservation. The mere fact that there are
embryos available to freeze seems more important than the number of embryos per
se, as 60% of patients who had embryos frozen became pregnant. The majority of
patients (72%) with no embryos to freeze did not become pregnant.
The following four chapters will summarise how each embryo was utilised during
the course of this project, and the results obtained from the associated experiments
and analysis.
[149]
Chapter Four
Potential Molecular and Morphological Markers of Human
Embryo Viability
[150]
Chapter Four
Potential Molecular and Morphological Markers of Human
Embryo Viability
4.1 Introduction
Several morphokinetic markers of human preimplantation embryo viability, which
relate to the morphology and rate of developmental progression, have been
identified. These markers are routinely visualised during embryo culture in the
clinical IVF laboratory to assist in the identification and selection of those embryos
that are most likely to result in a pregnancy (Montag et al 2013). These are
considered to be non-invasive, as the need for manipulation of the embryos is
minimal when assessing morphology. In addition, a number of invasive methods of
predicting human preimplantation embryo viability also exist, including polar body,
blastomere, and trophectoderm biopsy for preimplantation genetic diagnosis
(Montag et al 2013). The ultimate goal in clinical embryology is to be able to
accurately predict the implantation potential of a single embryo using the least
invasive methods possible. Time lapse imaging is an emerging non-invasive
technology used to identify cleavage patterns and temporal behaviour in developing
embryos, and this is investigated in more detail in chapter six of this thesis.
Fragmentation is a common occurrence in human embryos, and may be a
permanent feature or a transient episode during preimplantation embryonic
development (Van Blerkom et al 2001). Fragments may be associated with
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apoptosis, during which large aggregations of chromatin form on the inner nuclear
membrane of cells, condensation of the cytoplasm occurs, and indentations of the
cytoplasmic membranes are observed. Following fragmentation of the nucleus, the
apoptotic cell breaks down into membrane-bound bodies which may contain
fragments of the nucleus (Hardy 1999). Apoptotic cells in human preimplantation
embryos have been identified, and are characterised by nuclear membrane
blebbing, condensation of chromatin, vacuoles in the cytoplasm, and fragmentation
of the nuclei and cytoplasm (Hardy 1999; Brison 2000; Chi et al 2011). These may be
associated with micronuclei, which may be seen frequently in human embryos
during clinical observation; however, a link with embryo quality had not previously
been explored at the time of initiating this project. Additionally, fragmentation
occurring as a direct consequence of apoptosis has been previously dismissed
(Antczak and Van Blerkom 1999). A significantly higher proportion of chromosomal
abnormalities have been identified in blastocysts derived from poorer quality
cleavage-stage embryos in comparison with those developing from good quality
embryos (Hardarson et al 2003). Furthermore, blastocysts arising from poor
morphology day two embryos had significantly fewer cells at the blastocyst stage
than those arising from good quality day two embryos (Hardarson et al 2003). More
recently, chromosome-containing fragments and micronuclei within developing
human embryos have been shown to contribute to embryonic aneuploid status
(Chavez et al 2012).
The number of cells within the human blastocyst is broadly associated with viability.
In early studies of human blastocysts, the number of TE cells remained largely
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unchanged between day 5 and day 6, but had doubled by day 7. Conversely, the
number of ICM cells doubled between day 5 and day 6 but remained unchanged on
day 7. The proportion of ICM cells ranged from one third to one half of the total cell
number depending upon the number of days since insemination (Hardy et al 1989).
The occurrence of human monozygotic twins is increased following assisted
reproductive treatment (Edwards et al 1986; Behr et al 2000), and significantly
increased when blastocysts are transferred compared to the transfer of cleavage
stage embryos (Milki et al 2003). One suggested mechanism for this phenomenon is
the development of two inner cell masses in the blastocoelic cavity (Meintjes et al
2001). One study observing the behaviour of mouse blastocysts with double inner
cell masses found that each inner cell mass continued to develop after hatching
(Chida 1990). Additionally, the characterisation of monozygotic twins identifies four
types depending upon the time of embryonic division, with type II being derived
from a separation of a single inner cell mass into two. This is the most commonly
occurring (~80%) of all monozygotic twin types (Hogenson 2013).
Excluded cells, which exhibit poor interaction with other embryonic cells, are
commonly seen in compacting and cavitating stage preimplantation embryos (Hardy
et al 1996). Early electron microscopy studies of abnormal mouse embryos showed
that one or more large excluded cells, possessing the structural characteristics of 8-
cell stage blastomeres, were present at the blastocyst stage. The excluded cells
were usually confined to the periphery of the blastocyst, although they were
occasionally observed within the blastocoel (Calarco and Perdersen 1976). These
are likely to be cells that have arrested at some point during the development of
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the embryo, and are banished into the perivitelline space during compaction,
excluding them from becoming part of the eventual blastocyst (Hardarson et al
2012). Cells at the cleavage stages are not necessarily identical, with variations in
both chromosomal and cytoplasmic components evident. It is unknown whether
these cells may be a response to abnormality, for example, allowing improved
distribution of what material is present, or an abnormality per se. However, when
compaction and cavitation occur in human embryos, substantial rearrangements
are also noted (Mihajlovic et al 2015).
Non-invasive markers currently offer limited information about embryonic
molecular constitution, which normally requires invasive analysis. Conversely,
invasive analysis cannot be directly related to developmental potential, since this
cannot be measured following invasive testing. Proposed molecular markers of
embryo viability include the integrity of the actin cytoskeleton and the polar
distribution of the closely-associated regulatory proteins leptin and STAT3 (Antczak
and Van Blerkom 1997).
Actin is a ubiquitous contractile protein which has key roles in cellular shape and
motility (Small et al 1999). The uniformity of the actin cytoskeleton is an indicator
of the quality of preimplantation embryos (Levy et al 1998; Wang et al 1999).
Initially, actin was selected for this project in order to highlight and visualise the
borders between cells with a view to developing computer-generated models of
human embryo development. The results reported in this chapter are therefore
secondary to the initial purpose of actin staining.
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Polarisation refers to the non-uniform organisation of components of the oocyte
and embryo, and is believed to underlie the ability of the early embryo to
differentiate into two cell types at the blastocyst stage (Edwards and Beard 1997).
Polarity in oocytes can be identified by reference to the polar body positions
(Gardner 1997; Garello et al 1999), but cytoplasmic rotations may make these
assessments unreliable.
Leptin and STAT3 have previously been shown to have a polarised distribution in
the oocytes of mice and humans, and to be distributed differentially between
blastomeres of cleavage stage human embryos (Antczak and Van Blerkom 1997).
Leptin, the product of the mouse obese (ob) gene, is a 16-kDa non-glycosylated
peptide hormone synthesised primarily by adipocytes, with the characteristics of a
secreted protein (Zhang et al 1994). Leptin is associated with the activation of
STAT3, during which Janus kinases catalyse the phosphorylation of cytoplasmic
STAT3 via the Jak/STAT signalling pathway, forming homo- and/or heterodimers
which translocate to the nucleus and activate transcription of target genes (Duncan
et al 1997). The use of leptin and STAT3 labelling during this project was aimed at
investigating whether these polarised markers were affected by or associated with
embryo quality. Such molecular markers cannot be detected using conventional
light microscopy as applied in the clinical setting. Instead, specialised fluorescent
stains and microscopy techniques are required in order to highlight the target
marker (Lichtman and Conchello 2005). Unlike time lapse imaging, these techniques
preclude live cell imaging, since fixation of the embryos is required prior to staining,
and therefore these methods are considered highly invasive and non-compatible
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with continued embryo development. For this reason, it is impossible to fully
quantify how the distribution of proteins within human preimplantation embryos
directly relates to achievement of pregnancy. However, examining the distribution
of structural and cytoplasmic proteins within three-dimensional reconstructions of
human embryos under experimental conditions may help to increase our
understanding of the mechanisms of development, which can be used to advantage
in the clinical IVF laboratory.
4.2 Aims
The aims of the experiments presented in this chapter were:
To detect and confirm the distribution of the actin cytoskeleton in cleavage stage,
compacting, and arrested human preimplantation embryos and blastocysts.
To establish whether the regulatory proteins STAT3 and leptin are polarised within
human oocytes and preimplantation embryos, and whether their distribution differs
in relation to the position of the polar body in metaphase II stage oocytes and
oocytes that have failed to fertilise, and between the cells of the trophectoderm
and the inner cell mass.
To determine the number of cells in the inner cell mass and the trophectoderm in
human blastocysts during in vitro development, and to consider morphological
characteristics of cleavage stage embryos and blastocysts and their relationship
with quality and possible clinical outcomes.
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4.3 Methods
171 human oocytes and embryos of varying developmental stage and quality were
fixed and stained with fluorescent probes to determine the distribution of actin,
STAT3, pSTAT3 and leptin, as described in section 2.11, and imaged using confocal
microscopy with standardised settings, as described in section 2.12. Relative
fluorescence intensities were measured using Image J with techniques validated
using positive and negative controls, as described in section 2.13. Morphological
features of stained and unstained blastocysts, such as free cells, excluded cells,
cytoplasmic projections, and double ICMs were identified, and cell numbers in the
ICM and TE of blastocysts were determined.
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4.4 Results
4.4.1 Actin
A total of 26 frozen-thawed and 24 fresh embryos were fixed and labelled with
AlexaFluor® 488 phalloidin in order to visualise the actin cytoskeleton, and mounted
in DAPI medium to highlight the nuclear chromatin, as described in section 2.11.1.
Figure 4.1 shows the pattern of actin distribution in poor quality fresh cleavage
stage embryos. Figure 4.1 (a) shows two images of a day four embryo with five cells.
There are clear borders around each blastomere and around individual fragments.
Note the appearance of the nucleus in the top cell in figure 4.1 (a), this may be
disorganised chromatin or poorly organised mitotic chromosomes. Figure 4.1 (b)
shows a day four fresh embryo with a large arrested cell. There are distinct actin
borders visible around the edges of the intact cells, and around the morphologically
normal cell nuclei. There is no discernible actin border surrounding the
fragmented/mitotic chromosomes of the nucleus in the arrested cell.
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(a)
(b)
Figure 4.1: Confocal images showing actin distribution in (a) fresh 5-cell
arrested embryo (b) fresh 4-cell embryo with a large arrested cell on the left
hand side of the image. Distinct actin borders are seen around each cell,
intact nuclei, and small individual fragments, but not around the
disorganised chromatin of the fragmenting/mitotic nuclei
[159]
The patient who donated the embryos in figure 4.1 did not have an embryo transfer
during the fresh cycle, so the implantation potential of the sibling embryos is not
known.
Figure 4.2 shows confocal images of day two frozen-thawed embryos of varying
quality. There are no distinct actin borders around the individual blastomeres or the
cell nuclei. The cell survival rates were 2/2 (100%, a) and 3/4 (75%, b), thus both
embryos in this example would be deemed clinically viable post-thaw. Each of the
cells visible is mononucleated and both polar bodies are also identifiable in these
images. Both of the embryo donors became pregnant after embryo transfer in the
fresh cycle.
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(a)
(b)
Figure 4.2: Confocal images showing actin distribution in the cells of (a) 2-
cell frozen-thawed embryo (b) 3-cell frozen-thawed embryo. The cytoplasmic
actin distribution is non-uniform, and the blastomeres lack a distinct actin
border
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Figure 4.3 shows examples of actin distribution patterns in morphologically normal
appearing day two and day three frozen-thawed embryos. All of the embryos have
clear actin boundaries around the individual blastomeres. The percentage cell
survival for the embryos were 75% (c) 85% (f) and 100% (a), (b), (d), (e) respectively,
thus each of these embryos would have been deemed viable upon thawing
according to our clinical laboratory protocols. The fresh cycles of the three patients
who donated these particular embryos all resulted in live births.
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(a) (b) (c)
(d) (e)
(f)
Figure 4.3: Confocal images showing (a) a day 3 frozen-thawed
morphologically normal appearing embryo with chromosomes apparently
well aligned in metaphase, (b) a day 3 frozen-thawed embryo with some
multi-nucleated cells (c) a day 2 frozen-thawed embryo, (d) a day 2 frozen-
thawed embryo, (e) a day 2 frozen-thawed embryo (f) a day 2 frozen-thawed
embryo
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Figure 4.4 shows confocal images of a day four fresh compacting embryo. There is
actin fluorescence at the periphery and at the junctions between cells, which are
beginning to flatten against one another. The areas lacking in fluorescence are
vacuoles, and some stained areas of fragmentation can be observed in the
perivitelline space.
Figure 4.4: Confocal images showing actin distribution in a compacting day 4
fresh embryo. There is actin fluorescence seen at the periphery and junctions
between cells. The differences in image intensity are due to the focal z-plane
[164]
Figure 4.5 shows day six fresh blastocysts at varying degrees of expansion. Actin
staining is most intense at the junctions between cells but is variable from cell to
cell. This is noticeable in both the trophectoderm and the inner cell mass.
(a) (b)
(c)
Figure 4.5: Confocal images showing actin borders around individual cells of
the trophectoderm and inner cell mass of (a) a day 6 fresh early blastocyst
(b) a day 6 fresh 1CC grade blastocyst, and (c) a day 6 fresh hatching
blastocyst
[165]
The variability of actin staining and the lack of consistent findings even within
embryos of apparently similar morphology, did not allow it to be used as a reliable
cell surface marker for modelling purposes, nor did it have any potential as a useful
viability marker in embryos.
4.4.2 Leptin, STAT3 and pSTAT3 distribution
A total of 121 oocytes and human preimplantation embryos were fluorescently
labelled in order to visualise the regulatory proteins leptin, STAT3 and pSTAT3, as
described in section 2.11.2.
Fluorescently labelled cleavage stage embryos were analysed to investigate
whether there were differing levels of leptin and STAT3 between individual cells.
However, since the analysis was deemed to be incorrectly executed, these results
have not been included in this chapter.
Distribution of leptin in unfertilised oocytes
Leptin distribution was measured in mature oocytes that had been exposed to
spermatozoa, but had failed to fertilise, herein referred to as 0PNs. The
fluorescence intensity of the leptin staining was determined at the periphery and
centre of the 0PNs, and near and opposite the polar body using Image J software, as
described in section 2.13. The results are shown in figure 4.6. There was a
significantly higher level of leptin staining at the periphery of the 0PNs compared to
the central area (p=0.001; Student’s t-test). There was no difference in the
distribution of leptin near and opposite the polar body.
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Figure 4.6: Distribution of leptin at the periphery versus the centre,
beneath the polar body versus opposite the polar body in unfertilised m
oocytes. There is a distinct pattern of leptin distribution between t
periphery and centre of the 0PNs, but no discernible difference betwee
region under the polar body versus the area directly opposite the polaand
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Distribution of leptin in cleavage stage embryos
Leptin distribution within the cell was assessed by measuring the fluorescence
intensity at the periphery and the perinuclear region of each individual cell. The
results show generally higher expression of leptin at the periphery of each cell in
comparison to the perinuclear region, as summarised in figure 4.7.
Figure 4.7: Intracellular leptin distribution in cleavage stage embryos. There
is evidence of higher leptin levels at the edge of each cell in comparison to
the perinuclear region
[168]
Distribution of leptin in blastocysts
Leptin was measured in the inner cell mass and the trophectoderm cells using
Image J, to establish whether there was a differential distribution between the two
cell populations. The images, as demonstrated in figure 4.8 (a) and (b), show a trend
towards higher levels of leptin in the trophectoderm compared to the inner cell
mass, although this is not true for all blastocysts, as seen in figure 4.8 (c).
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(a)
(b)
(c)
Figure 4.8: Confocal images showing examples of the distribution of leptin (green)
in (a) day 6 fresh 2BB (b) day 7 fresh 4CC (c) day 7 fresh 2CC blastocysts
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The results are summarised in graphical form in figure 4.9. There does not appear to
be a link between expansion status or blastocyst quality and leptin expression
levels.
Figure 4.9: The distribution of leptin in the inner cell mass relative to the
trophectoderm in blastocysts of varying degrees of expansion and quality. Whilst
there was a trend towards higher levels of leptin in the TE compared to the ICM,
there were no significant differences and no correlation between leptin
distribution and the stage of development
[171]
Distribution of STAT3 in unfertilised oocytes
STAT3 distribution at the periphery and the centre of unfertilised mature oocytes
(0PNs) was determined to establish whether there was a differential distribution of
STAT3 within the cytoplasm of oocytes exposed to spermatozoa, but which failed to
fertilise. There appeared to be higher levels of STAT3 at the periphery of 0PNs in
comparison to the central region, similar to leptin distribution, however, these
differences were not significant. Also similar to leptin, there was no apparent
difference in STAT3 levels directly beneath the polar body compared to the region
directly opposite the polar body in 0PNs. These results are summarised in figure
4.10.
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(a) (b)
Figure 4.10: Distribution of STAT3 at the periphery versus the centre, and beneath
the polar body as compared to opposite the polar body in unfertilised mature
oocytes (a) (b). There appeared to be more STAT3 at the periphery compared to
the centre of the 0PNs, however these differences were insignificant. There was no
discernible difference between the region under the polar body and the area
directly opposite the polar body
[173]
Distribution of STAT3 in cleavage stage embryos
STAT3 distribution was determined intracellularly by measuring the fluorescence
intensity at the periphery (edge) and the perinuclear region of each individual cell.
In contrast to leptin distribution in cleavage stage embryos, there was a trend
towards higher levels of STAT3 at the perinuclear region of the cell in comparison to
the periphery of the cell in some embryos, as summarised in figure 4.11.
(a) (b)
Figure 4.11: Cleavage stage embryos fluorescently labelled to identify the
distribution of STAT3 between individual cells (a) day seven fresh 5 cell (b) day
seven fresh 5 cell
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Distribution of STAT3 in blastocysts
Blastocysts labelled with anti-STAT3 antibodies (see figure 4.12) were assessed to
determine whether there was a differential distribution of STAT3 between the inner
cell mass and the trophectoderm. There was a non-significant trend towards higher
expression of STAT3 in the ICM compared to the TE cells, which was in contrast to
the distribution of leptin in blastocysts.
Figure 4.12: Confocal images of blastocysts of varying degrees of expansion and
quality fluorescently labelled for STAT3 (green). There was a trend for higher
levels of STAT3 in the ICM compared to the TE, although the differences were not
significant, and there was no apparent relationship between STAT3 distribution
and the stage of development
[175]
The results are summarised in graphical form in figure 4.13. There does not appear
to be a link between expansion status or blastocyst quality and STAT3 expression
levels.
Figure 4.13: The distribution of STAT3 in the inner cell mass relative to the
trophectoderm in blastocysts of varying degrees of expansion and quality. Whilst
there was a trend towards higher levels of STAT3 in the ICM compared to the TE,
there were no significant differences and no correlation between STAT3
distribution and the stage of development
[176]
Distribution of pSTAT3 in unfertilised oocytes and cleavage stage embryos
pSTAT3 distribution at the periphery and the centre of mature unfertilised oocytes
(0PNs), and at the periphery and in the perinuclear region of cleavage stage embryo
blastomeres was determined to establish whether there was a differential
distribution of cytoplasmic pSTAT3. There was no distinct pattern of distribution
between the regions, and levels of pSTAT3 were similar at all measured points.
There was little staining of pSTAT3 in 0PNs or cleavage stage embryos. These results
are summarised in figure 4.14.
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(a)
(b)
Figure 4.14: The distribution of pSTAT3 at (a) the periphery and centre of 0PNs, or
beneath the polar body versus opposite the polar body and (b) at the periphery
and perinuclear regions of individual blastomeres. There was no discernible
pattern of distribution, and the levels were generally similar at all measured
points
[178]
Distribution of pSTAT3 in blastocysts
Blastocysts of varying quality and at differing degrees of expansion were
fluorescently labelled to determine whether there was a differential distribution of
pSTAT3 in the inner cell mass versus the trophectoderm. Similar to the distribution
pattern of non-phosphorylated STAT3, there was a trend towards higher levels of
pSTAT3 in the ICM than the TE, although they were not significantly different. These
results are summarised in figure 4.15.
(a) (b)
(c)
Figure 4.15: Confocal images of (a) day 7 fresh 2DC blastocyst (b) day 6 fresh 1CC
blastocyst (c) day 6 fresh 1CC blastocyst, fluorescently labelled for pSTAT3
[179]
The results are summarised in graphical form in figure 4.16. There does not appear
to be a link between expansion status or blastocyst quality and pSTAT3 expression
levels.
Figure 4.16: The distribution of pSTAT3 in the inner cell mass relative to the
trophectoderm in blastocysts of varying degrees of expansion and quality. Whilst
there was a trend towards higher levels of pSTAT3 in the ICM compared to the TE,
there were no significant differences and no correlation between pSTAT3
distribution and the stage of development
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Negative controls
To ensure that the labelling for leptin, STAT3 and pSTAT3 was specific, cleavage
stage embryos and blastocysts were fluorescently stained using the same protocol
as described in 2.11.2, but with the primary antibody step omitted. Examples of
confocal images are shown in figure 4.17.
(a) (b)
Figure 4.17: Confocal images of (a) cleavage stage and (b) blastocyst stained with
secondary antibody only, and mounted in DAPI media
[181]
4.4.3 OCT-4 and JC-1 staining
A small number of embryos and blastocysts were labelled with OCT-4 to investigate
whether it was present in cells of the ICM and TE of blastocysts. An example is
shown in figure 4.18 (a). Additionally, cleavage stage embryos were stained with JC-
1 to assess the distribution of polarised mitochondria. An example is shown in figure
4.18 (b).
These experiments were discontinued, and the remaining fluorescence labelling
work focussed on leptin, STAT3, and pSTAT3.
(a) (b)
Figure 4.18 (a) blastocyst labelled with OCT-4 antibodies and (b) a cleavage stage
embryo labelled to detect mitochondrial distribution
[182]
4.4.4 Free cells
Approximately 38% of the blastocysts analysed in this study contained cells in the
blastocoelic cavity that were not attached to the inner cell mass or the
trophectoderm, herein referred to as free cells. Since they were most obviously
visible in the confocal images of blastocysts fluorescently labelled with pSTAT3, the
levels of pSTAT3 in free cells were measured in relation to the levels in the ICM and
TE. The level of pSTAT3 in free cells was similar to those observed in the ICM cells of
blastocysts, as summarised in figure 4.19. Additionally, time lapse image sequences
indicate that free cells originate from the ICM of expanding blastocysts. Examples
are shown in figure 4.20.
Figure 4.19: Bar graph showing the relative fluorescence intensities of pSTAT3
staining in ICM, TE and free cells (FC). The ICM and FC have similar fluorescent
staining profiles
[183]
(a)
(b)
Figure 4.20: (a) confocal images showing fluorescently labelled blastocysts with
free cells in the blastocoelic cavity and (b) time lapse images showing the free cells
originating from the ICM of live blastocysts. White arrows indicate location of free
cells
[184]
4.4.5 Excluded cells
Excluded cells were observed in 36% of blastocysts analysed in this study,
predominantly in the space between the trophectoderm and the zona pellucida,
having been expelled outwards prior to or during expansion of the blastocyst.
Occasionally excluded cells were seen in the blastocoelic cavity. Examples are
shown in figure 4.21.
[185]
Figure 4.21: Confocal images of fluorescently labelled blastocysts at varying
degrees of expansion and quality showing cells extruded into the perivitelline
space, or in one example, into the blastocoelic cavity. White arrows indicate
location of extruded cells
[186]
4.4.6 Cell numbers in blastocysts
A total of 25 fresh and frozen-thawed blastocysts of varying degrees of expansion
and quality were assessed for cell numbers in the ICM and the TE. The mean
number of cells in the whole blastocyst was 118.76 (±48.73), in the ICM was 21.28
(±12.3) and in the TE was 97.48 (±41.0), so approximately one fifth of the cells in the
blastocyst were allocated to the ICM. Figure 4.22(a) shows the number of cells in
the ICM versus the TE in all blastocysts, and figure 4.22(b) shows the numbers of
cells in the ICM versus the TE in day 5, day 6 and day 7 blastocysts. The results imply
a decrease in the cell numbers of the ICM, the TE and the blastocyst as a whole
from day 5 to day 7 post-insemination, however it is likely that this is an artefact of
the material selected as available for research.
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(a)
(b)
Figure 4.22: (a) the number of cells in the ICM and the TE. Approximately one fifth
of cells in the blastocyst were allocated to the ICM (b) the number of cells in the
blastocyst according to day of culture post-insemination
[188]
4.4.7 Cytoplasmic projections
Approximately 30% of blastocysts in this study were observed to have cytoplasmic
projections that tethered the inner cell mass to the polar TE and mural TE by
traversing the blastocoelic cavity. Interestingly, these projections were more
common in the morphologically better quality blastocysts. Examples are shown in
figure 4.23.
[189]
Figure 4.23: Confocal (labelled green) and brightfield (greyscale) images of human
blastocysts with cytoplasmic strings connecting the ICM to the TE. White arrows
indicate location of cytoplamsic projections.
[190]
4.4.8 Double ICM
Double inner cell masses were observed in several blastocysts (~5%) labelled with
fluorescent markers. Sometimes, the two ICMs were seen in entirely different
planes, although in some blastocysts they were clearly visible within the same
confocal plane. Examples of double ICMs are shown in figure 4.24.
(a)
(b)
Figure 4.24: Confocal images of fluorescently labelled blastocysts showing double
inner cell masses. The ICMs are visible in two entirely different planes (a) or in the
same plane (b). White arrows indicate location of ICM 1 and ICM 2
[191]
4.4.9 Micronuclei and chromatin-containing fragments
Micronuclei were observed in fresh and frozen cleavage stage embryos regardless
of apparent morphological quality. Fragments containing chromatin were visible in
fresh and frozen cleavage stage embryos and blastocysts. Examples are shown in
figure 4.25.
(a) (b)
Figure 4.25: Poor quality cleavage stage embryos with (a) micronucleus and (b)
chromatin-containing fragments. White arrows indicate the locations of
micronucleus and chromatin-containing fragment
[192]
4.5 Discussion
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structural changes associated with expected human preimplantation embryo
development show a pronounced cellular compaction around four days post-
insemination, evidenced by the flattening of blastomeres against one another. Non-
compacted cells were also frequently present in these embryos (Nikas et al 1996).
Furthermore, the cytoplasmic strings, or filopodia, seen connecting the ICM to the
TE in the early and expanded blastocyst of the mouse, were confirmed to contain
actin (Salas-Vidal and Lomeli 2004).
The results in this study tend to confirm these findings, as poor quality cleavage
stage embryos displayed disorganised actin cytoskeletons around the blastomeres
and the nuclei. The ability of an embryo to cleave in a regular fashion may be
impaired by poor actin structure, thus resulting in unequal sized cells and the
inability to compact effectively, impeding the development of the embryo to the
blastocyst stage. Conversely, those embryos with well organised actin matrices, are
able to cleave evenly, compact efficiently, and expand into blastocysts based upon
the actions of their cytoskeletal proteins. However, actin was not found to be
sufficiently clearly and reliably localised to use as a cell edge marker for modelling
of embryos in 3D, or for use as a quality indicator, so no further work on this protein
was undertaken in this thesis. Instead focus was shifted to leptin and STAT3, given
reports of their polarised distribution which may have functional correlates in
development.
Previously, STAT3 and leptin have been reported to be co-localised in mouse and
human oocytes and cleavage stage embryos (Antzcak and Ven Blerkom, 1997),
however in this work, STAT3 and leptin appear to be co-localised only in human
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oocytes. In embryos there appeared to be no consistent co-localised distribution
pattern, and in blastocysts STAT3 and leptin were localised to regions to differing
extents. Interestingly, STAT3 was repeatedly more concentrated at perinuclear
regions in cleavage stage embryos and blastocysts. This may be because STAT3
translocates to the nucleus after activation to enable targeted gene transcription,
and therefore may be located nearer to the nucleus in readiness for rapid
movement. Alternatively, this could be an artefact of STAT3 having recently
translocated out of the nucleus after deactivation.
Consistent, but non-significantly, higher levels of STAT3 and pSTAT3 in the ICM
compared to the TE as observed in the blastocysts analysed here may emphasise
the role of STAT3 in implantation. In utero, the blastocyst is positioned with the ICM
orientated towards the endometrium in readiness for attachment and invasion of
the trophoblast, which is a prerequisite for implantation (Weimar et al 2013).
Human studies of implantation are scarce due to the practical difficulties of
obtaining human endometrium and embryos, however the relationship between
STAT3 and implantation in murine models has been extensively investigated.
Ablation of STAT3 in the uterine epithelium of mice resulted in total implantation
failure due to an inability of the blastocyst to attach to the endometrium, and
demonstrates that STAT3 is critical in the process of implantation (Pawar et al 2013;
Sun et al 2013), whilst dysregulation of the LIF- STAT3 pathway via induction of
diabetes in mice resulted in a significant reduction in implantation (Wang et al
2015).
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The majority of fresh embryos used in the fluorescent staining experiments in this
project were arrested or poor quality, since they were surplus to patient treatment
requirements and therefore unsuitable for transfer or cryopreservation. This may
have had an effect on the distribution of markers previously found to be polarised
in human oocytes and embryos, and may not be representative of normally
developing, good quality human embryos. Conversely, the non-polar distribution of
the identified proteins may in part explain the arrest or poor quality of the embryos
shown here, as abnormal development is known to be related to aberrant cleavage
and unequal division of cytoplasm in daughter cells (Prados et al 2012).
Free cells, which were seen exclusively in the fluid-filled cavity of expanding
blastocysts, had a non-degenerate appearance and a uniform shape. The
observation that free cells have a similar pSTAT3 staining profile to cells of the ICM,
and that they were observed being expelled from the ICM in time lapse image
sequences, suggests that they may originate from the ICM. Excluded cells were
observed in 36% of blastocysts analysed in this study, most often identified as
degenerating cells expelled outwards into the perivitelline space between the
embryo proper and the ZP prior to the commencement of cavitation. Occasionally,
large multi-nucleated cells were observed in the blastocoelic cavity. It is possible
that excluded cells and free cells are left out of the developing embryo as a result of
an innate corrective mechanism, to ensure that abnormal cells are not included in
the fully expanded blastocyst, and therefore are not part of the implanting embryo.
This theory is supported by a previous publication, where chromosomal
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abnormalities were found to exist in 38.8% of good quality human blastocysts
(Fragouli et al 2008).
The proportion of cells allocated to the ICM and the TE were similar to previous
reports, with approximately one fifth of cells in the blastocyst allocated to the ICM,
however, the total number and the proliferation of the ICM and TE cells over time
differed to previously published results (Hardy et al 1989). In this study the mean
number of cells in the ICM was 28.33 (±24.21) on day 5, 23.1 (±10.73) on day 6, and
18 (±9.9) on day 7. The TE contained on average 135.33 (±15.9) on day 5, 107.3
(±50) on day 6, and 79.83 (±27.6) on day 7. This is in contrast to previously
published results, where the ICM reportedly contained an average of 20 (±4) on day
5, 41.9 (±5) on day 6, and 46 (±10.2) on day 7, and the TE contained an average of
37.9 (±6) on day 5 to 80.6 (±15.2) on day 7 (Hardy et al 1989). In this study the total
mean number of cells in fully expanded blastocysts was 163.7 (±33.8) on day 5,
130.4 (±56.3) on day 6, and 97.8 (± 35) on day 7, whereby in the reference report,
the blastocyst as a whole contained 58.3 (±8.1) cells on day 5, 82.2 (±7.8) on day 6,
and 126.2 (±21) on day 7 (Hardy et al 1989). The differences in cell number over
time may be explained by the improvements in the techniques and culture systems
used for blastocyst culture during recent years, with a general acceptance that day
5 is the optimal day of blastocyst expansion in modern clinical embryology
laboratories (Gardner et al 1998). More rapid development of larger numbers of
cells by day 5 might be expected in response to improvements in culture media over
the years between the two studies. The results in this study also concur with a
previous report on the developmental behaviour of cells in mouse blastocysts,
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where the proliferative ability of TE cells during development of the early blastocyst
depends on interaction with the cells of the ICM, and declines following the
migration of the polar TE to the side of the blastocoelic cavity furthest away from
the ICM, the so-called mural region (Copp, 1978). This may explain the declining TE
cell numbers in the human blastocysts studied here.
The cytoplasmic projections connecting the cells of the ICM to both the mural and
polar TE in the blastocysts in this study have previously been observed in around
40% of in vivo derived mouse blastocysts, where those projections traversing the
fluid-filled cavity of the blastocoels were purported to aid in the continued division
of TE cells following their migration to the abembryonic pole via a direct
communication mechanism (Salas-Vidal and Lomeli 2004). This is a similar
percentage to those seen in the human blastocysts in this project (~30%), however
cytoplasmic projections were noted in the majority of in vitro cultured mouse
blastocysts, suggesting that in vitro culture may have a stabilising influence on their
structure. In the mouse, the assembly of these structures was apparently actively
maintained in the increasingly expanding blastocyst, as observed using time lapse
imaging, suggesting that they have a function, perhaps in enabling mural TE cells to
continue to divide when necessary, despite their distance from the ICM (Salas-Vidal
and Lomeli 2004). Interestingly in this study, the majority of blastocysts that had
cytoplasmic projections from the ICM to the TE were of superior morphological
quality, and therefore despite previous assumptions that cytoplasmic “strings” are
indicative of reduced viability (Scott 2000), it is possible that these blastocoel-
traversing structures are in fact an indicator of increased implantation potential.
[198]
Further research to investigate the clinical pregnancy rate following transfer of
blastocysts containing cytoplasmic strings is needed in order to clarify this.
Higher order gestations are commonly associated with in vitro fertilisation, most
notably due to the practice of replacing more than one embryo at the time of
transfer. In recent years, the HFEA has produced guidelines on the acceptable
percentage of multiple pregnancies resulting from fertility treatments with the
introduction of the Multiple Births Minimisation Strategy (HFEA, 2009) and
consequently, there have been moves to limit the numbers of embryos transferred
simultaneously. The incidence of monozygotic (MZ) twinning resulting from transfer
of a single embryo in IVF has been reported as approximately 1.1% to 2.3%,
whereas monozygotic twins occur naturally in around 0.4% of pregnancies
(Vaughan et al 2016; Aston et al 2008). This may indicate an increasing incidence of
MZ twins after IVF, however, not all clinics report similar data and an effect of
certain combinations of culture media and laboratory and clinical protocols may be
one explanation. The mechanism by which MZ twinning occurs is not well defined,
although the most likely reason is thought to be via the splitting of the ICM or the
formation of two ICMs in the blastocyst (Saito et al 2000). Alternatively, double
ICMs may result from the continuation of cell division at the mural TE via
cytoplasmic projections. There are four types of MZ twinning, defined by the
developmental stage at which the embryo splits. Type II occurs where the ICM
divides during day 4-8 of development, and is the most commonly occurring
(Hogenson 2013). Extended embryo culture beyond 4 days post-insemination and
PGD following blastomere biopsy are reported to be risk factors for MZ twinning
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(Vaughan et al 2016). In the work presented here, double ICMs were observed in a
small proportion of human blastocysts (~5%), at a rate similar to that reported in
murine blastocysts (Chida et al 1990). Since these blastocysts were fixed and/or not
transferred, it is not known whether the presence of a double ICM would
necessarily result in a monozygotic twin pregnancy, and it would be unethical to
transfer double ICM blastocysts actively in order to confirm whether this is indeed
the case, since MZ twins have higher risks for both mother and babies than other
pregnancies. It would seem sensible, therefore, to avoid selecting blastocysts with
an obvious double ICM for transfer to the uterine cavity during ART procedures,
unless no other suitable options were available.
The appearance of micronuclei and chromosome-containing fragments has
previously been reported. These are thought to reflect the aneuploid status of
many human preimplantation embryos (Chavez et al 2012). The authors
hypothesised that missing chromosomes in the developing embryo may have been
contained within fragments during cleavage, and that these distinct fragments
originated from micronuclei (Chavez et al 2012). Blastomeres containing
micronuclei have also been reported in mosaic human embryos, and their presence
is deemed to be a mechanism of mitotic aneuploidy generation which may result in
the arrested development of preimplantation human embryos (Kort et al 2015).
Indeed, the embryos in this study which were found to contain micronuclei and
chromatin-containing fragments were generally of poor quality and had arrested in
their development at the cleavage stage. It may therefore be prudent to avoid
selecting cleavage stage embryos exhibiting such characteristics for uterine transfer
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due to the significantly increased risk of aneuploidy, and the known association with
poor implantation potential (Kort et al 2015).
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Chapter Five
Investigating the possible role of STAT3 activation in human embryo-
endometrial communication
5.1 Introduction
Leptin, the product of the obese (ob) gene, is a 16-kDa non-
glycosylated regulatory peptide hormone synthesised by several cell
types, including adipose tissue (Zhang et al 1994) and human placenta (Senaris et
al 1997). Leptin is known to regulate body weight by increasing energy expenditure
and decreasing appetite (Messinis and Milingos 1999), and has roles in reproductive
function (Cervero et al 2005) and early embryo development (Kawamura et
al 2002). Leptin deficient ob/ob mice are sterile due to a point mutation in the ob
gene, rendering them incapable of synthesising functional leptin (Zhang et al 1994),
and resulting in complete lack of circulating leptin (Malik et al 2001). Interestingly,
administration of human recombinant leptin to sterile homozygous ob/ob female
mice can correct their infertility (Chehab et al 1996), and withdrawal of exogenous
leptin treatment following detection of the copulatory plug in ob/ob mice does not
have an adverse affect on implantation or foetal growth (Mounzih et al 1998).
Leptin is secreted by human blastocysts, and is present in
human midsecretory endometrium (Gonzalez et al 2000), and pre-ovulatory human
follicular fluid (Cioffi et al 1997).
Leptin binds to specific receptors (OB-R) on the cell membrane, which may be of the
long or short form (Tartaglia 1997). Both variants are present in the human
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endometrium (Kitawaki et al 2000), granulosa cells and
cumulus oophorus complexes (Cioffi et al 1997). The long form of leptin receptor
(OB-RL) is reported to possess signalling capacity (Ghilardi and Skoda 1997; Wang et
al 1997), in contrast to its truncated isoforms which lack the intracellular domain
(Campfield et al 1996; Ghilardi and Skoda 1997). Leptin receptor mRNA is expressed
in the human ovary (Karlsson et al 1997), granulosa and cumulus cells (Cioffi et
al 1997), suggesting a role for leptin in reproductive function. The expression of
leptin receptor mRNA in human endometrium peaks during the early secretory
phase (Kitawaki et al 2000), and is also expressed in human mid secretory phase
endometrium, which is the time when implantation occurs (Gonzalez et
al 2000), suggesting that leptin may have a possible role in endometrial-blastocyst
interaction and early human development.
Leptin is known to be an activator of STAT3, during which Janus kinases catalyse the
phosphorylation of cytoplasmic STAT3 via the receptor-mediated Jak/STAT
signalling pathway, forming homo- and/or heterodimers which translocate to the
nucleus and activate transcription of target genes (Duncan et al 1997). STAT3 is
implicated in successful apposition, adhesion and penetration of the luminal
epithelium by the trophoblast of the hatched blastocyst in rodents and humans
(Cheng et al 2001). High levels of STAT3 in the glandular and luminal epithelium,
and phosphorylated STAT3 (pSTAT3) in the luminal epithelium were detected in
mice during peri-implantation on day four of pregnancy. Furthermore, strong p-
STAT3 staining was observed in the luminal epithelium and in the stroma
surrounding the blastocyst at the site of implantation on day five, suggesting that
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STAT3 has some involvement in the establishment of early pregnancy in mice (Teng
et al 2004). Activation of STAT3 in mouse endometrium occurs only during the
implantation window on day 4 post-fertilisation (Cheng et
al 2001), and moreover, inhibition of STAT3 activation in murine endometrium
significantly reduces implantation rates (Catalano et al 2005). Unexplained infertility
refers to the ~30% of couples who are unable to conceive, but whose fertility
investigations reveal no obvious abnormality in either partner (Evers 2002).
Interestingly, significantly lower levels of p-STAT3 have been reported in the
glandular epithelial endometrium of infertile women with unexplained infertility
(Dimitriadis et al 2007). Couples with diagnosed male factor infertility were
excluded from the study, whilst all female participants had regular menstrual cycles,
and no evidence of endometriosis, anovulation, or tubal defects, thus increasing the
possibility that the cause of the subfertility may be related to oocyte and embryo
developmental factors or endometrial dysfunction, and reinforcing the possibility of
a role for activated STAT3 (pSTAT3) in the acquisition of uterine receptivity
(Dimitriadis et al 2007). Activated STAT3 has also been observed
in the trophectoderm and inner cell mass of mouse blastocysts, and in the cell
membrane of blastocysts that have been exposed to leptin
(Fedorcsak and Storeng 2003), and has been detected in endometrial tissues
proximal to the blastocyst implantation site in mice (Teng et al 2004), reinforcing
the potential role of pSTAT3 in implantation.
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5.2 Aims
The aim of this work was to establish whether STAT3 activation may represent a
mechanism by which the embryo and endometrium communicate at implantation.
Human recombinant leptin protein was tested as a potential medium supplement
to promote the activation of STAT3 in human preimplantation blastocysts, and the
optimal time of exposure to leptin protein in order to activate STAT3 was
determined. The ICM and TE cells were compared in terms of their responses to
leptin, and different expression patterns in the nucleus versus the cytoplasm were
analysed. The presence of leptin receptor mRNA on human blastocysts was then
investigated in order to determine whether the leptin system plays a role in the
activation of STAT3. Finally, the interaction between embryos and Ishikawa cells, as
a model of the endometrial epithelium, was tested using exposure to spent culture
media.
5.3 Methods
Thirteen blastocysts were fixed and stained with anti-pSTAT3 antibodies without
exposure to human recombinant leptin protein, and fourteen blastocysts were fixed
and stained with anti-pSTAT3 antibodies following exposure to human recombinant
leptin protein for 10 minutes, 20 minutes, 30 minutes or 24 hours, as described in
section 2.17. Two blastocysts were cultured with stromal cell-enriched medium, and
two blastocysts were cultured with Ishikawa cell-enriched medium, and labelled
with anti-pSTAT3 antibodies after fixation, as described in section 2.20. All fixed and
labelled embryos were imaged using confocal microscopy with standardised
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settings, as described in section 2.12. Relative fluorescence intensities were
measured using Image J with techniques validated using positive and negative
controls, as described in section 2.13.
Two normally fertilised zygotes, two cleavage stage embryos and two blastocysts
were subjected to qRT-PCR to detect the presence of long-form leptin receptor
mRNA, and two oocytes, two normally fertilised zygotes, two cleavage stage
embryos and two blastocysts were subjected to qRT-PCR for the detection of SUMO
mRNA, as described in section 2.18.
5.4 Results
5.4.1 Activated STAT3 distribution in human embryos not exposed to human
recombinant leptin protein
A total of 10 frozen-thawed day 5, and 3 fresh day 7 blastocysts of varying quality
were fixed without exposure to human recombinant leptin protein, and stained
with FITC-conjugated anti-pSTAT3 antibodies as described in section 2.11.2. The
embryos were imaged using confocal microscopy and the relative fluorescence
intensity of the FITC and DAPI measured using Image J, as described in section 2.12
and 2.13.
Figure 5.1 shows examples of single plane confocal images of blastocysts that were
not exposed to leptin protein. The images show the presence of pSTAT3 in the
cytoplasm and nuclei of the cells (green), and chromatin in the nuclei of the cells
(blue). The intensity of pSTAT3 staining in the embryos is highly variable despite
standardisation of image capture. Figure 5.2 shows the relative fluorescence
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intensity of pSTAT3 staining in the cytoplasm and nuclei of the ICM and TE of
blastocysts not exposed to human recombinant leptin protein, measured using
Image J, as described in section 2.14.
Figure 5.1: Confocal images of blastocysts stained with FITC-conjugated anti-
pSTAT3 antibody and mounted in DAPI media, without exposure to leptin protein
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Figure 5.2 shows these results in graphical form.
Figure 5.2: Distribution of pSTAT3 in the cytoplasm (cyto) and nuclei (nuc) of the
ICM and TE cells in blastocysts not exposed to leptin protein
5.4.2 Activated STAT3 distribution in human embryos exposed to human
recombinant leptin protein
Four frozen-thawed morula stage embryos were cultured with 1µg/ml human
recombinant leptin protein for 24 hours. All embryos degenerated, and therefore
the exposure concentration was reduced.
Ten frozen-thawed embryos, from day 4 to day 7 post-insemination, were cultured
with 20ng/ml human recombinant leptin protein for 10 minutes, 20 minutes, 30
minutes or 24 hours, as described in section 2.17. The embryos were fixed and
stained with FITC-conjugated anti-pSTAT3 antibodies, and imaged using confocal
microscopy, as described in sections 2.11 and 2.12. Relative fluorescence intensities
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were measured in the cytoplasm and nuclei of all cells in the ICM and TE using
Image J, as described in section 2.13.
Figure 5.3 shows single plane confocal images of human frozen-thawed blastocysts
cultured with 20ng/ml human recombinant leptin protein for varying lengths of
time before being fixed and stained with FITC-conjugated anti-pSTAT3 antibodies.
Balstocyst (a) was cultured for 10 minutes, (b) was cultured for 20 minutes, and (c)
was cultured for 30 minutes. In all blastocysts there was an upregulation of pSTAT3
staining in the cytoplasm, high intensity staining in the perinuclear regions, and
distinct brightly stained spots in the nuclei of ICM and TE cells, when compared to
blastocysts that had not been cultured with leptin protein.
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(a) (b)
(c)
Figure 5.3: Confocal images of human frozen-thawed blastocysts cultured with
20ng/ml leptin protein for (a) 10 minutes, (b) 20 minutes and (c) 30 minutes, and
labelled with FITC-conjugated anti-pSTAT3 antibody
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Figure 5.4 shows single plane confocal images of frozen-thawed blastocysts cultured
with 20ng/ml human recombinant leptin protein for 24 hours. The pattern of
pSTAT3 staining was similar to that observed in the control embryos, with lower
levels of pSTAT3 present in the cytoplasm and nuclei of cells, and residual bright
spots of staining in the perinuclear regions.
Figure 5.4: Confocal images of frozen-thawed human blastocysts cultured with
20ng/ml human recombinant leptin protein for 24 hours, stained with FITC-
conjugated anti-pSTAT3 antibody
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Figure 5.5 shows the mean relative intensity values for pSTAT3 fluorescence in the
nuclei and cytoplasm of the ICM cells in human blastocysts cultured with or without
20ng/ml human recombinant leptin protein for 10 minutes, 20 minutes, 30 minutes
or 24 hours. There was a significantly lower level of pSTAT3 in the ICM nuclei and
cytoplasm of control embryos in comparison to embryos that were exposed to
leptin protein for any of the exposure times (*p=0.008; two-tailed t-test).
Figure 5.5: Mean relative intensity values for pSTAT3 fluorescence in the nuclei (N)
and cytoplasm (C) of the ICM in human blastocysts. Control = not exposed to leptin
protein
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Figure 5.6 shows the mean relative intensity values for pSTAT3 fluorescence in the
nuclei and cytoplasm of the TE cells in human blastocysts cultured with or without
20ng/ml human recombinant leptin protein for 10 minutes, 20 minutes, 30 minutes
or 24 hours. There were no significant differences in the levels of pSTAT3 in the
TE nuclei and cytoplasm of control embryos in comparison to embryos that were
exposed to leptin protein. There was a non-significant increase in fluorescence
intensity at 10, 20 and 30 minutes, however levels had returned to pre-exposure
levels by the 24-hour exposure time.
Figure 5.6: Mean relative intensity values for pSTAT3 fluorescence in the nuclei (N)
and cytoplasm (C) of the TE of human blastocysts. Control = not exposed to leptin
protein
There were higher or equal levels of pSTAT3 in the ICM in comparison to the TE at
all exposure times, although these differences were not significant.
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5.4.3 Effect of human recombinant leptin protein on blastocyst cell numbers
Following exposure to human recombinant leptin protein, as described in section
2.17, the cell numbers in the ICM and the TE of blastocysts were counted and
compared to those that had not been exposed.
The average ICM cell number for blastocysts not exposed to leptin protein was
20.94 (±10.02) compared to 26.13 (±15.7) for blastocysts that had been exposed.
This difference was not significant. The average number of cells in the TE for
blastocysts that had not been exposed to leptin protein was 87.4 (±10.02)
compared to 119 (±33.09) for those blastocysts which had been exposed. This
difference was approaching significance (p=0.06; two-tailed t-test). The results are
summarised in figure 5.7.
Figure 5.7: Cell numbers in the ICM versus the TE in blastocysts exposed to human
recombinant leptin protein compared to blastocysts that were not exposed
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5.4.4 Culture of human blastocysts with stromal cell-enriched medium
Two blastocysts were cultured with stromal cell-enriched medium (1x10 minutes,
1x20 minutes), and two blastocysts were cultured with Ishikawa cell-enriched
medium (1x10 minutes, 1x20 minutes).
The levels of pSTAT3 present were similar to those in blastocysts exposed to leptin
protein for 24 hours. There was an increase in pSTAT3 levels in the cytoplasm of the
ICM and TE in blastocysts exposed to Ishikawa cell-enriched medium compared to
those exposed to stromal cell-enriched medium (see figure 5.9), however there
were no significant differences observed within or between cell types. Further
investigative work is necessary.
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Figure 5.8: (a) day 6 frozen-thawed blastocyst cultured with Ishikawa cell-
enriched medium for 10 minutes (b) day 5 frozen-thawed blastocyst cultured with
stromal cell-enriched medium for 10 minutes, stained with FITC-conjugated anti-
pSTAT3 antibody and mounted in DAPI media.
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Figure 5.9: Relative fluorescence intensity of pSTAT3 staining in the ICM cytoplasm
(cyto), ICM nulcei (ICM nuc), TE cytoplasm (cyto), and TE nuclei (nuc) in blastocysts
exposed to Ishikawa cells (Ishi10) and stromal cells (Stro10) for 10 minutes
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5.4.5 Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR)
for the detection of long-form leptin receptor mRNA in human zygotes, cleavage
stage embryos and blastocysts
Two normally fertilised zygotes, two cleavage stage embryos, and two blastocysts
were thawed and subjected to qRT-PCR for the detection of leptin receptor mRNA,
as described in section 2.19.
Figure 5.10 shows the level of long form leptin receptor (LEPRL) mRNA at each
developmental stage. A higher level of leptin receptor mRNA was detected at the
blastocyst stage, in comparison to both pronuclear and cleavage stages, however
these differences were not significant.
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Figure 5.10: Comparison of the amount of LEPRL mRNA in frozen-
thawed pronucleates (2PN), cleavage stage embryos (CL), and blastocysts (BL)
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To demonstrate specificity, two oocytes (Metaphase) two normally fertilised
zygotes (2PN), two cleavage stage embryos (CL), and two blastocysts (BL) were
thawed and subjected to qRT-PCR for the detection of SUMO mRNA, as described in
section 2.19. Figure 5.11 shows the level of SUMO mRNA at each developmental
stage. There was an increase in the level of SUMO mRNA at the zygote stage
compared to all other stages.
Figure 5.11: Comparison of the level of SUMO mRNA in frozen-thawed oocytes
(Metaphase), pronucleates (2PN), cleavage stage embryos (CL), and blastocysts
(BL). Error bars represent the standard error of the mean
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5.5 Discussion
This work suggests for the first time that exogenous human recombinant leptin
activates STAT3 via the leptin receptor in human blastocysts, inducing translocation
of cytoplasmic pSTAT3 to the nucleus. This finding is in agreement with a previous
report in which exposure of mouse oocytes to recombinant leptin led to an increase
in the phosphorylation of STAT3 (Matsuoka et al 1999). However, the human
embryos used during these experiments were variable in their stages of
development and morphological quality, and were cultured using a range of culture
media and conditions. Some of the embryos in the non-exposed group were fresh,
whilst all of the embryos in the exposed group were frozen-thawed. Additionally,
whilst some of the frozen-thawed embryos were slow-frozen, others had been
vitrified. Therefore, caution must be applied when interpreting these results,
particularly when comparing those embryos which had been exposed to leptin
protein with those that had not been exposed to leptin protein.
The effect of leptin protein on the activation of STAT3 in human blastocysts
observed using a concentration of 20ng/ml was not seen when the concentration
was increased to 1µg/ml, when all exposed embryos degenerated. This may be due
to the lower concentration of 20ng/ml more closely representing physiological
levels of leptin, as measured in blood serum obtained from
the umbilical cords of newborn humans (19.9ng/ml) (Matsuda et al 1997), and may
indicate a toxic effect of leptin on human blastocysts at higher concentrations.
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The observed up-regulation of STAT3 activation in human blastocysts by leptin
protein suggests that human blastocysts have the long form of transmembrane
leptin receptor, since the truncated forms lack the signalling properties of the long
form (Wang et al 1997). The long form of leptin receptor mRNA and protein have
also been detected in mouse metaphase II oocytes (Matsuoka et al 1999), and total
leptin receptor mRNA has been previously detected in human oocytes and
preimplantation embryos (Cervero et al 2004), although distinction between the
short and long forms was not made. When verifying the presence of leptin receptor
mRNA in human preimplantation embryos in this work using qRT-PCR, primers
for the specific detection of the long form of the receptor were used, thus
confirming this theory. In order to ensure that the qRT-PCR was detecting the
specified target gene, a control plate was prepared with primers directed
against SUMO, a small polypeptide implicated in nuclear integrity, chromosome
segregation and embryonic viability in mice (Nacerddine et al 2005), which showed
higher levels of SUMO mRNA in pronucleates in comparison to cleavage stage
embryos and blastocysts, thus confirming detection of specific target genes.
Ishikawa cells, derived from human endometrial adenocarcinoma (Nishida et
al 1985) represent a robust model of normal functioning endometrial epithelium
during the implantation window (Castlebaum et al 1997), and therefore may be
expected to exert a similar effect to leptin protein upon the activation of STAT3 in
human embryos at the time of implantation. Stromal cells regulate human epithelial
growth and differentiation, and are used here as a control. The results showing no
significant increase in activation of STAT3 in human blastocysts cultured with
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Ishikawa-cell enriched media in comparison to blastocysts cultured with stromal
cell-enriched media are likely due to the small numbers involved, due to the limited
availability of embryos, and warrants further investigation.
The upregulation of pSTAT3 in the ICM of blastocysts exposed to human
recombinant leptin protein resonates with a previous finding that several genes
involved in the Jak-STAT signalling pathway were upregulated in the ICM of bovine
blastocysts (Ozawa et al 2012). This may indicate that the activation of STAT3 by
leptin via the Jak-STAT pathway is important for the regulation of ICM function, in a
similar way to the promotion of cell differentiation in ICM-derived
cells by leukaemia inhibitory factor (LIF) in mice, which also acts via the Jak-STAT
signalling pathway (Smith et al 1992), and is a known activator of STAT3
(Auernhammer and Melmed 2000). The transient effect of exogenous leptin protein
on the activation of STAT3 observed in this work may be explained by the short half-
life of human recombinant leptin. This has previously been reported as 60 minutes
when monitored in the circulation of mice after injection, with circulating leptin
levels becoming undetectable 7 hours post-injection (Chehab et al 1997).
Since activated STAT3 is implicated in invasive cell behaviour including
implantation (Teng et al 2004), and leptin is reported to promote blastocyst
attachment and adhesion during implantation in mice (Yang et al 2006), these
results may provide important insights into the molecular mechanisms involved in
human implantation.
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Chapter Six
Analysis of Time Lapse Images of Live Human Preimplantation
Embryos
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Chapter Six
Analysis of Time Lapse Images of Live Human Preimplantation
Embryos
6.1 Introduction
Normal fertilisation is usually evidenced by two abutting pronuclei, centrally located
in the ooplasm, and observed approximately 16-20 hours after insemination (Payne
et al 1997). Visible markers of embryo growth and morphology at key
developmental stages include appearance, disappearance, number and positioning
of pronuclei and nuclei (Payne et al 1997; Garello et al 1999), embryo cleavage rate,
cell number (Lemmen et al 2008), cell shape, blastomere orientation (Edwards and
Beard 1997), fragmentation, blastocyst development rate, and blastocyst inner cell
mass location (Hardarson et al 2003). These indicators of embryo quality are
routinely assessed microscopically in the clinical embryology laboratory at intervals
of approximately 24 hours in order to select the embryo deemed most suitable for
uterine transfer (Prados et al 2012) although increasingly, time-lapse video
microscopy is applied.
Hatching of the blastocyst from the ZP is the final stage of human preimplantation
embryo development, and is believed to be essential for attachment and
subsequent implantation in utero (Ren et al 2013). Interaction between the
blastocyst and the endometrium are necessary to facilitate implantation in the
optimal uterine location, and in the correct polar orientation to enable successful
establishment and continuation of pregnancy (Achache and Revel 2006).
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Approximately 7% of human oocytes in IVF fertilise abnormally, exhibiting multiple
pronuclei (MPN) (Balakier 1993) which have been previously discussed in this thesis.
Some MPN embryos have developmental capacity that includes the ability to form a
blastocyst, although the majority arrest prior to differentiation and many will
harbour chromosomal and structural aberrations. While most MPN embryos fail to
implant, the small proportion that do implant may result in spontaneous abortion,
or the occasional birth of a triploid foetus which dies at birth (Balakier 1993). A
further possible consequence is modification of the genetic complement resulting in
the formation of a hydatidiform mole (Edwards et al 1992) which may lead to
choriocarcinoma (Magrath et al 1971). For this reason, MPN zygotes created during
clinical treatment cycles are routinely discarded rather than transferred.
Consequently, the proportion of MPN implantations after IVF is lower than in the
natural population.
The high variability of cell cleavage timings and appearance during embryo
development has been widely reported, moreover embryo morphology can change
markedly within a few hours (Montag et al 2011). Evaluating such a dynamic
process once daily as is routine in many clinical IVF laboratories, may therefore
result in important developmental events being overlooked and the incorrect
grading of good quality embryos as poor quality or vice versa (Lemmen et al 2008).
One of the ways in which these challenges are being addressed is via the use of time
lapse imaging. Time lapse microscopy, usually involving the acquisition of images at
intervals of between 5 and 20 minutes, enables observation of preimplantation
embryo development during the entire culture period from fertilisation through to
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blastocyst, whilst maintaining the stable culture conditions required for optimal
embryo growth (Kirkegaard et al 2012).Collecting images at multiple focal planes is
superior because it enables details that would otherwise be out of focus to be
documented and analysed. The presence of a computerised record of images for
every embryo facilitates direct comparisons between individual embryos, and the
analysis of trends and characteristics associated with particular outcomes. It is
possible to return to images later to evaluate new prospective markers of potential
importance for development.
Integrated time lapse monitoring systems such as the Embryoscope have been
shown to be comparable to traditional CO2 incubators, with no reported adverse
effects on embryo quality and viability (Cruz et al 2011). Furthermore, selecting
embryos for transfer with the assistance of time lapse monitoring may result in an
estimated 20% increase in clinical pregnancy rate, in comparison to standard
morphological grading alone (Meseguer et al 2012).
In order to assess the genetic complement of an oocyte or embryo directly, a
sample of genetic material has to be acquired for analysis (Hardy et al 1990). This
may be achieved by removing polar bodies from oocytes, one or more blastomeres
from cleavage stage embryos, or by harvesting a few cells of the trophectoderm
from blastocysts (Kirkegaard et al 2012). Currently, the most common method of
collecting DNA for PGD is via blastomere biopsy (Harper et al 2010). This method
was initially found to have no adverse effect on the development of human
preimplantation embryos to the blastocyst stage (Hardy et al 1990), however, there
is evidence to suggest a significant influence on blastocyst formation when
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comparing the removal of one versus two blastomeres from day 3 embryos
(Goossens et al 2008). Some research indicates that there may be a developmental
delay in mouse embryos after biopsy (Duncan et al 2009), and recent research using
time lapse imaging suggests that biopsied human embryos reach the compacting,
cavitating, and blastocyst stages significantly later than non-biopsied controls
(Kirkegaard et al 2012).
In some animal species, such as flies and frogs, the spatial arrangement of the pre-
implantation embryo is known to be important for its developmental potential.
Polarised development from the fertilised egg to the implanting embryo gives rise
to the eventual axes of the organism, a fundamental requirement for normal
function. It has been proposed that the position of the animal pole in the oocyte,
containing nuclear material and indicated by the first polar body, establishes the
first embryonic axis (Edwards and Beard 1997). After the first division along the
meridian of the pronuclei, the first dividing blastomere of the newly formed 2-cell
embryo forms a cleavage furrow along the meridian axis prior to division into
daughter cells which pass through the embryonic and vegetal poles. The second-
cleaving blastomere then rotates and divides transversely, resulting in the classical
“crosswise” arrangement observed in normal 4-cell embryos (Edwards and Beard
1997). Disruption of normal cleavage could lead to interruption of axis formation,
and thus embryonic developmental delay or lethality, which may have some
implication when selecting which blastomere(s) to remove for PGD screening.
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6.2 Aims
The aims of this work were to identify potential markers of embryo viability and
predictors of embryo development by assessment of human preimplantation
embryos using time lapse monitoring.
The potential effect of deliberately damaging the daughters of the first dividing cell
at the third cleavage division (4-8 cells) with respect to ensuing cleavage patterns
and blastocyst formation was also investigated, to determine whether damage of
specific blastomeres may impact on axis establishment and subsequent embryo
development.
Finally, the initial site of blastocyst hatching from the ZP with respect to the position
of the inner call mass was examined, to establish whether there was any association
between the site of hatching and pregnancy potential.
6.3 Methods
536 human live preimplantation embryos were imaged using a selection of time
lapse imaging systems, as described in detail in section 2.14, with varying degrees of
success. Known indicators of embryo quality, including cell cleavage timings,
blastomere dynamics, and blastocyst formation were analysed and compared in
both fresh and frozen-thawed embryos. Identification and deliberate damage of the
daughters of the first-dividing cell was executed as described in section 2.16, and
the development of the embryos monitored using advanced time lapse technology.
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6.4 Results
6.4.1 Analysis of time lapse images acquired using the Embryoscope self-
contained monitoring system
Initially, a total of 40 fresh embryos arising during clinical treatment and 39 frozen-
thawed research embryos at various developmental stages (day 1 - day 6) were
imaged every 10 or 20 minutes for up to 6 days in the Unisense FertiliTech
Embryoscope ™self-contained embryo monitoring system, to assess development in
vitro, as described in section 2.14. A further 401 fresh clinical embryos were
analysed later, following establishment of the Embryoscope ™ as a clinical tool at
the CRM. Unfortunately, due to the paucity of embryos frozen in early development
and then donated to research, the same number of frozen embryos could not be
assessed.
6.4.2 Arrested embryos
A total of 25 fresh embryos and 15 frozen embryos from the small initial cohort,
recorded in a pre-clinical study of the Embryoscope™, arrested at various
developmental stages during the culture period. Figure 6.1 shows the specific stage
at which fresh and frozen-thawed embryos arrested; 1-4 cell, 5-8 cell, compaction,
or cavitation.
A significantly higher proportion of frozen embryos arrested at the 1-4 cell stage in
comparison to fresh embryos (*p = 0.01; 2-sample t-test).
Figure 6.1: Compariso
thawed embryos arrest
6.4.3 Embryo cleavage
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IVF or ICSI, and were cryopreserved or vitrified at varying stages of development,
according to the requirements of the patient during the fresh treatment cycle.
These embryos were not transferred, and therefore the implantation potential of
these embryos is unknown.
Figure 6.2 shows the mean time taken to complete cleavage in all fresh embryos.
The mean first cleavage time was 27.98 (±4.62) hours post-insemination, and the
mean blastocyst formation time was 116.0 (±13.93) hours post-insemination.
Figure 6.2 : Mean cleavage completion times in all fresh embryos. The mean first
cleavage time was 27.98 (±4.62) hours post-insemination, and the mean
blastocyst formation time was 116.0 (±13.93) hours post-insemination Error bars
represent standard error of the mean
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Figure 6.3 shows the mean time taken to complete cleavage in all frozen embryos.
The mean first cleavage time was 33.8 (±6.8) hours post-insemination, and the
mean blastocyst formation time was 136.6 (±36.12) hours post-insemination.
Figure 6.3: Mean cleavage completion times in all frozen embryos. Error bars
represent standard error of the mean. The mean first cleavage time was 33.8
(±6.8) hours post-insemination, and the mean blastocyst formation time was
136.6 (±36.12) hours post-insemination
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Figure 6.4 shows the comparison between the mean cleavage completion times in
all frozen and fresh embryos. Fresh embryos completed cleavage into 2 cell, 3 cell,
4 cell, 7 cell and 8 cell, and formed blastocysts at a significantly faster rate than
frozen embryos (*p=<0.001; independent groups t-test between means). All other
differences in cleavage rates, compaction, and cavitation were insignificant
between the two groups.
Figure 6.4: Mean cleavage completion time in all frozen versus fresh embryos.
Error bars represent standard error of the mean. Fresh embryos completed
cleavage into 2 cell, 3 cell, 4 cell, 7 cell and 8 cell, and formed blastocysts at a
significantly faster rate than frozen embryos (*p=<0.001; independent groups t-
test between means). All other differences in cleavage rates, compaction, and
cavitation were insignificant between the two groups
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Figure 6.5 shows the cleavage completion times in all frozen embryos created using
standard IVF versus those created using ICSI. The embryos created using standard
IVF were significantly slower to complete cleavage into two cells (42.70±11.8 vs
32.64 ±4.30) (*p=0.05; unpaired t-test), three cells (66.62 ±13.0 vs 41.74 ±6.71) and
four cells (66.95 ±18.42 vs 44.06 ±5.5) (**p=0.002; unpaired t-test) than embryos
created using ICSI. Whilst ICSI embryos developed generally faster than IVF
embryos, the differences were not significant from the 5-cell stage to the blastocyst
stage.
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Figure 6.5: Mean cleavage completion times in all frozen IVF versus ICSI embryos.
Error bars represent standard error of the mean. The embryos created using
standard IVF were significantly slower to complete cleavage into two cells
(42.70±11.8 vs 32.64 ±4.30) (*p=0.05; unpaired t-test), three cells (66.62 ±13.0 vs
41.74 ±6.71) and four cells (66.95 ±18.42 vs 44.06 ±5.5) (**p=0.002; unpaired t-
test) than embryos created using ICSI. Whilst ICSI embryos developed generally
faster than IVF embryos, the differences were not significant from the 5-cell stage
to the blastocyst stage
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6.4.4 Time spent at each developmental stage
Figure 6.6 shows the mean time spent at each developmental stage in all fresh
embryos. Fresh embryos spent an average of 27.8 hours at the 1 cell stage. Embryos
spent significantly longer at developmental stages involving even cell numbers (2
cell, 4 cell, 6 cell, 8 cell) in comparison to those involving odd cell numbers (3 cell, 5
cell, 7 cell) (a vs b; p = 0.02; independent groups t-test).
Figure 6.6: Mean time spent at each developmental stage in all fresh embryos.
Error bars represent the standard error of the mean. (a vs b; p = 0.02; independent
groups t-test)
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Figure 6.7 shows the mean time spent at each developmental stage in all frozen
embryos. Frozen embryos spent an average of 29.2 hours at the 1 cell stage.
Embryos spent significantly longer at developmental stages involving even cell
numbers (2 cell, 4 cell, 6 cell, 8 cell) in comparison to those involving odd cell
numbers (3 cell, 5 cell, 7 cell) (a vs b; p = 0.02; independent groups t-test).
Figure 6.7: Mean time spent at each stage of development in all frozen embryos.
Error bars represent the standard error of the mean. (a vs b; p = 0.02; independent
groups t-test)
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In order to reflect different culture conditions and to allow for the time taken to
freeze and thaw the embryos, figure 6.8 shows a comparison of the absolute
cleavage timings of fresh and frozen embryos at each developmental stage. There
are no significant differences between fresh and frozen embryos.
Figure 6.8: Absolute cleavage times at each developmental stage in frozen versus
fresh embryos. Error bars represent the standard error of the mean. There were no
significant differences inthe mean time spent at each developmental stage
between the frozen and fresh embryos
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6.4.5 Blastocyst development
The proportion of fresh embryos developing to blastocyst was 34% and the
proportion of frozen embryos developing to blastocyst was 29%.
Figure 6.9 shows the mean cleavage completion times in fresh embryos arresting
before the blastocyst stage, versus those developing to the blastocyst stage.
Embryos that became blastocysts completed cleavage into 2 cells and 4 cells
significantly faster than those not developing to blastocyst (*p=0.03; independent
groups t-test). All other differences in cleavage completion times were insignificant.
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Figure 6.9: Mean cleavage completion rates in fresh embryos not developing to
the blastocyst stage versus developing to the blastocyst stage. Error bars
represent the standard error of the mean. Embryos that became blastocysts
completed cleavage into 2 cells and 4 cells significantly faster than those not
developing to blastocyst (*p=0.03; independent groups t-test).All other differences
in cleavage completion times were insignificant
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Figure 6.10 shows the mean time spent at each developmental stage in fresh
embryos that arrested prior to the blastocyst stage versus those embryos that
reached the blastocyst stage. Embryos that developed to blastocyst spent a
significantly shorter time at the 1-cell stage (*) and a significantly longer time at the
7-cell stage (**) (p=0.02; independent groups t-test) than embryos that did not
develop to blastocyst.
Figure 6.10: Mean time spent at each developmental stage in all fresh embryos
not developing to blastocyst versus developing to blastocyst.Error bars represent
the standard error of the mean. Embryos that developed to blastocyst spent a
significantly shorter time at the 1-cell stage (*) and a significantly longer time at
the 7-cell stage (**) (p=0.02; independent groups t-test) than embryos that did not
develop to blastocyst.
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Figure 6.11 shows the mean cleavage completion times in frozen embryos arresting
before the blastocyst stage, versus embryos developing to the blastocyst
stage.Frozen embryos developing to blastocyst completed developmental stages
from three-cell to cavitating on average 20.2 hours later than embryos not
developing to blastocyst. The differences were not significant.
Figure 6.11: Mean cleavage completion rates in frozen embryos not developing to
the blastocyst stage versus frozen embryos developing to the blastocyst
stage.Error bars represent the standard error of the mean. Frozen embryos
developing to blastocyst completed developmental stages from three-cell to
cavitating on average 20.2 hours later than embryos not developing to blastocyst.
The differences were not significant
[242]
Figure 6.12 shows the mean time spent at each developmental stage in frozen
embryos that arrested prior to the blastocyst stage versus those embryos that
reached the blastocyst stage. The times were highly variable, and no significant
differences were observed.
Figure 6.12: Mean time spent at each developmental stage in frozen embryos not
developing to blastocyst versus frozen embryos developing to blastocyst. Error
bars represent the standard error of the mean. The times were highly variable,
and no significant differences were observed
[243]
6.4.6 Blastocyst hatching
Analysis of the initial hatching sites in blastocysts, where hatching blebs were
identified in relation to the position of the inner cell mass in fresh embryos on day 5
and day 6, showed that hatching is initiated by trophectoderm (TE) at various sites
relative to the inner cell mass in an apparently unpredictable fashion in vitro.
Twenty three hatching blastocysts were observed following culture in the
Embryoscope for five or six days post-insemination. Eight blastocysts hatched from
the mural TE directly opposite the ICM, ten hatched near the ICM, and five hatched
directly adjacent to the ICM. Occasionally, hatching blebs were observed at more
than one site. Figure 6.5.1 shows examples of hatching sites (a) in close proximity to
the ICM (b) opposite the ICM (c) at multiple consecutive sites.
(a)ICM[244]
(b)
(c)
Figure 6.13: Hatching sites in three different blastocysts
the ICM (b) opposite the ICM (c) at multiple coHatching siteICMHatching site 1 Hatching site 2 Hatching site 3(a) in cl
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Six of the hatching blastocysts observed were transferred in elective single embryo
transfers, resulting in five pregnancies testing positive for urinary hCG two weeks
later. Four fetal hearts were detected by abdominal ultrasound seven weeks post-
transfer. There was no apparent pattern in the site of hatching in those blastocysts
resulting in pregnancy compared to those that did not.
6.4.7 Development of human preimplantation embryos following blastomere
damage
Following deliberate damage to one or two daughters of the first-dividing cell at the
7-8 cell stage, all embryos (n=9) reached the compaction stage, 89% reached the
cavitation stage, and 67% developed to blastocyst. In the control, non-damaged
embryos (n=10) 47% reached the compaction stage, 33% reached the cavitation
stage, and 27% developed to blastocyst.
Figure 6.14 shows the time to completion of each developmental stage in non-
damaged, pre- damaged and post-damaged embryos. There were no significant
differences between the groups.
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Figure 6.14: Average time to cleavage completion in all non-damaged, pre-
damaged and post-damaged embryos. Error bars represent the standard error of
the mean. There were no significant differences between the groups
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Embryos utilised in these experiments were created using either standard IVF or
ICSI. Figure 6.15 shows that the average cleavage completion times in non-damaged
embryos created using IVF were slower than those created using ICSI at all stages of
development, with significant differences seen at the 4-cell, 6-cell and 7-cell stages
of development (p=*0.008; p**=0.001; p***=0.05; two-tailed t-test).
Figure 6.15: Average time to cleavage completion in non-damaged embryos
created with IVF versus ICSI. Error bars represent the standard error of the mean.
The average cleavage completion times in non-damaged embryos created using
IVF were slower than those created using ICSI at all stages of development, with
significant differences seen at the 4-cell, 6-cell and 7-cell stages of development
(p=*0.008; p**=0.001; p***=0.05; two-tailed t-test)
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Figure 6.16 shows the average completion times of the compacting and cavitating
stages in damaged embryos created using IVF versus ICSI. The IVF embryos
completed compaction and cavitation faster than ICSI embryos, in contrast to non-
damaged embryos, although the differences were not significant.
Figure 6.16: Average time to cleavage completion in damaged embryos created
with IVF versus ICSI. Error bars represent the standard error of the mean. The IVF
embryos completed compaction and cavitation faster than ICSI embryos, in
contrast to non-damaged embryos, although the differences were not significant
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Figure 6.17 shows the time spent at each developmental stage in pre- or non-
damaged embryos compared to damaged embryos. Those with damaged
blastomeres spent a similar period of time at all stages of development, but
commenced compaction earlier and blastulation later than non-damaged embryos.
These differences were not significant.
Figure 6.17: Average time spent at each developmental stage in and pre- and non-
damaged embryos in comparison to damaged embryos. Error bars represent the
standard error of the mean. Those with damaged blastomeres spent a similar
period of time at all stages of development, but commenced compaction earlier
and blastulation later than non-damaged embryos. These differences were not
significant
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6.4.8 Cleavage patterns in abnormally fertilised zygotes
Figure 6.20 shows an interesting observation made during the first
cleavage division of a tripronucleate into a two-cell embryo following the
fusion of the three pronuclei and the formation of a “Y-shaped” centrally-
located blastomere arrangement. Consequent fusion of two of the
blastomeres resulted in the formation of a two-cell embryo which
subsequently arrested. This embryo was observed using the Cell IQ system
which was also trialled for embryo culture. It was determined as
unsuitable because, first, the plate moved and so the embryo did not
remain in a stable position for viewing, and second, because the focal plane
was fixed, and third, because the gas control was suboptimal. However, it
was a useful system for time-lapse observation of cell monolayers (data not
shown).
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Figure 6.18: Cleavage of a tripronucleate into a two-cell embryo
3PN appears to
form tripolar
division
Two blastomeres begin
to merge
Cleavage into 2-cell
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A total of 47 abnormally fertilised fresh embryos were cultured in the
Embryoscope (Fertilitech) for up to six days post-insemination, in order to
determine whether their cleavage patterns differed from normally
fertilised zygotes.
Figure 6.22 shows the mean cleavage completion times in fresh 1PN
patient zygotes, multiple-PN (MPN) zygotes, and 2PN zygotes. No
significant differences were observed between 1PN and MPN zygotes.
Abnormally fertilised oocytes were significantly slower at completing
compaction than normally fertilised oocytes (p=*0.0001; unpaired t-test).
No other significant differences were noted.
Figure 6.19: The mean cleavage completion times in 1PN, MPN and2PN zygotes.
Error bars represent standard error of the mean. No significant differences were
observed between 1PN and MPN zygotes. Abnormally fertilised oocytes were
significantly slower at completing compaction than normally fertilised oocytes
(p=0.0001; unpaired t-test). No other significant differences were noted
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Figure 6.23 shows the mean time spent at each developmental stage in
fresh 1PN patient zygotes, multiple-PN (MPN) zygotes and 2PN zygotes.
There were no significant differences observed.
Figure 6.20: The mean time spent at each developmental stage in 1PN versus MPN
zygotes. Error bars represent standard error of the mean. There were no
significant differences observed
These results reinforce the importance of correctly identifying abnormally fertilised
oocytes, and de-selecting them for uterine transfer, since early development of
embryos derived from singular or multiple pronucleates is not noticeably aberrant
when compared to normally fertilised oocytes.
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6.5 Discussion
Time lapse imaging has been used for several years in research to study the
temporal dynamics of embryo development (Payne et al 1997) although recently,
advancements in technology have resulted in time lapse imaging being introduced
into routine clinical laboratory practice (Kirkegaard et al 2012). Time-lapse
monitoring of embryos at frequent intervals from fertilisation to blastocyst
formation provides invaluable information regarding embryo kinetics that might
otherwise be overlooked using traditional 24-hourly evaluation methods. It also
allows precise measurement of the time at which key events in embryonic
development take place, such as pronuclear appearance and disappearance, and
specific cleavage divisions.
The variation in the timing of first cleavage in fresh zygotes into two-cell embryos
(25-33 hours post insemination) has been previously noted (Capmany et al 1996),
and cleavage of fresh zygotes into two-cells 25-29 hours post-insemination, is
positively associated with achievement of clinical pregnancy (Shoukir et al 1997;
Sakkas et al 1998; Lundin et al 2001; Bos-Mikich et al 2001), with slower-developing
embryos having less prospect of initiating pregnancy. The time taken to complete
cleavage from one-cell into two-cells in fresh embryos developing to blastocyst was
significantly faster than in those not developing to blastocyst (24.9±2.9 vs 27.4±3.5
hours), which supports the use of early cleavage as an indicator of embryo viability.
In addition, completion of division from three-cells to four-cells was significantly
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faster in fresh embryos developing to blastocyst versus arresting embryos (35.8±3.0
vs 39.3±5.7 hours). Meseguer et al (2011) reported that fresh embryos that went on
to form blastocysts spent a significantly shorter time at the one-cell stage than
embryos that did not form blastocysts, and furthermore the time taken to complete
cleavage from two to three cells, three to four cells, and four to five cells, was
significantly positively associated with implantation (Meseguer et al 2011).
In my study, the incidence of blastocyst formation in fresh and frozen embryos was
34% and 29% respectively, similar to results reported elsewhere (Dal Canto 2012).
Both fresh and frozen embryos that did not form blastocysts, arrested at a range of
developmental stages from two-cell to cavitation, however, the majority arrested
between two- and eight-cells, in concordance with Wong et al (2010).
The mean time to completion of cleavage of fresh one-cell two-pronucleate zygotes
into two cell embryos was 26.4 (±3.44) hours, which is in agreement with previously
published data (Bos-Mikich et al 2001), and in frozen-thawed pronucleates was 33.8
(±6.8) hours. This delay observed in cryopreserved pronucleate embryos is in
contrast to other authors who reported that cryopreservation did not retard human
embryo development (Wong et al 2010). My study utilised a lower number of
embryos than Wong et al (2010) because the availability of frozen pronucleate
embryos for use in research was limited due to changes in cryopreservation policies.
However, when cleavage stage embryos which had divided into 2-8 cells prior to
cryopreservation were included for temporal developmental analysis, a slower rate
of further cleavage was also observed. Interestingly, Macas et al (1998) reported
significantly slower cleavage in frozen-thawed ICSI-generated zygotes in comparison
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to frozen-thawed IVF-generated zygotes, a difference not noted in non-frozen
zygotes (Macaset al 1998). The authors postulated that the mechanism of cell
division was adversely affected due to freezing after syngamy had occurred in some
of these zygotes (Macaset al 1998). This appears to contradict an earlier study by
Wright et al, which found that a significantly higher number of zygotes frozen at ≥ 
29 hours after oocyte retrieval went on to implant in comparison to zygotes frozen
<29 hours after oocyte recovery. They suggested that this may be due to the
completion of pronuclear migration prior to syngamy, and the concomitant
embryonic organisation and implanting capacity of the zygote (Wright et al 1990).
In my study, frozen embryos were slower to complete all cleavage stages and
blastocoel formation compared to fresh embryos, and these timings were
significantly slower during the first three cleavages from one to two-cell (42.2±18.7
vs 26.4±3.4 hours), two to three-cell (53.4±19.4 vs 35.7±7.6 hours), and three to
four cell (54.5±22.1 vs 38.1±5.2 hours). Frozen embryos developing to blastocyst
completed all divisions from three-cell to eight-cell stage on average 19.7 hours
later, compaction 15.3 hours later, and cavitation 28.1 hours later than embryos not
developing to blastocyst. However, when the absolute cleavage timings between
fresh and frozen embryos were compared, there were no significant differences.
The lack of significance of these results is most likely due to the high variability in
cleavage completion times in frozen-thawed embryos. The putative developmental
delay of frozen-thawed embryos compared to fresh embryos observed in the time
to each stage of cleavage completion in this project may be indicative of an adverse
effect of cryopreservation on embryo development in humans, similar to that
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observed in mice (Uechiet al 1997), but is most likely due to different culture
conditions and the time taken to freeze and thaw the embryos. Additionally, human
frozen-thawed embryos have been previously seen to develop at a slower rate than
fresh embryos, regardless of their chromosomal status, although implantation rates
were not different after fresh or frozen embryo transfer (Edirisinghe et al 2005).
In addition, it has been reported that the time taken for embryos to initiate
compaction and blastulation was significantly slower in aneuploid embryos in
comparison to euploid embryos (Campbell et al 2013). It has been reported that
cryopreservation may induce mitotic chromosomal abnormalities in human
embryos (Iwarsson et al 1999) which could partly explain the delay in frozen-
thawed embryo development that I observed.
In this project, frozen-thawed embryos were significantly more likely to arrest at the
1-4 cell stages when compared to fresh embryos. However, the frozen embryo
cohort included partially intact embryos with ≥50% surviving blastomeres. Since the 
implantation potential of frozen-thawed embryos is related to the post-thaw cell
survival (Edgar et al 2000; Guerif et al 2002) and resumption of mitosis after
thawing (Guerif et al 2002; Van Landuyt et al 2013; Gallardo et al 2016), it follows
that the inclusion of the partially intact embryos in this analysis may have had an
influence on the results observed. A significantly reduced implantation rate has
been reported following transfer of partially intact embryos compared to fully intact
embryos (Van den Abeel et al 1997; Edgar et al 2000; Guerif et al 2002).
Furthermore, a maximum of 89% of partially intact frozen-thawed embryos resume
cleavage following thawing and overnight culture (Van Landuyt et al 2013; Gallardo
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et al 2016), therefore those embryos with damaged blastomeres, and those which
did not resume mitosis after thawing will have had an impact on the number of
arrested embryos at this early stage of development. Nevertheless, the similarities
in developmental arrest in the 4-8 cell, compaction, and cavitation stages echo the
findings that post-thaw embryos that continue to cleave have an implantation
potential comparable to fresh embryos (Edgar et al 2000).
Little research has been conducted on the effect of freezing on subsequent cleavage
patterns, although frozen-thawed cleavage stage embryos that continued to divide
during a 24 hour culture period post-thaw were significantly more likely to result in
a live birth after uterine transfer, compared to those not cleaving during the same
period (Van der Elst et al 1997; Guerif et al 2002). These studies stipulated that one
or more blastomeres must have divided during the time between thawing and
transfer (24 and 20 hours respectively), but these authors did not include details of
the number of divisions that the embryos completed, and it is not clear how quickly
the embryos were cleaving, however it appears that frozen embryos that do not
display further cleavage after thawing do not have the capacity to implant (Van der
Elst et al 1997). The time to completion of cytokinesis, defined as the final step
before full division into separate blastomeres, and the time between appearance of
the cleavage furrow and completion of cleavage into two distinct daughter cells,
have been shown to be predictors of blastocyst development in frozen-thawed
embryos (Wong et al 2010). The results in this study suggest that cleavage
completion times are an indicator of embryo viability. Synchronous divisions have
been associated with significantly higher chances of implantation (Lemmenet al
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2008). Thus, embryos cleaving from 2 cells to 4 cells, or from 4 cells to 8 cells,
within a short time period are considered to have synchronous cleavages.
Both fresh and frozen embryos remained at developmental stages involving even
cell numbers significantly longer than those stages involving odd numbers. Fresh
embryos that developed to blastocyst spent a significantly shorter time at the one-
cell stage than those that did not develop to blastocyst, confirming the results of
Sakkas et al 1998. These embryos also spent a significantly longer time at the seven-
cell stage, supporting the idea that synchronous division is associated with embryo
viability, and in agreement with previous findings published by Meseuger et al
(2011).
There were no such significant differences observed in the time spent at each
developmental stage in frozen embryos that developed to blastocyst in comparison
to those that did not develop to blastocyst, and the times were highly variable. This
may be explained by the relatively low number of embryos in this group compared
to the fresh group, as well as the potential chromosomal disturbances caused by
cryopreservation (Iwarsson et al 1999). An increase in aberrant cell cleavage times
is thought to be related to the different numbers of chromosomes present in the
blastomeres of euploid versus aneuploid human embryos, which have variable
chromosome segregation timings, manifesting as diverse cell division timings
(Chavez et al 2012).Therefore it is possible that cryopreserved embryos may exhibit
more asynchronous divisions, as previously seen in aneuploid embryos (Apryshkoet
al 2010), and may explain the differences observed between fresh and frozen
embryos in this project.
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Oocytes inseminated via conventional IVF are reportedly slower to cleave than their
ICSI-inseminated counterparts (Plachot 2000; Lemmen et al 2008).This is thought to
be due to the necessity of the sperm to infiltrate the cumulus cell complex, bind to
the ZP and penetrate the oolemma during standard IVF. During ICSI, these steps are
circumvented by removal of the cumulus cells, mechanical breach of the zona
pellucida, and direct injection of the sperm into the ooplasm (Cruz et al 2013),
resulting in a 2-4 hour difference in the timing of pronuclear fading and time to first
cleavage between IVF and ICSI embryos (Plachot 2000). The results in this study
confirm these findings, with frozen embryos created using ICSI cleaving significantly
faster from the two-cell to the four-cell stage than frozen embryos created using
IVF.
Early events in embryo cleavage lay the foundations for later development. For
example, it is reported that the orientation of the first cleavage division along the
AV axis tends to be perpendicular to the embryonic-abembryonic axis of the future
embryo (Bischoff et al 2008). Furthermore, following the first cleavage division
along the meridian of the pronuclear axis, the first dividing blastomere of the newly
formed 2-cell will form a cleavage furrow along the meridian axis prior to division
into daughter cells which pass through the embryonic and vegetal poles. The
second-cleaving blastomere then rotates and divides transversely, resulting in the
classical “crosswise” 4-cell arrangement observed in normally cleaving embryos
(Edwards and Beard 1997). Further evidence that that cleavage planes are regulated
rather than random is apparent from the observation that asymmetrically dividing
cells contribute more frequently to the ICM than the TE in mice (Bischoff et al
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2008). It is therefore possible that blastomeres rearrange themselves within the ZP
in order to position themselves in the correct orientation for subsequent cleavage
and distribution of cells into ICM or TE lineages. Those embryos with blastomeres in
the incorrect orientation due to a lack of reorganisation of cells may potentially be
more prone to delayed or non-existent establishment of polarity and consequent
embryonic developmental arrest and lethality, thus explaining the differences
observed in blastomere rearrangements in cleaving versus non-cleaving embryos.
The ability of embryos to develop to blastocyst is not adversely affected following
deliberate damage of the daughters of the first dividing cell, and in fact this
appeared to improve blastocyst formation. This may be due to the distinct sample
population used, since all embryos in this experiment were frozen surplus embryos
from clinical ART cycles, and were therefore good quality, and not necessarily
representative of a typical embryo cohort. Nevertheless, these findings are in
agreement with previously published data, which reported that the biopsy of one to
three blastomeres of the eight-cell embryo did not adversely affect human
preimplantation development in vitro, with an increase in blastocyst formation
observed in the biopsied group compared to the intact group (Hardy et al 1990).
Later studies appeared to confirm the results of Hardy et al (1990), reporting that
biopsy of one, two or three cells from embryos initially containing between four and
seven cells does not impede developmental competence (Van de Velde et al 2000),
and the removal of one or two cells from day three embryos at the six-cell to
compacting stages of development does not affect live birth rates (Goossens et al
2008). However, others dispute this, reporting significantly reduced blastocyst
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formation originating from eight-cell embryos with two cells removed compared to
intact controls, and significantly reduced live birth rates compared to embryos with
one cell removed (De Voset al 2009). I had hypothesised that this discrepancy
might be due to the unequal nature of blastomeres at the 8-cell stage; however, my
experiments have shown that destruction of the two leading cells in an 8-cell
embryo is not detrimental.
The time to completion of all stages of development was similar in post-damaged
embryos compared to non-damaged embryos, in agreement with a previously
published report, which found no differences in the time to completion of the two-
to the eight-cell stage in biopsied versus non-biopsied embryos (Kirkegaard et al
2012). There was an interesting difference observed in the time to completion of
the compaction and cavitation stages in embryos created using standard IVF in
comparison to ICSI, whereby the IVF embryos completed these stages faster than
ICSI embryos. This is in contrast to the usual pattern of IVF embryos cleaving at a
slower pace than ICSI embryos, and may be due to the embryos “catching up”
following damage of cells at the cleavage stage. The time spent at each
developmental stage from the five-cell to the expansion of the blastocoel was not
significantly different in damaged versus non-damaged embryos. This is in contrast
to Kirkegaard et al (2012), who found that embryos spent significantly longer at the
stage at which they were biopsied, although all other stages were not different.
In this project cells were damaged by aspiration of the cytoplasm rather than
completely removed, thus the results may be more comparable to post-thaw
blastomere degeneration than biopsy, and there remains a possibility that the
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detritus of the damaged cells affected the surviving cells of the embryo, resulting in
altered cleavage patterns. It is important to note that damaging the cells by piercing
with an ICSI injecting needle prior to removing the cytoplasm may not be the ideal
model for blastomere biopsy, since some cellular products may remain due to the
leakage following membrane rupture. Studies investigating the viability of day 2
frozen-thawed embryos found significantly higher implantation, clinical pregnancy,
and live birth rates following transfer of fully intact frozen-thawed cleavage stage
embryos in comparison to partially intact frozen-thawed cleavage stage embryos,
suggesting that the co-existence of damaged and non-damaged blastomeres is
detrimental to embryo implantation potential (Van den Abeel et al 1997; Guerif et
al 2002). These results were in agreement with the finding that fully intact day 2
frozen-thawed embryos had implantation rates comparable to their fresh
counterparts, and significantly higher than the partially intact day 2 frozen-thawed
embryos (Edgar et al 2000). It is therefore possible that, although the blastocyst
development rate of the embryos in this project was apparently unaffected by
blastomere damage, the implantation potential of those embryos may have been
compromised. Since these blastocysts were fixed and not transferred, this remains
unknown. Furthermore, the cytoplasm from the damaged cells in this study was
removed by aspiration rather than left within the embryo, which may have lessened
the deleterious effects. The toxic effect of damaged blastomeres on the intact
blastomeres is reportedly increased at earlier developmental stages (2-cell and 4-
cell) (Van den Abeel et al 1997), and therefore the impact of damaged blastomeres
may have been lower in these experiments, since damage occurred at the 7-cell and
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8-cell stages. Interestingly, the implantation potential of day 3 fully intact and
partially intact frozen-thawed embryos was similar, providing that mitosis resumed
in the 24 hours following thawing (Van Landuyt et al 2013), although this is not in
agreement with a more recent study, which found that fully intact day 3 embryos
had a significantly higher implantation rate than partially intact day 3 embryos, even
if a post-thaw resumption in mitosis was observed (Gallardo et al 2016).
Some studies have reported aberrant behaviour in blastocysts derived from
biopsied embryos around the time of hatching in mice (Ugajin et al 2010) and
humans (Kirkegaard et al 2012). In this project, however, the blastocysts were fixed
on day five or six for use in immunofluorescent labelling experiments, as described
in section 2.11. Therefore, it is not possible to assess the effect of cell damage on
hatching in these embryos.
As far as is known, this is the first study to identify and damage specifically the
daughters of the first dividing cell and monitor the ongoing development of the
embryo thereafter. Ideally, further work to identify and damage the daughters of
the slowest dividing cell would be performed to assess whether a different effect on
embryo development was apparent. This may provide valuable information
regarding which blastomeres to remove prior to PGD after time lapse monitoring.
Unfortunately, the limited availability of human cleavage stage frozen embryos,
combined with a change in clinical practice, did not allow for these further studies.
The mechanisms of blastocyst hatching in vitro, in the absence of endometrial
influences, are reportedly different to those hatching in vivo (Gonzales and Bavister
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1995). Human blastocysts have previously been observed as usually hatching away
from the ICM pole (Sathananthan 2003), however, the blastocysts in this study had
seemingly unpredictable hatching sites, which were not indicative of subsequent
pregnancy. This observation is in agreement with the findings of one group, who
concluded that implantation, pregnancy and live birth rates were not influenced by
the site of assisted hatching in vitrified-warmed blastocysts (Ren et al 2013).
Transfer of spontaneously hatching or hatched blastocysts resulted in a significantly
higher pregnancy and live birth rate when compared to transfer of non-hatched,
expanded blastocysts in clinical practice (Chimote et al 2013). These results accord
with my observation of an 80% pregnancy rate after transfer of a single hatching
blastocyst, however the number of cases was small.
In this project, F-actin has been shown by immunofluorescence to form part of the
structural cytoskeleton of individual cells in the human embryo (see chapter four).
The actin cytoskeleton provides support to maintain the shape of cells, and is
reorganised during and after mitosis to promote centrosome separation and
completion of cell division (Heng and Koh 2010). Disruption of the integrity of the
actin cytoskeleton due to cryopreservation of mouse embryos has been
demonstrated to adversely affect embryo development beyond the first cleavage,
hypothesised to be due to increased rigidity of the cytoskeleton (Hosu et al 2008).
Therefore, it is possible that a disorganised cytoskeletal structure prevents mitosis
and leads to embryonic arrest, as implied by the lack of membrane oscillations in
non-cleaving embryos in these experiments.
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It has been previously reported that the viscosity of the ooplasm is correlated with
embryonic development and pregnancy rate, whereby oocytes with less viscous
cytoplasm develop into superior quality blastocysts and result in a higher incidence
of clinical pregnancy (Ebner et al 2003). This is thought to be due to the promotion
of microtubule organisation and movement of pronuclei through the ooplasm to
their central abutting position prior to syngamy (Ebner et al 2003). The pattern of
cytoplasmic movements in newly-fertilised mouse oocytes has been shown to be an
indicator of embryo quality, where faster cytoplasmic movements were predictive
of cell number on day four of development and live birth potential (Ajduket al
2011). Therefore, the cytoplasmic movements observed in the cleaving embryos in
this project may be indicative of a less viscous cytoplasm pertaining to the correct
organisation of intracellular microtubules necessary for the advancement of mitosis
in viable embryos.
Cleavage of tripronucleate zygotes may involve an apparently normal division
pattern, with cleavage into two cells then four cells, however others have been
observed to divide into two cells with a simultaneously extruded cytoplasmic mass,
which does not participate further, resulting in a diploid embryo (Kola et al 1987).
Time lapse monitoring has allowed much greater insight into the complexities of
embryonic behaviour than previously realised. Many tripronucleate zygotes exhibit
a unique cleavage pattern, dividing directly into three equivalent sized cells via a
tripolar spindle, with chromosomes arranging into a Y-shape in the centre of the
zygote, although further division of these blastomeres involves bipolar spindles, so
the embryo then divides from 3-cell to 6-cell to 12-cell. The unusual pattern of
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division seen in figure 6.21, whereby the embryo formed a tripolar spindle but
actually cleaved into two distinct cells upon completion of cytokinesis, would not
have been observed without the use of time lapse imaging, and the embryo may
have been scored as a regularly dividing two-cell during assessment, despite the
presence of a tripolar spindle. One recent study reported that normally fertilised
zygotes cleaving directly from one cell into three cells were significantly less likely to
implant compared to those cleaving from one cell into two cells, prompting the
authors to recommend disregarding such embryos when selecting which to transfer
(Rubio et al 2012). Therefore, the use of time lapse imaging may prove invaluable in
identifying abnormally developing, and therefore non-viable, embryos. This may
improve clinical ART success rates via the avoidance ofsuch embryos in the process
of choosing embryos for uterine transfer.
In conclusion, cleavage timings and blastomere activity in human preimplantation
embryos can be used as a predictor of viability. Cryopreservation may delay post-
thaw embryo development, whilst the percentage of surviving cells after thawing is
more indicative of subsequent development than the number of cells at the time of
freezing. The site of hatching in preimplantation blastocysts with respect to the
location of the ICM is not predictive of pregnancy outcome. Damaging the
daughters of the first-dividing cell does not adversely affect ongoing embryo
development in good quality embryos. Abnormally fertilised oocytes do not display
significantly different cleavage timings during development to the blastocyst stage.
Time lapse monitoring is a useful tool to aid the identification of the most viable
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embryos, and may prove invaluable in improving implantation and live birth rates in
clinical IVF treatment cycles.
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Chapter Seven
Developing a computer-assisted model of embryos at different
stages of preimplantation development
[270]
Chapter Seven
Developing a computer-assisted model of embryos at different stages of
preimplantation development
7.1 Introduction
The use of computer software for the development of advanced image processing
systems has led to an increase in the application of digital imaging to human
medicine. Medical visualisation describes the generation of three-dimensional (3D)
models using digital algorithms, based upon living specimens, to increase the
understanding of biological structures and their functions (Klauschen et al 2009).
Commonly used image processing techniques include segmentation, thresholding
and 3D reconstruction. Segmentation is the division of an image into smaller distinct
regions that share certain detectable characteristics, such as cell nuclei, using
boundaries to create a set of separated images from which data may be obtained
(Chalana and Kim, 1997). Segmentation of cell nuclei is notoriously difficult due to
the non-uniform distribution, overlapping, and clustering of some nuclei (Oritz De
Soloranzo et al 1999). Thresholding involves isolating the image proper from the
background noise by identifying an upper and a lower pixel threshold, and
comparing each region of interest with the pre-determined threshold values (Chang
et al 2000). Edge detection segmentation can be used to create three dimensional
images, and combined with three dimensional rendering, allows for detailed
analysis of image structures (Rogowska 2000).
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The number, shape and size of individual blastomeres and cell nuclei in human
preimplantation embryos are markers of quality, and high developmental potential
is indicated by embryos with symmetrical cell division, equally sized spherical
blastomeres (Racowsky et al 2010), and a single regularly shaped nucleus per cell
(Kort et al 2015). Measurement of blastomere size using static, multi-plane, semi-
automated morphology assessment software has provided evidence that an
increasing degree of fragmentation is correlated with a significant decrease in cell
size, and multinuclearity is related to an increased cell size (Hnida et al 2004).
However, more precise and sophisticated markers are necessary in order to aid in
identifying the most viable embryos in a cohort.
The nuclear to cell volume ratio remains constant in normally dividing cells, even
when the cell size is altered as a result of cell cleavage. However, the mechanism by
which the cell to nuclear volume ratio is controlled is unclear, and disturbance of
the ratio may be indicative of abnormal or unequal cell cleavage resulting in
retarded embryo development (Webster et al 2009). Therefore, visualisation of the
number, shape and size of blastomeres and nuclei provides valuable information
about the potential viability of the embryo, and may help us to understand the
mechanisms of developmental failure.
A fourth dimension, namely ‘time’, is also a critical factor in assessing embryo
quality and potential for pregnancy because the timeliness of specific stages of
development is important to coordinate with the endometrial preparation for
receptivity and the woman’s menstrual cycle. Hence, there is increasing use of
spatio-temporal imaging in the clinical IVF laboratory. Consequently, time lapse
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monitoring of human preimplantation embryo development is increasing, and the
volume of data available from these images is potentially huge. However,
annotating Embryoscope™ time lapse images is time consuming and subjective, and
carries a high intra-operator variance (Sundvall et al 2013). Fully automated cell
tracking systems, such as Eeva™ are also not completely reliable, particularly when
abnormally cleaving or highly fragmented embryos are being monitored, and often
embryologists are required to manually input cell cleavages to obtain a more
accurate result. In addition, concerns remain about how completely any fully
automated system can replicate the decisions and interpretations that would be
made by a trained and experienced human operator. There is also concern that
computer-generated algorithms cannot be safely applied across all laboratories,
since there are many variables, including culture media systems and incubation
conditions (Mantikou et al 2013; Swain 2014). The implementation of a semi-
automated system may be the ideal solution, affording the clinical team a time-
saving option, whilst still requiring human input in ambiguous cases, thereby
allowing embryo development to be more accurately tracked.
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7.2 Aims
The aims of this chapter are:
To explore different options for computer-assisted image analysis of human
embryos at different stages of development and using different of image types.
To apply the most effective semi automated computer-assisted options to
investigate the nuclear to cell ratio in cleavage stage human preimplantation
embryos, and the nuclear volumes of different cell lineages in blastocysts, using
data derived from a semi-automated computer programme developed in
collaboration with colleagues at the Warwick Digital Laboratory, and Manchester
University School of Computing.
7.3 Methods
Fixed and stained human oocytes and preimplantation embryos were imaged using
confocal microscopy with standardised settings, as described in section 2.12, and
exported to Dr Silvester Czanner at the Warwick Digital Laboratory for processing,
alongside his own research group. I worked closely with Dr Czanner’s group, to
generate models that were intended to closely correspond to the biological and
clinical interpretation of the embryo images. The first student involved was
University of Warwick undergraduate James Michael, who began to set up methods
to process the images that I provided. Figure 7.1 shows the flowchart constructed
by James to summarise the procedures involved in the image processing pathway.
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Figure 7.1: Flow chart depicting the procedures involved in creating three-dimensional
models of human preimplantation embryos from confocal images.
Courtesy of James Michael.
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7.4 Results
The early intention of this project was to create a three-dimensional (3D) virtual
embryo using data derived from confocal image stacks of preimplantation human
embryos labelled with fluorescent probes. After fixing and labelling the embryos, as
described in section 2.11, I obtained multi-plane images using confocal microscopy
(see section 2.12). Data for a single embryo was available as a series of colour TIFF
files, each 512 pixels square. These images were stored together in individual
directories, and each image corresponded to a separate location on the z-axis. In
each original confocal image, blastomeres were coloured green (FITC), nuclei blue
(DAPI), and the background black. Each image is associated with a degree of
background noise as a result of out of focus fluorescence, which interferes with the
image resolution. Therefore, there is a need to pre-process the data to remove
noise and isolate the blastomeres from the background.
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7.4.1 Segmentation of the embryo
This section details the early attempts at edge detection and segmentation of the
images, and refinement of the process to improve output. Segmentation of human
preimplantation embryos began with simple single-cell images and progressed to
images of multi-cellular embryos, as shown in figure 7.2. Figure 7.2 (a) and (b)
shows the results of background detection (red line), additional edge detection
(pink lines), concave point detection (cyan circles), segmentation by connecting
concave points (white line), and detection of nuclei (yellow lines), with varying
results. Figure 7.2 (b) shows good segmentation of the cell boundary and
chromatin-containing bodies, although the polar body visible at the 11 o’clock
position has not been correctly identified as being separate from the cell. Figure 7.2
(c) shows reasonable outer edge detection for the blastomeres, but poor
segmentation. The blastomeres are separated by manual segmentation, although
this is a poor attempt, limited by the sensitivity of the mouse. Background noise in
the centre of the image shown in 7.2 (d) caused some incorrect pixel readings,
leading to inaccurate image segmentation, whilst better results were attained when
the background noise was reduced, although further reduction of the background
noise resulted in one of the blastomeres not being fully segmented. Figure 2.7 (e)
demonstrates the effect of a large amount of background noise, caused by confocal
detection of the blue colour of the DAPI mounting media. This also makes detection
of the nuclei difficult. Although the cell edges were detected in this image, the
result is generally poor. The image represented in figure 7.2 (f) also had a large
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amount of blue background noise; however by adjusting the parameters, a much
improved result could be achieved. Although the edges of all blastomeres were
separated from the background in this image, the cell boundaries were not fully
segmented. Adjustments to further refine the segmentation tool shows a
successfully segmented two-cell embryo, as shown in figure 7.2 (g).
[278]
(a) (b)
(c)
(d)
(e) (f) (g)
Figure 7.2: Segmentation of confocal images of human preimplantation embryos at
various stages of development.
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Figure 7.3 (a-c) shows early results of the edge detection method on confocal
images of fluorescently labelled blastocysts, showing poor detection of the whole
cells due to low contrast between cellular and background fluorescence, but well-
detected nuclei. Figure 7.3 (d) is an attempt at background detection of an early
blastocyst using an alternative technique.
(a)
(b)
(c) (d)
Figure 7.3: Edge detection in confocal images of human preimplantation blastocysts at
various stages of development.
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Following successful background and edge detection, circles approximating
individual cells and polar bodies were expanded and allocated a specific arbitrary
colour. Figure 7.4 shows examples of the colour-coding using this technique.
(a)
(c)
(b)
Figure 7.4: Circle detection, growth and colour coding of oocytes (a), (b) and the
individual blastomeres of an embryo (c).
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7.4.2 Visualising the three-dimensional structure of the embryo
A certain amount of trial and error was necessary to manually adjust the image
parameters, in order to gain segmented images that appeared correct by eye. At
this stage, automation could not account for the wide variability in image quality
and type, however, with manual intervention, appropriately segmented images
could be achieved.
Using these segmented images, three-dimensional versions were created, to
demonstrate the spatial structure of oocytes, cleavage stage embryos and
blastocysts. Figure 7.5 shows the preliminary results. Figure 7.5 (d) shows an early
3D model of individual blastomeres in a cleavage stage embryo, constructed using
the edge detection method. Some slices are incomplete, giving the impression that
some parts of the cells are missing. Figure 7.5 (e) demonstrates 3D modelling of all
of the nuclei present in a complete z-stack of a blastocyst, constructed using the
edge detection process.
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(a)
(b) (c)
(d) (e)
Figure 7.5: Three-dimensional plotting and rendering of segmented images of oocytes
(a), (b), blastomeres of an embryo (c), (d) and the nuclei in a blastocyst (e)
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7.4.3 Investigating the cell to nuclear volume in fixed specimens
The programming inititated by James Michael was continued by University of
Warwick MSc student Kieran Rafferty, resulting in the production of a segmentation
editor tool using concave corners to segment embryo images (Rafferty et al 2012).
Dr Czanner then moved away from Warwick to Manchester Metropolitan University
and Anna Mölder, a postgraduate researcher in his group, proceeded to improve
the segmenter and editor tool in order to facilitate the analysis of the confocal
images of embryos at various stages of development. For the preliminary stages of
this work using an early version of the software, four cleavage stage embryos and
six blastocysts that I had previously fixed and stained with actin, anti-STAT3 and
anti-leptin antibodies and imaged using the confocal microscope, were analysed
using the semi-automated embryo segmenter tool (Rafferty et al 2012). This
development improved the ability to resolve close and overlapping signals such as
cells or nuclei such that, despite the software having a number of practical
drawbacks and requiring labour-intensive manual modification of the
‘automatically’ analysed images, it was neverhteless possible then to address the
aim of analysing cell and nuclear volumes.
The cell and nuclear volumes of cleavage stage embryos, and the nuclear volumes
of cells identified as distinct populations in blastocysts, were measured and
compared. The cell populations identified were ICM and TE cells.
Figure 7.6 shows the cell volume (voxels) versus the nuclear volume (voxels) in
cleavage stage embryos. All blastomeres anaylsed were mononuclear, although a
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small number of blastomeres did contain micronuclei (n=2), however these were
ignored for the purpsose of this analysis.The nuclei in the 2-cell embryos (n=2)
comprised 1.9-2.5% of the total cell volume (mean=2.2%), whilst in a 4-cell embryo
(n=2), the nuclei comprised 2.4-5.7% of the total cell volume (mean=3.4%). Figure
7.6 (a) shows a day 2 frozen-thawed embryo where nucleus 1 comprises 2.5% of cell
1 and nucleus 2 comprises 1.9% of cell 2. Figure 7.6 (b) shows a day 2 fresh embryo,
where nucleus 1 comprises 2.1% of cell 1 and nucleus 2 comprises 2.1% of cell 2.
Figure 7.6 (c) shows a day 2 frozen embryo, with nucleus 1 comprising 2.5% of cell
1, nucleus 2 comprising 2.9% of cell 2, nucleus 3 comprising 2.4% of cell 3, and
nucleus 4 comprising 3.0% of cell 4. Figure 7.6 (d) shows a day 2 fresh 4-cell embryo
derived from a 3PN, where nucleus 1 comprises 5.7% of cell 1, nucleus 2 comprises
4.1% of cell 2, nucleus 3 comprises 3.3% of cell 3, and nucleus 4 comprises 3.4% of
cell 4.
The size of the cells versus the size of the nuclei is generally consistent, with smaller
cells having smaller nuclei relative to their volume. The exception in this example is
the 4-cell embryo derived from a 3PN, where the nucleus of cell 1 comprises almost
double the volume of the cell, and the nucleus of cell 2 comprises approximately
one third more of the volume of the cell, compared to the other two cells, which
are comparable to the cell/nuclear volume seen in 2PN embryos.
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(a)
(c)
(b)
(d)
Figure 7.6: Cell volumes versus nuclear volumes in cleavage stage embryos. The
embryos were fluorescently labelled with actin (green), anti-STAT3 or anti-leptin
antibodies, and DAPI (blue)
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7.4.5 Investigating the nuclear volumes in blastocysts
Figure 7.7 shows the differences in the nuclear volumes of cells in the ICM versus
the TE. There is a trend towards smaller nuclei in the ICM in comparison to the TE in
all blastocysts analysed. Figure 7.7 (a) shows a day 7 fresh blastocyst in which the
ICM cell nuclei are 26% of the volume of TE cells (or 74% smaller), although this
difference is not significant (p = 1.99; students t-test). Figure 7.7 (b) shows a day 6
fresh blastocyst with two distinct inner cell masses. The nuclei in ICM1 are 48%
smaller than those of the TE (p=3.7; students t-test), and the nuclei in ICM2 are 30%
smaller than the nuclei of the TE (p=0.005; students t-test). The inner nuclei,
defined as those furthest away from the TE inside the blastocoel, are visibly smaller
than the outer nuclei in the ICM. Figure 7.7 (c) shows the nuclei in the ICM versus
the TE of a day 7 fresh blastocyst. The nuclei in the ICM measure 20% smaller than
those in the TE, and appear visibly so (p=0.05; students t-test). Figure 7.7 (d) shows
the differences in the nuclei of the ICM compared to the TE in a day 7 fresh
blastocyst. The nuclei in the ICM are 35% smaller than the nuclei in the TE (p =
0.005; student’s t-test). Figure 7.7 (e) shows a day 7 fresh blastocyst in which the
volume of the ICM nuclei are 34% smaller than those of the TE (p = 0.001; students
t-test).
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(a)
(b)
(c)
(d)
(e)
Figure 7.7: Nuclear volumes in the ICM versus the TE of fresh blastocysts. ICM nuclei are
genrally smaller than TE cells in all blastocysts analysed
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7.4.5 Developing a semi-automated embryo analysis tool using live cell time
lapse imaging
Following implementation of the Embryoscope™ in the clinical Embryology
laboratory at CRM, and the subsequent increase in time lapse data available, I
collected suitable images and exported them to my colleague Anna Mölder at
Manchester Metropolitan University for processing. I worked closely with Anna
regarding the biological and clinical aspects of development of human
preimplantation embryos, current morphological markers of embryo quality, and
culture conditions in our laboratory. Images generated from live cells have much
less contrast than those from confocal microscope with fluorescent staining, so
whilst similar approaches were used, refined sensitivity was needed.
The primary aim was to utilise two-dimensional data from fixed cell confocal images
in combination with brightfield live cell images to construct simple three-
dimensional models of human embryos at varying stages of development (Mölder
et al 2016), in order to allow the visualisation of embryos in greater detail. Confocal
images were segmented as previously described (Rafferty et al 2012), and
reconstructed into three-dimensional models, as shown in section 7.4.2. Manual
selection of the ZP, individual blastomeres, and cell nuclei using the embryo
segmenter tool allowed for the visualisation of embryos in three dimensions, whilst
also permitting the study of connectivity between blastomeres (Mölder et al 2016).
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A further complexity of live cell imaging is that the embryoscope has up to 9 planes
of focus through the z-stack of the embryo at ~20µm thickness, but a maximum of 7
of these can be utilised without detriment to the embryo due to excessive exposure
to imaging. The degree of detail in the z-stacks was therefore greatly reduced in
comparison to the confocal versions, and extensive processing to remove out of
focus signals was necessary.
Further development of the preliminary program was undertaken to allow the semi-
automated detection of cell boundaries and nuclei in greyscale images obtained
from consecutive frames of live embryo images, using localised variation in the
distribution of brightfield image intensity. This would potentially permit faster and
more standardised analysis of large volumes of time lapse image data, with a view
to eventually identifying key developmental processes to aid in the selection of
viable preimplantation embryos for uterine transfer in the clinical setting. Optical
conversion of light and dark gradients on an even grey background results in the
edges of the images becoming the most prominent feature, and an increase in the
number of cell boundaries as the embryo divides results in a change in the
distribution of image intensity. The compaction stage of embryo development is
characterised by a loss of distinct cell boundaries, and a subsequent decrease in the
intensity of the greyscale, whilst cavitation causes an increase in intensity as the
edges of the cavity become apparent, followed by a decrease with the expansion of
the blastocoel (Mölder et al 2014). With this in mind, a region of interest in the
optimal focal plane was selected at each developmental stage, and the intensity of
the greyscale calculated in consecutive images using maximum and minimum
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variance. Superior quality embryos had a distinctive pattern of variance, with a
step-wise increase until a decrease at the compaction stage, and a further increase
as the blastocyst formed. Those embryos which were morphologically inferior, or
which exhibited chaotic cleavage or fragmentation had a greatly increased maximal
and minimal variance in the greyscale, and a much less ordered pattern (Mölder et
al 2014).
The computer-generated semi-automated analysis was compared to manual
annotations in order to determine the accuracy of the cell tracking during
development from syngamy to blastocyst formation. For the early developmental
stages up to 8 cells, the accuracy of both the computational analysis and the manual
analysis in detecting cell divisions were approximately 75%, although semi-
automated detection of blastocyst formation was less accurate, generating a false
positive result in ~28% of embryos (Mölder et al 2014). This work demonstrated
that semi-automated detection of key developmental events in human
preimplantation embryos may assist in the analysis of large volumes of time lapse
data to enable the clinical embryologist to reduce the amount of time spent
annotating images, and focus on fine tuning the process of embryo selection.
Throughout the development of the program, I provided clinical expertise in the
acquisition and interpretation of images, tested the reliability of the semi-
automated programme, annotated embryo images used in the programme and
validated each prototype version.
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7.5 Discussion
The visualisation of biological specimens in three-dimensions is a useful tool when
attempting to understand the mechanisms of development and/or abberant
behaviours. The investigation of the structure of complex multi-cellular specimens,
with the added bonus of accurate spatial resolution, is made possible with the
application of computational modelling (Klauschen et al 2009). Further
development of the semi-automated analysis tool may assist in generating reliable
and quantitative data to increase understanding of cell division patterns in relation
to clinical outcomes, and may improve our ability to select the most viable embryos
from a cohort from an early stage of development. This in turn will allow us to
predict embryos most likely to develop into a blastocyst, thus reducing multiple
gestations and maintaining clinical pregnancy and live birth rates, and improving
our outcomes with subsequent frozen embryo transfer cycles.
The development of semi-automated analysis of human embryo images is a
desirable prospect, particularly considering the increasing use of time lapse
technologies in clinical IVF laboratories worldwide. Annotation of images currently
involves a great deal of time and patience, and there is variability in the opinions of
operators in terms of the timings of completion of cell cleavage divisions,
commencement of compaction and cavitation, and expansion of the blastocoelic
cavity (Sundvall et al 2013). Those time lapse systems offering a semi-automated
analysis function are limited in their accuracy since they rely on the variations in
[292]
light intensity gradients that occur during cell cleavage, which are sometimes
confused with the occurrence of fragmentation and cellular reabsorption. The use
of dark field microscopy in such systems decreases the contrast of the images,
making it difficult to accurately correct the automated cell tracking manually when
necessary.
Eukaryotic cells have the ability to regulate their size and maintain nuclear volumes
that are appropriate to their developmental stage (Huber and Gerace 2007).
Throughout the cell cycle of budding yeast, the nucleus increases in volume (Umen
2005), and during the synthesis (S) phase, asynchronously growing mutant variants
maintain their constant nuclear/cell ratio at ~8% volume (Jorgensen et al 2007).
Studies regarding the nuclear/cell volume ratio in human preimplantation embryos
are scarce. In this project, as the cell number in cleavage stage human embryos
increases with each division round, there is a trend towards a higher percentage of
the cell being taken up by the nucleus. This is not unexpected, as although the cell
numbers are increasing, the voume of the embryo as a whole remains the same
until the commencement of cavitation (Hardarson et al 2012). This is
commensurate with murine studies, which demonstrated that whilst the
cytoplasmic volume of the embryo remains constant throughtout preimplantation
development, the nucleo-cytoplasmic ratio increases exponentially (Aiken et al
2004; Wennekamp et al 2013). A previous study has demonstrated that no
significant differences exist between chromosomally normal and chromosomally
abnormal embryos with regard to nuclear diameter, blastomere diameter, or
nuclear/cell ratio. However, the group did conclude that nuclei with missing
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chromosomes were significantly smaller than those with extra chromosomes
(Agerholm et al 2008). In this study, the embryo derived from a tripronucleate
zygote, known to have an abnormal chromosome complement, had two cells with a
higher cell to nuclear volume than those derived from normal 2PN zygotes. This
may be due to unequal division of the daughter cells during the first cleavage round
as a result of a tripolar spindle. The embryo derived from the 3PN zygote is of much
poorer quality than those derived from 2PNs, which may also explain the aberrant
cell to nuclear ratio.
Uneven embryo cleavage is negatively associated with implantation and pregnancy
rates, with those dividing unevenly having a higher likelihood of chromosomal
abnormalities and a higher number of multinucleated cells, which may interfere
with cytoskeletal function and cellular division (Hardarson et al 2001). The resulting
unequal distribution of cytoplasmic material in the daughter cells, particularly in the
case of polarised proteins, may cause disruption of embryonic axis establishment,
and may partially explain poor embryo development. Fragmentation is a commonly
used indicator of embryo viability (Hardarson et al 2003). Increasing degrees of
fragmentation in cleavage stage human embryos have been associated with a
significant reduction in total blastomere volume (Hnida et al 2004). Additionally,
binucleated blastomeres are reportedly significantly larger than their
mononucleated counterparts, indicating that uneven cell size may be associated
with multinucleation (Agerholm et al 2008), and embryos containing non-uniformly
sized blastomeres were more likely to be aneuploid and binucleated (Hardarson et
al 2001).
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Labelling fixed embryos with DAPI allows the visualisation of nuclear chromatin,
providing data on numbers of normal and abnormal nuclei, which are indicators of
embryo viability (Hardy 1999). Normal cell nuclei are characterised by a regular
rounded shape, with an even distribution of chromatin, whilst abnormal or
degenerating nuclei have fragmented or condensed chromatin, and may be
irregular in shape. Nuclei undergoing mitosis, the separation of chromosomes in the
nucleus prior to cell division, have a distinctive non-regular appearance.
During the transition to blastocyst, the human preimplantation embryo undergoes
compaction of the blastomeres, followed by cavitation and allocation of the cells
into two distinct cell populations; the inner cell mass and the trophectoderm
(Hardarson et al 2012). Cell division during expansion of the blastocyst increases
during this process, and the average good quality blastocyst contains upwards of 80
cells (Matsuura et al 2010). The results in this project indicate that some cells in the
blastocyst divide at a faster rate than others, and that these may be preferentially
allocated to the ICM.
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The initial idea for this project was to develop a computer-generated virtual embryo
using visual and mathematical data obtained from images of human
preimplantation oocytes, embryos and blastocysts, produced using fluorescently
labelled antibodies and high resolution confocal microscopy. The markers selected
would also provide insights into possible quality indicators and polarity markers of
embryos. Preliminary work conducted by my supervisor Professor Geraldine
Hartshorne suggested that the borders of cells in the preimplantation human
embryo could be sufficiently highlighted using fluorescent labelling of the
cytoskeletal protein F-actin. Whilst the resulting images were deemed unsuitable
for the development of computer-based models due to excessive variability, the
experiments did emphasise the importance of the actin cytoskeleton in the
maintenance of human preimplantation embryo development. Poor quality
cleavage stage embryos, such as those with slow or arrested development and
irregular shaped cells, had a disorganised actin cytoskeleton surrounding the
blastomeres, and actin-bound fragments. Good quality embryos displaying normal
temporal development and evenly shaped cells had distinct actin borders around
each blastomere and nucleus at the cleavage stage, at the flattened junctions of
compacting cells, and around the cells of the ICM and TE in blastocysts. Since actin
is known to have an important role in the regulation of cell division (Heng and Koh
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2010), it follows that the integrity of the actin cytoskeleton is important for normal
embryo development.
The purpose of investigating the distribution of leptin and STAT3 in human oocytes,
embryos and blastocysts, was to determine whether their previously reported
differential distribution within and between cells in both human and mouse
(Antczak and Van Blerkom 1997), could be used as a potential marker of
polarisation in preimplantation embryo development. This may have provided
evidence as to whether the allocation of cells to the ICM and TE in the blastocyst
may be pre-determined. Analysis of the images showed that, in agreement with
published data, leptin and STAT3 are co-localised in oocytes, with higher levels of
fluorescence at the periphery of the cell in comparison to the central cytoplasmic
region. However, in contrast, there was no difference in the fluorescence intensity
of either protein at the site of the PB versus the area opposite the PB. Similarly, in
cleavage stage embryos, leptin fluorescence was more intense at the periphery of
each blastomere than in the perinuclear region, whilst STAT3 fluorescence was
more intense in the perinuclear region compared to the peripheral region. In the
blastocyst, leptin staining was increased in the TE compared to the ICM, and
conversely STAT3 was increased in the ICM versus the TE. Therefore, whilst there
appears to be differential distribution of leptin and STAT3 within cytoplasmic
domains in the unfertilised oocyte and blastomeres of the cleavage stage embryo,
and in the ICM and TE cells of the blastocyst, the differences were non-significant,
and they did not seem to be co-localised after the first cell division, thus the results
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published by Antczak and Van Blerkom (1997) were not reproduced here and could
not be built upon in analysing polarity in human embryonic development.
Leptin, acting via the long form of the leptin receptor OB-RL, is known to be an
activator of STAT3, and activation of STAT3 in mouse oocytes can be induced by
exposure to exogenous recombinant leptin (Matsuoka et al 1999). In this project,
pSTAT3 fluorescence was observed at low levels of intensity in the ICM and TE of
human blastocysts, as has been previously reported in the mouse (Fedorcsak and
Storeng 2003). Exposure of human blastocysts to exogenous human recombinant
leptin protein for 10 minutes or more led to a significant increase in the relative
fluorescence intensity of pSTAT3 in the nuclei and cytoplasm of ICM cells, but not in
the cells of the TE. Interestingly, there was a significant increase in the total number
of TE cells in blastocysts that had been exposed to human recombinant leptin
protein for 10 minutes or more, which is in agreement with previously published
mouse data (Kawamura et al 2002).
The detection of OB-RL mRNA was confirmed in human pronucleate, cleavage stage
embryos and blastocysts. A non-significant increase in OB-RL mRNA levels was seen
in the blastocyst in comparison to pronucleate and cleavage stage embryos.
A number of interesting morphological features were observed in the fluorescently
labelled blastocysts. Free cells were seen in the blastocoelic cavity of around one
third of the blastocysts studied in this project. The similarities in relative
fluorescence intensity of pSTAT3 staining between these cells and those of the ICM,
along with the analysis of time-lapse image sequences, suggest that these cells
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originate from the ICM in human blastocysts. A similar proportion of blastocysts
exhibited excluded cells in the space between the trophectoderm and the ZP, and
these differed to free cells in that they had little fluorescent staining and were
degenerate in appearance. It is possible that both free cells and excluded cells are
part of an inherent self-correcting mechanism that excludes abnormal cells from the
implanting blastocyst. Cytoplasmic projections were seen in around one-third of
blastocysts, often traversing the entire diameter of the blastocoelic cavity, and
linking the ICM to the TE. One interesting theory is that they may serve as a direct
communication mechanism to maintain cell division of the mural TE following
migration to the abembryonic pole (Salas-Vidal and Lomeli 2004). Whilst previously
published data has suggested that these are indicative of reduced embryo viability
(Scott 2000), the majority of blastocysts with cytoplasmic projections in this project
were of superior quality, which certainly warrants further studies into the
implantation potential of such blastocysts. Double ICMs were observed in
approximately 5% of blastocysts, and have previously been linked with the
incidence of a monozygotic multiple order pregnancy (Meintjes et al 2001),
suggesting this as a useful morphological marker during selection of blastocysts
prior to uterine transfer. Micronuclei and chromosome-containing fragments may
be indicative of aneuploidy in human embryos (Chavez et al 2012), and may result
in developmental arrest (Kort et al 2015), thus the presence of micronuclei and
chromosome-containing fragments in cleavage stage embryos in this project may
also be utilised as a de-selection tool during microscopic assessment in the clinical
embryology laboratory.
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During the course of this project, decades after they were first proposed, time lapse
incubators of sufficient quality became available as a tool that could be applied
clinically for the monitoring and selection of embryos. The preliminary work in
chapter six of this thesis formed the basis of validation and implementation of time
lapse monitoring into clinical practice at the CRM.
Time lapse analysis of fresh and frozen-thawed human preimplantation embryos
showed that frozen-thawed embryos completed cleavages at a slower rate than
fresh embryos, significantly at the 2-cell, 3-cell, 4-cell, 7-cell and 8-cell completion
times, and at the commencement of blastocyst development. Frozen embryos have
previously been reported to develop at a slower rate than fresh, regardless of their
chromosomal status (Edirisinghe et al 2005). Frozen embryos created using
standard IVF developed at a significantly slower rate until the 5-cell stage, which is
in agreement with previous studies showing a delay in development after IVF in
comparison to ICSI derived embryos, particularly at the early cleavage stage (Van
Landuyt et al 2005). Fresh embryos that developed into blastocysts completed
cleavage into 2-cell and 4-cell significantly faster, and spent a significantly shorter
time at the 1-cell stage, emphasising the importance of early cleavage as a marker
of human embryo viability (Sakkas et al 1998). In contradiction to other reports,
those embryos developing into blastocysts spent a significantly longer time at the 7-
cell stage than those that arrested (Cetinkaya et al 2015), although published
reports into specific investigations of the 7-cell stage of development are rare, and
most concentrate on the total time taken to develop from the 5-cell to the 8-cell
stage (Desai et al 2014).
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Time lapse monitoring has provided insight into fascinating embryo behaviours
which would ordinarily be missed during microscopic assessment at 24-hourly
intervals, such as blastocyst collapse and expansion prior to hatching (Marcos et al
2015). Blastocyst hatching is initiated by the TE, and whilst hatching from the polar
region near the ICM was once considered more common, and indeed superior
(Sathananthan et al 2003), analysis of the spontaneous site of hatching in relation to
the position of the ICM in this project has shown that the initial site of hatching in
relation to ICM position has no apparent influence on clinical pregnancy and
implantation rates.
Removal of blastomeres from cleavage stage embryos for PGD is routine practice in
clinical embryology, and is reported not to be detrimental to continued
development (Brodie et al 2012); however knowing which cell to remove may prove
important for the future development of the embryo. In this project, time lapse
imaging was used to identify and track the first-dividing cell of a two-cell embryo,
and specifically damage the daughters of that cell in order to investigate whether
this would potentially disrupt the polar axes and affect blastocyst formation. The
blastocyst development rate did not appear to be affected in the damaged
embryos, and whilst they did commence compaction earlier and cavitation later
than non-damaged embryos, the differences were non-significant. It would have
been interesting to repeat the experiments with focus on the slowest-dividing
daughter cells; however the paucity of available zygotes unfortunately prevented
this.
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Several observations in the earliest of the time lapse studies presented in this thesis
appeared to predict embryo cleavage. Ruffling of the blastomere membranes,
cellular cytoplasmic movements, and rearrangement of blastomeres within the ZP
occurred in a significantly higher proportion of cryopreserved embryos that
subsequently cleaved, in comparison to those that did not. These findings are in
contrast to others (Athayde Wirka et al 2014); however the results described were
based upon relatively poor quality images from a time lapse system in
development, the use of which was subsequently discontinued in our lab.
The use of fluorescent images obtained during this project in the development of
three-dimensional computer-generated models was not as successful as originally
predicted. However, they laid the foundations for structural studies (Rafferty et al
2013), and along with manual analysis of time lapse image sequences, we were able
to begin developing predictive algorithms of human embryo development (Mölder
et al 2015; Mölder et al 2016).
The usefulness of temporal and spatial images may be improved by combining the
findings of both. The analysis of the developmental timings of abnormally fertilised
oocytes (1PN or MPN) in comparison with normally fertilised oocytes (2PN) showed
no significant differences in the cleavage completion times, although 2PNs did
complete compaction significantly faster than MPNs. Investigation of the cell to
nuclear volume in a 4-cell embryo derived from a 3PN using semi-automated
software, showed that the cell to nuclear volume seemed greater than in 4-cell
embryos derived from 2PNs. This suggests that, although the development of
abnormally fertilised embryos is indistinguishable from that of normally fertilised
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embryos by morphokinetics, they may be severely chromosomally compromised,
thus reinforcing the importance of identifying such embryos during fertilisation
assessment in the clinical embryology laboratory.
Human preimplantation embryo development is complex and unpredictable. The
findings of the research conducted during this project show that, whilst our
understanding of the growth and developmental mechanisms of human
preimplantation embryos has improved since the birth of Louise Brown (Steptoe
and Edwards 1978), there is still much to learn. In particular, my research has
highlighted the need for further studies of polarity in human embryos, the lack of
markers of developmental functionality, and the potential of computer-assisted
image analysis to improve our understanding and selection based upon quality of
embryos in the clinical setting.
Human embryos are curious and fascinating. New and exciting technologies are
constantly emerging, and more research into this extraordinary area of medicine is
essential to allow us to continue our mission to improve outcomes for our ever-
expanding patient population.
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